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ABSTRACT 
 
Metal–organic frameworks (MOFs) are newly emerging inorganic–organic hybrid 
porous materials with diverse crystalline structures, high surface areas, and tunable pores. 
This dissertation primarily focuses on design and synthesis of MOFs as well as the 
development of synthetic methodologies to target stable MOFs with desired 
functionalities.  
In the second section, a linker exchange strategy was developed as a route to 
functionalize a mesoporous MOF, PCN-333, through thermodynamic control. This 
strategy allowed a facile incorporation of a variety of functional groups into the 
mesoporous MOF without compromising integrity of the parent MOF.  
In the third section, a dual-exchange method was studied using a sequential linker 
exchange and metal metathesis on PCN-333(Fe) to achieve a chemically robust 
mesoporous Cr-MOF with desired functional group. Dual exchange showed the potential 
of this method to be a general approach to highly stable Cr-MOFs with desired functional 
groups upon selection of appropriate MOF template. 
In the fourth section, a new Zn-MOF, SO-PCN, was designed and synthesized as 
a host of two dye linkers. SO-PCN showed energy transfer between the 2D porphyrinic 
photosensitizer layer and the photochromic switch pillar in the framework. Using 
photochromic reaction of the linker in SO-PCN, a reversible control of singlet oxygen 
generation was demonstrated. The catalytic activity of SO-PCN was also studied for 
photooxidation of 1,5-dihydroxynaphthalene. 
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In the fifth section, a new synthetic strategy to incorporate multiple functional 
molecules within the MOF nanoparticles was demonstrated for control of 1O2 generation 
for PDT. This strategy was developed to improve several inherent limitations from SO-
PCN in the previous section. First, a Zr-MOF nanoplatform showed much improved 
stability in aqueous media, compatible under physiological conditions. This strategy 
allows for tuning of the ratios between the photosensitizer and the switch molecule within 
the Zr-MOF nanoparticles, thus enabling maximization of the 1O2 generation 
controllability. As a result, MOF nanoparticle formulation showed an enhanced PDT 
efficacy with superior 1O2 control compared to that of homogeneous molecular analogues. 
In the sixth section, size-controlled synthesis of Zr-based porphyrinic MOF 
nanoparticles was studied through a bottom-up approach. The study provided mechanistic 
insights about the size control of the porphyrinic Zr-MOF nanoparticles. Size-dependent 
cellular uptake and ensuing PDT efficacy were also investigated to optimize the size of 
the MOF nanoparticles for PDT. Additionally, folic acid modification on the Zr6 node in 
the MOF showed further enhanced PDT efficacy via active targeting, demonstrating 
multifunctional MOF nanoplatform. 
In summary, methodologies to allow functionalization of highly stable MOFs have 
been designed and studied. Conceptual utilizations of MOF nanoparticles for biomedical 
applications have also been demonstrated with stable MOF nanoparticles, showing the 
advantages of the MOF formulation. The findings in this dissertation provide design 
principle and possible options for preparing targeted MOFs as required in desired 
applications. 
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NOMENCLATURE 
 
2D two-dimensional 
3D three-dimensional 
BET Brunauer-Emmett-Teller 
DEF N,N-Diethyl Formamide 
DMF N,N-Dimethyl Formamide 
DMSO Dimethyl Sulfoxide 
EDS Energy-dispersive X-ray Spectroscopy  
FW Formula Weight 
MOF Metal–Organic Framework 
NMR Nuclear Magnetic Resonance 
PCN Porous Coordination Network 
PDT Photodynamic Therapy 
PSM Postsynthetic Modification 
PXRD Powder X-Ray Diffraction 
SEM Scanning Electron Microscopy 
TEM Transmission Electron Microscopy 
TGA Thermogravimetric Analysis 
XPS X-ray Photoelectron Spectroscopy 
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1. INTRODUCTION 
 As a new class of inorganic–organic hybrid materials, metal–organic frameworks 
(MOFs) have been rigorously explored as advanced porous materials.1 The limitless 
combination of organic and inorganic building blocks in MOFs allow diverse 3D 
crystalline structures with high internal surface area and well-defined molecular level of 
functionality with remarkable accessibility, thus making MOFs viable for various 
applications, which might have not been readily achievable from other conventional 
porous materials, including activated carbons, mesoporous silica, and zeolites.2-4 With 
these features, recently MOFs have become a useful tool for deciphering fundamental 
questions in chemistry, including a mechanistic study of a controversial intermediate with 
crystallographic analysis, a well-defined energy transfer platform, and gas storage and 
separation.5-7 
 
Figure 1.1 Topological illustration of representative 3D MOFs. 
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Unlike other conventional porous materials constructed from extremely robust 
covalent bonds or ionic bonds, however, prototypical MOFs suffered from weak chemical 
stability due to the relatively labile coordination bond and void space in the framework. 
Particularly, in the early stage of MOF development, the combination of hard base, 
carboxylate containing linkers (L) and soft acid metal species [M(II); M = Zn, Cu] has 
been extensively adopted, which results in labile M-L bonds according to hard soft acid 
and base (HSAB) theory.8,9 Consequently, most MOFs tend to undergo decomposition 
when applied in harsh chemical environments. Such instability has been the most 
challenging problem for early MOFs to be practically utilized. To maximize the utility of 
MOFs in various applications, therefore, their chemical stability has to be a prime 
consideration to guarantee their advantageous features to be fully utilized. To improve 
chemical stability of the MOFs, there are two major strategies commonly adopted: (1) 
using the combination of high valent metal species [e.g., Al(III), Fe(III), Cr(III), Zr(IV)] 
and carboxylate linkers, giving rise to robust M-L bonds from stronger electrostatic 
interaction; (2) a combination between soft acid metal species [e.g., Cu(II), Ni (II)] and 
soft base containing linkers, including imidazolate, pyrazolate, or thiolate, leading to 
stronger orbital interactions.10,11 As a result of robust M-L bonds in the framework, these 
MOFs exhibit extraordinary stability against attacks from reactive chemical species. 
Although the stability of MOFs was improved by involving robust M-L bonds, 
synthesizing these MOFs is very difficult because more stable M-L bonds are less 
reversible during the growth of MOFs, inhibiting crystallization.12 Aside from such 
synthetic difficulty to get stable MOFs, when functionalization is concerned for specific 
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use, obtaining highly crystalline products of stable MOFs out of the functionalized linkers 
from direct synthesis becomes extremely challenging for the following reasons. First, the 
preinstalled functionality on the linker is likely to undergo decomposition or side reactions 
under the harsh synthetic conditions of stable MOFs (e.g., high temperature and acidic 
environment).10 In addition, the functionalization prior to MOF synthesis could alter the 
molecular geometry of the linker, leading to undesired products. Therefore, development 
of synthetic strategies to obtain a stable MOF platform with both desired functionalities 
and wanted structure is of great importance in terms of exploring a broad applicability of 
MOFs. 
 Aside from the predesigned functions on the building blocks in the framework, the 
morphology and size of the MOFs could also play a critical role in many aspects of 
practical applications. In this regard, controllability of MOF nanoparticles can further lead 
to a fine-tuning of their properties with synthetic tunability to establish multiple 
functionalities into one platform. Therefore, the control of size and morphology of 
targeting MOFs is highly desired to optimize the performance of MOFs for target 
applications.13 
 While an extensive research effort has been made to discover new MOF structures, 
MOFs as a class of nanomaterials with such controllability have been significantly 
understudied, though the understanding of crystal growth could provide us insights to take 
the advantage of controllability of MOFs. Because MOF growth can be greatly simplified 
as traditional coordination chemistry using a ligand substitution process, studies of MOF 
growth could provide important insights about their controlled growth both in morphology 
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(phase selectivity) and size. Together with the findings in chemical stabilization and 
functionalization of stable MOFs, understanding of MOF nanocrystal growth control 
could thus prove a powerful tool for optimization of materials and further grant this class 
of materials to be promising in desired applications. 
 
 
 
Figure 1.2 Routes to functionalized stable MOF nanoplatform. 
 
 In this dissertation, synthetic methodologies to tackle the challenges mentioned 
above in targeting specific MOFs have been developed. Starting from questioning MOF 
growth process, the understanding of MOF growth via thermodynamics and kinetics 
analysis in MOF systems is discussed. Two approaches to achieve highly stable MOFs 
with desired functionality were developed via postsynthetic dual exchange and in situ 
incorporation of multiple functionalities. Through combination of the presented synthetic 
strategies, fine-tuning of the MOF products, including their size, morphology, and tunable 
function-density of the multiple functional species in the MOF, has been realized. As a 
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result, judiciously designed MOFs were successfully demonstrated for biomedical 
applications (i.e., photodynamic therapy) where stability, functionality, and controllability 
allowed for screening of the best performing materials.  
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2. STRUCTURE-ASSISTED FUNCTIONAL ANCHOR IMPLANTATION IN 
ROBUST METAL‒ORGANIC FRAMEWORKS WITH ULTRALARGE PORES* 
2.1 Introduction 
 Ordered mesoporous materials have been extensively studied because of their 
potential toward practical applications including heterogeneous supports for catalysis, 
separation, enzyme immobilization, drug delivery, and sensing taking advantage of their 
high surface areas and large pores.3,14-17 In particular, for large guest molecules such as 
organometallic species, nanoparticles, and enzymes the mesoporosity is of great 
importance.18,19 Traditional mesoporous materials including mesoporous silica, 
mesoporous carbon, and metal oxides have paved the ways for such applications, but there 
are major limitations to these materials such as lack of structural diversity (e.g., pore 
geometry) and versatile functionality. Moreover, to effectively prevent leaching of the 
immobilized species, postsynthetic modification of functional groups to covalently anchor 
the guest species is highly desired. However, it has been challenging due to the lack of 
easily modifiable sites in these traditional mesoporous materials.20-22 
 In the last two decades, metal–organic frameworks (MOFs) have emerged as a 
class of promising organic–inorganic hybrid materials that are composed of metal 
ions/clusters and bridging organic linkers.1 Due to their tunable structures derived from a 
judicious selection of inorganic building blocks and the molecular-level design of organic 
linkers, MOFs can provide tailor-made structures for desired applications compared with 
                                                
*Reproduced with permission from Park, J.; Feng, D.; Zhou, H.-C., J. Am. Chem. Soc. 2015, 137, 1663–
1672. Copyright 2015 American Chemical Society. 
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conventional mesoporous materials.23-25 Apart from the structural diversity of MOFs, their 
three-dimensional (3D) cavities can facilitate the accessibility of the guest molecules. 
Therefore, mesoporous MOFs with predesigned covalent anchors (pendant functional 
groups) can serve as ideal platforms to immobilize functional species. 
 However, most MOF materials reported to date are mainly restricted to a 
microporous regime.26-35 Even for mesoporous MOFs, the accommodation of large 
molecules into the pores such as bulky catalysts or enzymes is challenging because such 
large entities will take up a substantial volume of the pore.10,36 As a result, efficient 
diffusion is slowed, and the accessibility of incoming species will be reduced substantially. 
In addition, introduction of covalent anchors could further reduce the original pore size, 
leaving even less space to immobilize large species. Most importantly, an excellent 
stability of the framework is a prerequisite to guarantee the framework intactness, 
especially with inclusion of immobilized guests working in harsh conditions. However, 
most reported mesoporous MOFs show relatively weak chemical stability.37-39 Therefore, 
stable MOFs with ultralarge pores and functional groups are highly desired. 
 Herein we report a facile route to functionalize PCN-333(M) (M = Fe and Sc), a 
robust MOF isoreticular to MIL-100 with ultralarge pores (∼5.5 nm), via postsynthetic 
ligand exchange that is assisted by structural integrity of PCN-333. A wide range of 
functional groups were introduced into the PCN-333(M) while maintaining the porosity 
and crystallinity of the parent framework. Furthermore, several experiments were 
performed to illustrate a better understanding of the ligand exchange process in PCN-
333(Fe). Ultimately, introduction of a secondary functional group into functionalized 
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PCN-333 was successfully demonstrated through click chemistry. These findings will 
allow for functionalized PCN-333(M) to be used as a useful scaffold for a variety of 
promising applications by taking advantage of facile functionalization, framework 
robustness, and ultralarge pores which allow for more possible chemistry within the MOF. 
2.2 Experimental section 
Materials 
 All starting materials and solvents were used as received without further 
purification from commercial suppliers. (Alfa Aesar, Sigma-Aldrich, TCI America, 
Cambridge Isotope, Oakwood Products) Silica gel (40−42 µm) was purchased from 
Silicycle Inc. The abbreviation for some solvents and reagents were listed here: 1,2-
Dimethoxyethane (DME), CH2Cl2 (DCM), N,N-dimethylformamide (DMF), N,N-
diethylformamide (DEF), dimethylsulfoxide (DMSO), and tetrahydrofuran (THF). 
Instrumentation  
 Synthetic manipulations that required an inert atmosphere (where noted) were 
carried out under nitrogen using standard Schlenk techniques. Nuclear magnetic resonance 
(NMR) spectra were recorded on Mercury 300 spectrometer and Varian Inova 500 
spectrometer. The chemical shifts are given in units of δ (ppm) relative to 
tetramethylsilane (TMS) where δ (TMS) = 0, or referenced to the residual solvent 
resonances. Splitting patterns are denoted as s (singlet), d (doublet), t (triplet), q (quartet), 
m (multiplet), and br (broad). Powder X-ray diffraction (PXRD) was carried out on a 
Bruker D8-Focus Bragg-Brentano X-ray powder Diffractometer equipped with a Cu 
sealed tube (λ = 1.54178) at 40 kV and 40 mA. Thermogravimetric analyses (TGA) were 
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conducted on a Shimadzu TGA-50 thermogravimetric analyzer from room temperature to 
600 °C at a ramp rate of 2 °C/min in a flowing nitrogen atmosphere. Fourier transform 
infrared (IR) measurements were performed on a Shimadzu IR Affinity-1 spectrometer. 
Fluorescence spectra were recorded on PTI QuantaMaster series spectrofluorometer. N2 
adsorption-desorption isotherms at 77 K were measured by using a Micrometritics ASAP 
2420 system. A high-purity grade (99.999%) of gases was used throughout the adsorption 
experiments. Prior to adsorption measurement, the sample was activated by solvent 
exchange (in several cycles using fresh acetone), followed by degassing at elevated 
temperature (150 °C) for 5 h. 
Synthesis 
 General procedure of hydrolysis: To a round bottomed flask, methyl ester 
compound (~500 mg) was dissolved in a mixture of THF and MeOH (100 mL, v/v = 
1:1), and 50 mL 2 M KOH solution was added. The mixture was stirred and refluxed 
overnight at 40 °C. The organic phase was evaporated under reduced pressure. The 
resulting aqueous phase was diluted to ca. 100 mL and acidified with 6 M HCl. 
Resulting precipitates were collected, washed thoroughly with water, and dried to 
afford corresponding acid products. 
 
Scheme 2.1 Synthetic scheme of L1. 
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 2,4,6-tri-p-tolyl-1,3,5-triazine (1). To a three neck flask, AlCl3 (20 g) was 
dissolved in dry toluene and heated to 60 °C. C3N3Cl3 (S1, 8.3 g) was then added 
portionwise for an hour and the mixture was stirred overnight. Then resulting red sticky 
oil was poured into a large amount of ice water to quench the catalyst and extracted with 
CHCl3. After removing solvent, a crude product was precipitated out from methanol to 
yield a needle-like solid. Resulting solid was recrystallized from hot toluene to afford a 
white needle-like crystalline solid (10 g, 63%). 1H NMR (300 MHz, CDCl3): δ = 8.64 (d, 
6 H), 7.35 (d, 6 H), 2.46 (s, 9 H). 
 4,4′,4′′-s-triazine-2,4,6-triyl-tribenzoic acid (L1). To a 500 mL three-necked 
flask 1 (2.78 g) was dissolved in acetic acid (70 mL) and then 4.4 mL of H2SO4 was added. 
A solution of chromium oxide (7.2 g) in acetic anhydride (4.8 mL) was carefully added 
into the reaction flask with an ice bath. The resulting dark-green slurry was stirred 
overnight. The reaction mixture was poured into 250 mL cold water, stirred 1 h to well 
mixed, and filtered. The solids were washed with water to remove chromium acid. 
Dissolve the white solid in 200 mL 2 M NaOH solution. After the unreacted starting 
material was removed by filtration, the solution was acidified with 6 M HCl solution to 
give white crude product (until pH < 3). Resulting crude product was then filtered and 
dried. Recrystallization from DMF afforded pure product as a white solid (3.0 g, 86%). 
1H NMR (500 MHz, DMSO-d6): δ = 13.35 (s, 3 H), 8.85 (d, 6 H), 8.20 (d, 6 H). 
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Scheme 2.2 Synthetic scheme of L2. 
 
L2 was synthesized according to the literature procedure. 1H NMR (500 MHz, DMSO-
d6): δ = 8.09 (d, 6H), 8.06 (d, 6H), 8.04 (s, 3H). 
 
 
Scheme 2.3 Synthetic scheme of L3. 
 
 Dimethyl 2'-hydroxy-5'-(4-(methoxycarbonyl)phenyl)-[1,1':3',1''-terphenyl]-
4,4''-dicarboxylate (3). A mixture of 2,4,6-tribromophenol (S4, 3 g, 9.06 mmol), (4-
(methoxycarbonyl)phenyl)boronic acid (S3, 14.6 g, 91.1 mmol), Na2CO3 (6.7 g, 63.2 
mmol), Pd(OAc)2 (200 mg, 5 mol%) were dissolved in distilled water (100 mL) and 
degassed DMF (100 mL), and heated to 60 °C overnight under nitrogen atmosphere. 
Afterwards, the reaction mixture was poured into water, and pH value was adjusted to ~ 
5. The resulting crude was filtered and washed with water. The crude product was purified 
by flash column chromatography on silica gel using progressively more polar to 1:1 
mixture of hexanes: EtOAc as the mobile phase to afford 3 as a pale pink solid (3.6 g, 
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80%). 1H NMR (300 MHz, CDCl3): δ = 8.17 (d, 4H), 8.10 (d, 2H), 7.68 (m, 6H), 7.59 (s, 
2H), 3.95 (s, 9H). 
 5'-(4-carboxyphenyl)-2'-hydroxy-[1,1':3',1''-terphenyl]-4,4''-dicarboxylic 
acid (L3). Compound 3 (500 mg) was hydrolyzed by following the general procedure 
described above to afford L3 a light-brown solid (410 mg, 90%). 1H NMR (500 MHz, 
DMSO-d6): δ = 12.95 (s, 3H), 8.02 (d, 4H), 7.97 (d, 2H), 7.87 (d, 2H), 7.77 (d, 4H), 7.65 
(s, 2H). 
 
 
Scheme 2.4 Synthetic scheme of L4. 
 
 Dimethyl 2'-amino-5'-(4-(methoxycarbonyl)phenyl)-[1,1':3',1''-terphenyl]-
4,4''-dicarboxylate (4). A mixture of 2,4,6-tribromoaniline (S4, 3.3 g, 10.0 mmol), 4-
(methoxycarbonyl)phenyl)boronic acid (S3, 7.2 g, 40.0 mmol), CsF (6.0 g, 40.0 mmol), 
Pd(PPh3)4 (578 mg, 5 mol%) were dissolved in degassed 1,2-dimethoxyethane (300 mL), 
and heated to 130 °C to reflux overnight for 3 d under nitrogen atmosphere. Afterward, 
the solvent was dried under reduced pressure. The residue was washed with distilled H2O 
and then extracted with CH2Cl2 followed by drying with anhydrous MgSO4. After the 
solvent was removed, the crude product was purified by flash column chromatography on 
a silica gel (hexanes: EtOAc = 5: 1) to afford 4 as a light brown solid (4.16 g, 84%). 1H 
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NMR (300 MHz, CDCl3): δ = 8.18 (d, 4H), 8.08 (d, 2H), 7.66 (m, 6H), 7.45 (s, 2H), 3.96 
(s, 9H). 
 2'-amino-5'-(4-carboxyphenyl)-[1,1':3',1''-terphenyl]-4,4''-dicarboxylic acid 
(L4). Compound 4 (500 mg) was hydrolyzed by following the general procedure 
described above to afford L4 as a light-brown solid (435 mg, 95%). 1H NMR (300 MHz, 
DMSO-d6): δ = 8.10 (d, 4H), 7.98 (d, 2H), 7.85 (d, 2H), 7.74 (d, 4H), 7.52 (s, 2H), 4.74 
(s, 2H). 
 
Scheme 2.5 Synthetic scheme of L5. 
 
 Azido-2-bromoethane (9). To dibromoethane (S5, 5 g, 27 mmol) dissolved in 
DMF (18 mL) sodium azide (1. 04 g, 16 mmol) was added portion-wise for 4 h. The 
reaction was then diluted with ether and the organic layer was washed with water. The 
organic layer was dried with MgSO4 and concentrated under vacuum to afford 9 as a pale 
yellow oil (2.95 g, 73%). 1H NMR (300 MHz, CDCl3) δ = 3.72-3.62 (m, 2H), 3.48 (t, 2H).  
 Dimethyl 2'-(2-azidoethoxy)-5'-(4-(methoxycarbonyl)phenyl)-[1,1':3',1''-
terphenyl]-4,4''-dicarboxylate (5). To a solution of compound 3 (500 mg, 1.07 mmol) 
and K2CO3 (442.6 mg, 3.195 mmol) in DMF (8 mL) was added compound 9 (800 mg, 
5.35 mmol). The mixture was stirred at 60 °C 12 hours, and water was added. Afterwards, 
the crude product was extracted with dichloromethane and dried under reduced pressure. 
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The crude product was purified by flash column chromatography (hexanes: EtOAc = 6:1) 
to afford 5 as a pale yellow oil (574 mg, 95%). 1H NMR (500 MHz, DMSO-d6): δ = 8.08 
(dd, 4H), 8.04 (d, 2H), 8.00 (d, 2H), 7.88 (dd, 4H), 7.83 (s, 2H), 3.96 (s, 9H), 3.13 (t, 2H), 
3.05 (t, 2H). 
 2'-(2-azidoethoxy)-5'-(4-carboxyphenyl)-[1,1':3',1''-terphenyl]-4,4''-
dicarboxylic acid (L5). Compound 5 (380 mg) was hydrolyzed by following the general 
procedure described above to afford L5 as an ivory solid (350 mg, 99%). 1H NMR (500 
MHz, DMSO-d6): δ = 13.04 (br, 3H), 8.05 (dd, 4H), 8.01 (d, 2H), 7.95 (d, 2H), 7.84 (dd, 
4H), 7.79 (s, 2H), 3.52 (t, 1H), 3.32 (t, 1H), 3.13 (t, 1H), 3.05 (t, 1H). 
 
 
Scheme 2.6 Synthetic scheme of L6. 
 
 Dimethyl 2'-(allyloxy)-5'-(4-(methoxycarbonyl)phenyl)-[1,1':3',1''-
terphenyl]-4,4''-dicarboxylate (6). To a solution of compound 3 (600 mg, 1.208 mmol) 
and K2CO3 (501 mg, 3.63 mmol) in DMF (8 mL) was added S6 (365.4 mg, 3.02 mmol). 
The mixture was stirred at 65 °C 12 hours, and water was added. Afterwards, the crude 
product was extracted with dichloromethane and dried under reduced pressure. Resulting 
crude product was purified by flash column chromatography (hexanes: EtOAc = 6.5:1) to 
afford 7 as a white oil (520 mg, 80%). 1H NMR (500 MHz, CDCl3): δ = 8.11 (dd, 6H), 
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7.74 (d, 4H), 7.70 (d, 2H), 7.62 (d, 2H), 5.39 (qd, 1H), 4.89 (d, 1H), 4.84 (d, 1H), 3.96 (s, 
9H), 3.74 (d, 2H). 
 2'-(allyloxy)-5'-(4-carboxyphenyl)-[1,1':3',1''-terphenyl]-4,4''-dicarboxylic 
acid (L6). Compound 6 (500 mg) was hydrolyzed by following the general procedure 
described above to afford L6 a light-yellow solid (460 mg, 100%). 1H NMR (500 MHz, 
DMSO-d6): δ = 13.03 (br, 3H), 8.04 (d, 4H), 8.00 (dd, 2H), 7.95 (d, 2H), 7.83 (d, 4H), 
7.78 (s, 2H), 5.40 (qd, 1H), 4.90 (d, 2H), 3.75 (d, 2H). 
 
Scheme 2.7 Synthetic scheme of L7. 
 
 Dimethyl 5'-(4-(methoxycarbonyl)phenyl)-2'-(prop-2-yn-1-yloxy)-[1,1':3',1''-
terphenyl]-4,4''-dicarboxylate (7). To a solution of compound 3 (500 mg, 1.07 mmol) 
and K2CO3 (414.6 mg, 3.21 mmol) in DMF (8 mL) was added S7 (238 mg, 2.14 mmol). 
The mixture was stirred at 60 °C 12 hours, and water was added. Afterwards, the crude 
product was extracted with dichloromethane and dried under reduced pressure. Resulting 
crude product was purified by flash column chromatography (hexanes: EtOAc = 6:1) to 
afford 7 as a pale yellow oil (519 mg, 96%). 1H NMR (300 MHz, DMSO-d6): δ = 8.17-
8.05 (m, 6H), 7.76 (d, 4H), 7.68 (d, 2H), 7.63 (d, 2H), 3.96 (s, 9H), 3.93 (s, 2H), 2.13 (s, 
1H). 
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 5'-(4-carboxyphenyl)-2'-(prop-2-yn-1-yloxy)-[1,1':3',1''-terphenyl]-4,4''-
dicarboxylic acid (L7). Compound 7 (510 mg) was hydrolyzed by following the general 
procedure described above to afford L7 a light-yellow solid (465 mg, 99%). 1H NMR 
(500 MHz, DMSO-d6): δ = 8.01 (m, 4H), 7.97 (d, 2H), 7.86 (d, 2H), 7.75 (d, 4H), 7.72 (s, 
2H), 3.95 (d, 2H), 3.24 (t, 1H). 
 
 
Scheme 2.8 Synthetic scheme of L8. 
 
 (R)-dimethyl 5'-(4-(methoxycarbonyl)phenyl)-2'-(2-methylbutoxy)-
[1,1':3',1''-terphenyl]-4,4''-dicarboxylate (8). To a solution of compound 3 (2.0 g, 4.28 
mmol) and K2CO3 (0.7 g) in DMF (30 mL) was added S8 (1.2 g). The resulting mixture 
was heated to 60 °C for 12h. The crude mixture was extracted with dichloromethane, 
washed thoroughly with water, and dried to afford 8 as an ivory powder (2.1 g, 93%). 1H 
NMR (CDCl3) δ = 8.11 (m, 6H), 7.72 (m, 6H), 7.61 (s, 2H), 3.95 (m, 9H), 3.05 (m, 2H), 
1.24 (m, 1H), 1.01 (m, 1H), 0.78 (m, 1H), 0.49 (m, 6H). 
 (R)-5'-(4-carboxyphenyl)-2'-(2-methylbutoxy)-[1,1':3',1''-terphenyl]-4,4''-
dicarboxylic acid (L8). Compound 8 (500 mg) was hydrolyzed by following the general 
procedure described above to afford L8 a white solid (400 mg, 86%). 1H NMR (500 MHz, 
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DMSO-d6) = 13.01 (br, 3H), 8.02 (m, 6H), 7.94 (d, 2H), 7.81 (d, 4H), 7.78 (s, 2H), 3.05-
2.98 (ddd, 2H), 0.95 (m, 1H), 0.76 (m, 2H) ,0.46 (d, 3H) ,0.37 (t, 3H). 
 
 
Scheme 2.9 Synthetic scheme of 14. Reagents and conditions a) i) TFA, THF, 12 h, r.t., 
ii) DDQ, CH2Cl2, 5 h, r.t., iii) TEA, BF3·OEt2, 12 h, r.t., 49%; b) propargyl bromide, 
K2CO3, acetone, 12 h, reflux. 
 
 5,5-difluoro-10-(4-hydroxyphenyl)-1,3,7,9-tetramethyl-5H-dipyrrolo[1,2-
c:2',1'-f][1,3,2]diazaborinin-4-ium-5-uide (13). To a solution of S11 (1 g, 8.19 mmol) 
and 2,4-dimethylpyrrole (1.85 mL, 18.02 mmol) in THF (150 mL) was added several 
drops of trifluoroacetic acid under a nitrogen atmosphere. The mixture was stirred at 
ambient temperature for 6 h, and the solution of 2,3-dichloride-5,6-dicyano-p-
benzoquinone (2.05 g, 9.01 mmol) in THF (100 mL) was added. The resulting mixture 
was stirred continuously for another 5 h. After the addition of triethylamine (25 mL) and 
BF3·OEt2 (31 mL) dropwise to the reaction mixture with an ice-water bath, the mixture 
was kept stirring at ambient temperature overnight, then filtered through Celite. The crude 
compound was washed with CH2Cl2 and the combined filtrate was evaporated to dryness. 
The residue was re-dissolved in CH2Cl2 and the solution was washed with 15% aqueous 
NaHCO3 solution followed by water. The organic portion was dried over anhydrous 
MgSO4, then evaporated. The crude product was purified by column chromatography on 
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silica gel using progressively more polar 50:1 to 9:1 (hexanes: EtOAc) as a mobile phase 
to afford 13 as an orange solid (1.2 g, 43%). 1H NMR (500 MHz, CDCl3): δ = 7.15 (d, 
2H), 6.97 (d, 2H), 5.99 (s, 2H), 4.95 (br, 1H), 2.56 (s, 6H), 1.45 (s, 6H). 
 5,5-difluoro-1,3,7,9-tetramethyl-10-(4-(prop-2-yn-1-yloxy)phenyl)-5H-
dipyrrolo[1,2-c:2',1'-f][1,3,2]diazaborinin-4-ium-5-uide (14). To a solution of 
compound 13 (300 mg, 0.882 mmol), K2CO3 (609.5 mg, 4.41 mmol) in dried acetone (100 
mL) was added propargyl bromide (524 mg, 4.41 mmol). The mixture was heated to 55 °C 
and stirred for 12 h. Resulting mixture was evaporated to dryness and purified by column 
chromatography on silica gel using progressively more polar 50:1 to 15:1 (hexanes: 
EtOAc) as an eluent to afford 14 as a deep pink solid (175 mg, 53%). 1H NMR (500 MHz, 
CDCl3): δ = 7.20 (d, 2H), 7.09 (d, 2H), 5.98 (s, 2H), 4.76 (d, 2H), 2.55 (s, 6H), 2.17 (s, 
1H), 1.42 (s, 6H). 
 Synthesis of PCN-333(Fe). H3TATB (60 mg), anhydrous FeCl3 (60 mg), and 
trifluoroacetic acid (0.6 mL) were dissolved in 10 mL of DEF. The mixture was heated in 
150 °C oven for 12 h until a brown precipitate formed. The resulting brown precipitate 
was centrifuged and washed with fresh DMF several times. Yield (based on ligand) = ~ 
85%. 
 Synthesis of PCN-333(Sc). H3TATB (80 mg) and anhydrous ScCl3·6H2O (200 
mg) were dissolved in 10 mL of DMF. The mixture was heated in 150 °C oven for 2 h 
until a white precipitate formed. The resulting white precipitate was centrifuged and 
washed with fresh DMF several times. Yield (based on ligand) = ~ 85%. 
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 Direct synthesis of PCN-260. BTB (10 mg), FeCl3 or Fe2CoO(CH3COO)6 (10 
mg), and acetic acid (0.25 mL) in 2 mL of NMP were ultrasonically dissolved in a Pyrex 
vial. The mixture was heated in 150 °C oven for 24 h. After cooling down to room 
temperature, dark brown crystals were harvested by filtration. 
 Direct synthesis of PCN-262. OH-BTB (10 mg), FeCl3 or 
Fe2NiO(CH3COO)6 (10 mg), and acetic acid (0.20 mL) in 2 mL of DMF were 
ultrasonically dissolved in a Pyrex vial. The mixture was heated in 150 °C oven for 15 h. 
After cooling down to room temperature, dark brown crystals were harvested by filtration. 
General procedure for ligand exchange of PCN-333(Fe)  
 First, synthesized PCN-333(Fe) (ca. 50 mg) was thoroughly washed with hot 
DMF, and the isolated sample was then incubated with a stock solution of BTB or BTB 
derivatives (50–55 mg in DMF) at different temperatures (rt, 85 °C, 100 °C). Upon 
completion of ligand substitution, the supernatant was removed to examine whether there 
was TATB that came from the parent MOF after the exchange of ligand. The aliquot of 
supernatant was filtered through a syringe filter to exclude the possibility of exchanged 
PCN-333(Fe) crystals remaining, and ligands were recovered by acidification with few 
drops of 1 M HCl, followed by washing with water. The resulting precipitates were dried 
and analyzed by 1H NMR spectroscopy. 
MOF digestion  
 Approximately 15 mg of each ligand exchanged PCN-333(Fe) sample was 
digested with 37% HCl, refluxed overnight, and washed with water until a neutral pH was 
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reached. DMSO-d6 (0.6 mL) was added to dissolve the ligands. The 1H NMR spectrum 
(500 MHz) of exchanged PCN-333(Fe) was collected at room temperature (∼21 °C). 
Click reaction  
 Compound 14 (5 mg) was added to a mixture of azide-BTB exchanged PCN-
333(Sc) (10 mg) and CuI (0.5 mg) in THF (1.0 mL) in a 4 mL vial. The reaction mixture 
was stirred at 60 °C for 20 h. The resulting precipitate was collected by centrifugation, 
washed thoroughly with DMF followed by acetone, and dried to afford a light brown solid 
in quantitative yield. 
2.3 Results and discussion  
 
Figure 2.1 Structure of PCN-333 with three different cages. (a) Structure of PCN-333 
with three different cages. (b) Structure of PCN-262, direct synthesis product from OH-
BTB. 
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Direct synthesis of isoreticular structure of functionalized PCN-333(Fe) 
 Most recently, our group reported a mesoporous MOF, PCN-333, which consists 
of a trimeric metal cluster and tritopic linker, 4,4′,4″-s-triazine-2,4,6-triyl-tribenzoic acid 
(TATB).40 PCN-333 [M3O(OH)(TATB)2] (M = Fe, Al, Sc) exhibits the largest cage of 5.5 
nm among all reported MOFs (Figure 2.1). Meanwhile, the trivalent metal nodes endow 
PCN-333 with excellent chemical stability allowing for its utilization under harsh 
conditions. Therefore, decoration of PCN-333 with covalent anchors would provide a 
great platform to immobilize versatile functional species, especially those in the 
nanoscale, which cannot be successfully accomplished by other MOFs. 
 
 
Scheme 2.10 (a) Library of ligands involved in exchange in PCN-333. (b) Schematic 
illustration of solid-liquid phase ligand exchange. 
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 Having examined the PCN-333 structure, we chose 1,3,5-benzenetribenzoic acid 
(BTB) to exchange TATB due to the structural resemblance including molecular size and 
connectivity. As a result of the 2-position on the central benzene ring of BTB allowing for 
chemical derivatization (Scheme 2.10a), the functionalized BTB derivative was expected 
to introduce various covalent anchors into the mesoporous PCN-333. A series of ligands 
bearing different functional groups were synthesized. The covalent anchor was designed 
to occupy only a small portion of the pores while leaving most space available for the 
immobilization of large guest species. Therefore, we intuitively attempted a direct 
synthesis of functionalized PCN-333 from preinstalled functional groups on the BTB 
derivatives. Direct synthesis was performed by using the kinetically tuned dimensional 
augmentation (KTDA) method with preformed cluster Fe3(O)(CH3COO)6 as a starting 
material to obtain isoreticular structures of PCN-333 with BTB and OH-BTB.41 Although 
large single crystals of Fe-MOFs, PCN-260, and PCN-262 were harvested, respectively, 
single crystal X-ray diffraction revealed different structures even in the presence of the 
same inorganic building block, Fe3(O)(COO)6, as in PCN-333 (Figure 2.1b). 
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Figure 2.2 Scheme of ligand exchange in (a) supertetrahedron in PCN-333. (b) One face 
of supertetrahedron in PCN-333 showing the distance (top) and the angle (bottom) in the 
bent geometry. (c) Schematic illustration of M-O dissociation. 
 
 As shown in Figure 2.2a, the structure of PCN-333 is built from a supertetrahedron 
unit, of which each face is a TATB linker. Although TATB does not adopt 
perfect D3h symmetry in the framework, six oxygen atoms on TATB reside in the same 
plane which gives rise to a stable tetrahedral cage in C3v symmetry from bent geometry 
(Figure 2.2b). However, coplanar D3h symmetry of BTB is highly energetically unfavored 
due to the repulsion between H atoms on the central benzene ring and the three peripheral 
benzene rings. With BTB derivatives, the attached functional groups on the central 
benzene ring would cause additional steric hindrance resulting in even higher energy of 
the coplanar geometry. Considering in situ MOF synthesis, when possible inorganic nodes 
have a negligible energy difference, a major product is dominated by energy demands of 
linkers. Because free rotation of single bonds in the BTB derivative allows the linker to 
stay in a lower energy conformation in solution, TATB and BTB derivatives could lead to 
different structures with the same inorganic node, Fe3(O), where preferential conformation 
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of linkers dominates the final products. Although the isostructure of PCN-333 constructed 
with BTB has been reported,35 the functionalized isoreticular structure of PCN-333 cannot 
be achieved through the direct synthetic approach. 
Structure-assisted ligand exchange process 
 Due to ligand conformation dominating the framework growth process in direct 
synthesis leading to an unwanted structure, we turned to the postsynthetic ligand exchange 
method.42-64 Postsynthetic ligand exchange (PSE) and solvent-assisted linker exchange 
(SALE) have appeared as powerful routes to modify a parent MOF in which the ligand 
exchange occurs in relatively stable MOFs with a functionalized incoming ligand. For 
instance, Cohen and co-workers studied ligand exchange in UiO-66(Zr), and several MIL 
series with bromo and amino analogues of the original ligands.49,54,64 The Hupp group also 
demonstrated solvent-assisted linker exchange in a ZIF series.45,46 Also, using stepwise 
ligand exchange strategy, establishment of extended isoreticular structures has been 
studied.43,53,55 To establish a versatile platform having large pores and chemical stability 
via postsynthetic ligand exchange in PCN-333(Fe), we started from BTB, the simplest 
form bearing a resemblance to TATB, as the exchanging ligand. With thoroughly washed 
PCN-333(Fe), ligand exchange was performed via a biphasic (solid–liquid) manner as 
illustrated in Scheme 1b. To exclude a dissolution–recrystallization pathway, the 
exchange reaction was performed under lower temperature than that of the MOF synthetic 
condition.  
 Despite many noticeable examples that have shown postsynthetic ligand exchange 
in stable MOFs, there has not yet been a successful example demonstrating ligand 
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exchange in extremely stable mesoporous MOFs, such as MIL-100 and MIL-101, 
although both MOFs have been widely employed in many applications. Surprisingly, a 
successful ligand exchange was achieved in PCN-333(Fe) by using BTB as the incoming 
ligand. In general, most ligand substitution reactions in octahedral complexes undergo a 
dissociative pathway. The rate-determining step in the dissociative pathway is known to 
be a breaking of metal–ligand (M–L) bond.65,66 Similarly, the ligand exchange process in 
MOF can be generalized to the principle in coordination chemistry that the M–L bond 
should be dissociated to exchange ligands. MIL-101 and MIL-100 have been reported as 
extremely robust frameworks, suggesting strong coordination (M–L bond) in these two 
MOFs which in turn leads to an extremely slow bond dissociation rate for the ligand 
exchange. One reason that could account for this is the strong electrostatic interaction 
between carboxylates and the high Z/r valued trivalent metal ions used in these MOFs. To 
achieve an effective ligand exchange, therefore, longer reaction time and/or higher 
temperature might be expected in these frameworks. 
 However, the exchanging environment provides not only extra carboxylates (from 
incoming ligands) but also solvent molecules as competing reagents, both of which could 
destruct the framework by forming fractions or amorphous products. Therefore, in the 
extremely robust MIL-101 and MIL-100, the frameworks could be severely damaged 
before an apparent exchange happens. On the contrary, PCN-333(Fe), an isoreticular 
structure of MIL-100, showed successful ligand exchange. As the bond nature is identical 
in both frameworks, the elongation of the linker could explain the exchange event. Unlike 
common coordination complexes, each linker in MOFs binds to multiple metal nodes. 
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Considering that a complete ligand exchange of a linker includes breaking of all 
coordinated carboxylates, the case where only one of them is dissociated while the others 
remain bound onto the framework prevents total dissociation. Consequently, the structural 
restraint from multiple coordination sites impedes complete ligand dissociation, which 
eventually slows the ligand exchange in the framework. In addition, when the connectivity 
of the linker is higher, it takes more steps for the complete ligand dissociation, resulting 
in a more difficult exchange process. Furthermore, for similar linkers of differing length, 
the extent of such restraint varies. For instance, assuming d in Figure 2.2b (describing only 
one binding site) stands for a distance allowing for efficient dissociation–association of 
the ligand exchange. When the dissociation is happening (moving distance to d), longer 
linker l takes a smaller angle θ compared to that of shorter linker l′, which would result in 
less strain to the remaining coordination sites on the linker. If l gets infinitely longer, then 
the structural restraint from each coordination site becomes negligible, and the 
dissociation process in the MOF would be similar to the case of a small coordination 
complex in a homogeneous system. Therefore, ligand exchange can happen more easily 
in isoreticular structures constructed with longer linkers. 
 In the supertetrahedron of PCN-333, Fe3(O) clusters act as vertexes. The dihedral 
angle between the carboxylate plane and the Fe3(O) plane is inherently determined by the 
octahedral coordination environment of each Fe atom. However, it is not precisely 
compatible to be directly connected in the triangular face of a perfect tetrahedron (0.281°) 
as shown in Figure 2.2b. Thus, TATB must adopt a bent geometry to hold three Fe3(O) 
clusters in the supertetrahedron unit. This generates a distance of about 1.6 Å between the 
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center of TATB and the ideal triangular plane formed by six oxygen atoms in the 
tetrahedron, which suggests TATB would bear high energy (Figure 2.2b). Although bond 
dissociation happens between the carboxylate and Fe, such an energetically unfavorable 
conformation would still facilitate the dissociation in order to lower the energy of the 
linker. In the meantime, TATB is almost twice as large as benzene-1,3,5-tricarboxylic acid 
(BTC), which makes all cages in PCN-333 much larger than that in MIL-100, and thereby 
such extra space allows for faster diffusion of both incoming and dissociating ligands to 
further promote the ligand exchange process in PCN-333. All structural features of PCN-
333 including the greatly bent conformation of TATB, less mutual restriction between 
each coordinating site because of its larger size (compared to MIL-100), and extremely 
large pores assist the ligand exchange in spite of the strong M–L bond, all combined make 
this system the first example of successful ligand exchange in highly robust mesoporous 
MOF with tritopic linkers. 
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Optimization of ligand exchange in PCN-333(Fe) with BTB 
 
 
Figure 2.3 NMR studies of ligand exchange. (a) Relative TATB (%) in supernatant at 
different temperatures (incubation time = 24 h). (b) Time-dependent relative TATB (%) 
in supernatant (incubation temperature = 85 °C). (c) Ratio of exchanged BTB (%) in PCN-
333(Fe) incubated at different temperatures (incubation time = 24 h). (d) Ratio of 
exchanged BTB (%) in PCN-333(Fe) at different incubation times (incubation temperature 
= 85 °C). (e) Comparison of BTB exchange ratio (%) in PCN-333(Fe) upon provision of 
fresh stock solution. (f) BTB exchange ratio (%) in PCN-333(Sc) as a function of 
incubation time. 
 
 Systematic studies to further investigate the ligand exchange process in PCN-
333(Fe) were performed. First, PCN-333(Fe) was incubated for 24 h in BTB stock solution 
at different temperatures [room temperature (rt), 85 °C, 100 °C]. Upon completion of 
ligand exchange, the relative composition of the ligands (BTB was used excess amount) 
was analyzed by 1H NMR of the resulting supernatant. The ligand exchange reaction at 
room temperature showed the lowest content of TATB (∼1%) while both higher 
temperatures (85 °C, 100 °C) yielded higher contents of TATB (∼11% for both) coming 
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out from the parent MOF, which indicates the ligand exchange was facilitated at higher 
temperatures (Figure 2.3a). Next, the ligand exchange process was investigated for 
different incubation times. The supernatants of BTB exchanged PCN-333(Fe) samples 
were taken after different incubation times at 85 °C. The 1H NMR spectroscopy showed 
the supernatant incubated for 3 h was composed of ∼7% of TATB relative to BTB and the 
ratios of TATB gradually increased as incubation time increased up to 24 h. However, the 
exchange ratios were saturated at a longer period of exchange process (72 h), and almost 
the same concentrations of TATB were obtained (∼11%) (Figure 2.3b). 
 
Figure 2.4 PXRD patterns of synthesized materials. 
 
 As supernatant analyses merely indicate the exchange event indirectly, 1H NMR 
spectroscopy of digested MOFs was performed to determine the absolute composition of 
  30 
exchanged PCN-333(Fe). Due to the high chemical stability of exchanged PCN-333(Fe), 
the samples were treated with concentrated HCl (37%) and refluxed for 12 h to be 
digested. The digested sample that was incubated at room temperature showed 22% 
exchange of BTB. Consistent with the previous observations from the supernatant, the 
samples exchanged at 85 and 100 °C showed higher extent of exchange, 34% and 33%, 
respectively (Figure 2.3c). The effect of incubation time was also examined on the 
digested samples. The exchange ratios gradually increased from 29% (3 h exchanged 
sample) to ∼34% (12–72 h exchanged samples) (Figure 2.3d). Similar to the results from 
supernatant studies, the composition of BTB did not increase with extension of incubation 
time longer than 24 h. Ligand exchange in PCN-333(Fe) showed a faster rate of exchange 
in that approximately 30% exchange could be achieved within 3 h under mild conditions. 
Also, these findings clearly showed promise that the degree of exchange can be modulated 
by controlling temperature and exchange time. Powder X-ray diffraction of these samples 
indicates that the structural integrity of parent PCN-333(Fe) was well-retained after the 
ligand exchange (Figure 2.6a). 
 After discovering the previous result, we further sought to find whether the 
exchange ratio could become higher or whether there would be a maximum extent of 
exchange within a capacity allowing the retention of framework. To drive the equilibrium 
of the system forward, the supernatant was exchanged with fresh BTB stock solution every 
24 h. Ligand exchange was performed by following the routine procedure at 85 °C. A 
higher BTB exchange ratio (∼45%) was achieved when the fresh stock solution was 
provided after 24 h during 48 h of exchange. However, there was no significant increase 
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when fresh BTB solution was subsequently provided each day for longer periods of time 
(Figure 2.3e). 
 
 
Figure 2.5 Entropy and enthalpy changes of the system during ligand exchange. (a) Gibbs 
free energy change of the system for ligand exchange in PCN-333. (b) Enthalpy change 
of the system during ligand exchange. 
 
 
Thermodynamics behind ligand exchange in PCN-333 
 Having observed that the exchange ratio stopped increasing after a certain point 
despite successive provision of fresh incoming ligands while maintaining crystallinity of 
PCN-333(Fe), we further sought to understand the process in our system. At the very 
beginning of the ligand exchange process, the drastic entropy increase (ΔSsys) results in a 
negative ΔGsys, which spontaneously drives the exchange reaction forward. When the 
concentration of TATB in solution increases up to a certain point, ΔSsys would be 
insufficient to maintain the negative value of ΔGsys, and eventually, an equilibrium is 
established where ΔGsys = 0. Such rationale is consistent with the experimental results that 
the maximum exchange ratio was observed for each batch of BTB exchanged sample. 
 Thus, the exchange of fresh BTB stock solution reinitiated the high entropy 
increasing process. To some extent, a new equilibrium was established, but over time the 
exchange ceased again. Ideally, the ligand exchange process could keep going close to full 
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exchange (∼100%) upon successive provision of fresh incoming ligands. In the case of 
PCN-333, however, the exchange process was terminated when the system reached a 
certain exchange ratio regardless of whether refilling of fresh BTB solution occurred 
(Figure 2.3e). This may imply the total enthalpy change (ΔHa + ΔHb) is no longer the same 
value as in the circumstance of low BTB exchange ratio in PCN-333. In other words, 
ΔHb becomes an even larger positive value whereas ΔHa remains the same, which leaves 
the framework in high energy when more BTB molecules are inserted after the maximum 
tolerance that PCN-333 can bear until its destruction. As a result, the ligand exchange can 
hardly be driven further by the entropy change (ΔSsys) due to the huge enthalpy increase 
(ΔHa + ΔHb) and the saturation point appears. Theoretically, raising the temperature 
(increasing TΔSsys value) could overcome such enthalpy increase (ΔHa + ΔHb) to further 
drive the ligand exchange process. However, the increased temperature could also destroy 
the framework as previously discussed. Thus, a balance must be struck by controlling 
temperature to affect optimum ligand exchange process while maintaining framework 
integrity. 
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Figure 2.6. Characterization of BTB exchanged PCN-333(Fe). (a) PXRD patterns of BTB 
exchanged PCN-333(Fe) for different incubation times. Ligand exchange was performed 
at 85 °C. (b) N2 sorption isotherms of BTB-exchanged PCN-333(Fe) performed at 
different temperatures. (c) N2 sorption isotherms of BTB-exchanged PCN-333(Fe) for 
different incubation times at 85 °C. (d) N2 sorption isotherms of BTB exchanged PCN-
333(Fe) for different incubation times at 100 °C.  
 
 To examine whether an exchange saturation point (maximum exchange ratio) lies 
on the thermodynamic equilibrium, we further carried out a reverse ligand exchange 
reaction using extra TATB to replace the inserted BTB in the exchanged PCN-333. When 
TATB from the solution replaces the inserted BTB in the framework, the enthalpy change 
will be inversed to a negative value, −(ΔHa + ΔHb). Because the entropy change maintains 
a similar trend (a positive value), the overall change in Gibbs free energy will become 
negative to spontaneously drive the exchange process (reverse reaction). As expected, 
after soaking BTB-exchanged PCN-333(Fe) into TATB solution for 12 h at 85 °C, the 
composition of BTB in the reversibly exchanged PCN-333(Fe) decreased from ∼35% to 
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less than 6% with well-retained crystallinity, validating the explanation for the presence 
of the exchange saturation point in the system. 
 As previously discussed, framework destruction is inevitable during the ligand 
exchange process due to the competing association–dissociation at the M–L bond from 
extra ligands in the solution and some solvent dissociatives such as formate. When the 
exchange is extremely slow, the framework can be destroyed before evident exchange 
happens, which would result in unsuccessful exchange as in the case of MIL-101 and MIL-
100. In order for successful ligand exchange in the robust MOF, optimization becomes 
important to balance the exchange ratio and framework intactness. To optimize such a 
balance of the exchange ratio, porosity and crystallinity of exchanged PCN-333(Fe), the 
nitrogen sorption measurement and PXRD were employed. As shown in Figure 5b, when 
the exchange reaction was conducted for 24 h at different temperatures, the lower 
temperature (rt) gave the better porosity than that of higher temperatures (85 °C, 100 °C). 
Although a slight decrease in porosity (∼13%; relative to the parent MOF) was observed 
for the samples treated at higher temperatures, they still exhibited high porosity. We then 
examined whether the incubation time affects the porosity as well. For the exchanged 
PCN-333(Fe) incubated at 85 °C, shorter reaction time (12 h) rendered better porosity than 
that of longer exchange time (24 h) (Figure 2.6c). 
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Figure 2.7 (a) Photographs of PCN-333(Fe) samples after ligand exchange with different 
BTB derivatives (after activation). (b) PXRD patterns of exchanged PCN-333(Fe) with 
different BTB derivatives. (c) Nitrogen sorption isotherms of PCN-333(Fe) exchanged 
with different BTB derivatives. Incubation temperature = 85 °C. Incubation time = 12 h. 
 
Ligand exchange with various functional groups 
 One of the most valuable advantages of MOFs over other conventional porous 
materials is synthetic versatility from the design of diverse ligands. Utilizing the powerful 
tool of organic chemistry, we sought to expand our library of ligands to accommodate 
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various functional groups in PCN-333(Fe) through the structure-assisted ligand exchange 
process. Most incoming BTB derivatives with various substituents at the 2-position of the 
central benzene ring (Scheme 2.10a) were synthesized from OH-BTB via a simple 
nucleophilic substitution reaction with excellent quantitative yields. 
 
Table 2.1 Summary of N2 sorption isotherm measurement. 
Ligand Exchange ratio (%)a N2 uptake (cm3/g, STP)b 
BET surface area 
(m2/g) 
BTB 35.0 1797 3903 
OH-BTB 
NH2-BTB 
azide-BTB 
27.5 1657 3595 
NH2-BTB 18.0 1632 3448 
azide-BTB 31.0 1676 3559 
alkene-BTB 26.5 1587 3391 
alkyne-BTB 
chiral-BTB 
39.4 1631 3463 
chiral-BTB 27.3 1679 3624 
aLigand exchange was performed at 85 °C for 12 h. bN2 sorption was measured at 77 K. 
 
 Ligand exchange of BTB derivatives in PCN-333(Fe) was performed by adopting 
the optimized condition from BTB exchange studies (85 °C, 12 h). A 12 h period of 
incubation time was chosen as a shorter reaction time and gave better porosity with 
compatible extent of exchange. Photographs of the exchanged samples are shown in 
Figure 2.7a. Notably, distinctive color changes were observed for the samples exchanged 
with OH-BTB (olive) and NH2-BTB (dark brown), which clearly indicate the 
incorporation of different ligands. To determine the exchange ratio for each ligand, 1H 
NMR spectra of the digested samples were taken. The exchange ratio for each ligand is 
summarized in Table 2.1. Presumably due to different enthalpy changes (ΔHb) of each 
ligand before and after ligand exchange resulting from their different solubility as well as 
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steric and/or electronic effects, each ligand showed different extent of exchange ranging 
from 18.0% to 39.4% under identical conditions. Nevertheless, all of the functionalized 
BTB ligands were successfully exchanged into PCN-333(Fe) with significant exchange 
ratios. Figure 2.7b shows well-maintained crystallinity of exchanged samples regardless 
of the functional groups (Figure 2.7b).  
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Figure 2.8 IR spectra of azide-BTB exchanged PCN-333(Fe). Inset: magnification of 
characteristic azide group stretching band at ~ 2100 cm-1. 
 
 Particularly, infrared (IR) spectroscopy of the azide-BTB exchanged PCN-333(Fe) 
shows a characteristic stretching band at 2106 cm–1, which is indicative of the presence of 
an azide group (Figure 2.8). The porosity of each exchanged PCN-333(Fe) sample was 
then evaluated by N2 adsorption measurements at 77 K. As expected, the total uptake of 
each sample slightly decreased after the exchange with a functionalized ligand 
(Figure 2.7c). However, it is worth noting that the decrease in total pore volume of 
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exchanged PCN-333(Fe) compared to that of the parent material was not critical 
(approximately decreasing in a range from 7% to 18%, Table 2.1). To the best of our 
knowledge, our materials exhibit one of the highest N2 uptakes among all reported 
mesoporous MOFs with functionalized covalent anchors.39,55 Slight shifts to the lower 
pressures in steps of the N2 adsorption isotherm, in comparison to that of the parent 
material at approximately 0.32 P/P0 and 0.44 P/P0, were observed suggesting changes in 
pore size due to the incorporation of ligands with substituents. DFT pore size distribution 
analysis showed that the smallest pore, which corresponds to the supertetrahedron unit, 
was affected the most by appended functional groups on the BTB derivatives compared 
to that of parent MOF. For example, the pore size distribution of the PCN-333(Fe) 
exchanged with azide-, alkene-, alkyne-, and chiral-BTB that contains larger functional 
groups showed a sharper shift in distribution toward the smaller pores than that of BTB, 
OH-BTB, or NH2-BTB exchanged PCN-333(Fe). In comparison, the middle-sized cages 
and the largest cages are less affected. Assuming the inserted BTB derivatives are well-
distributed, the exchange extent exceeding 25% would suggest at least one face of the 
supertetrahedron is replaced. While the additional functional groups reduce the available 
space inside of the smallest cage, the middle-sized and especially the largest cages are 
much less affected due to their inherent ultralarge pores. Therefore, characteristics of 
mesoporous PCN-333 should be mostly preserved after the implantation of the functional 
anchors. 
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Figure 2.9 Click reaction of azide-BTB exchanged PCN-333(Fe). (a) IR spectra of azide-
BTB exchanged PCN-333(Fe) having different ratios of azide-BTB. (b) Comparison of IR 
spectra of before/after click reaction with azide-BTB exchanged PCN-333(Fe). 
 
Introduction of secondary functionality 
 After successful implantation of covalent anchors into PCN-333, further 
examinations were performed on azide-functionalized PCN-333(M) (M = Fe, Sc) to 
demonstrate introduction of secondary functionality via click chemistry.39,44,67 As 
previously found, before reaching the exchange saturation point providing fresh stock 
solution of the incoming ligand increased the exchange ratio. 
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 Taking this into account, the characteristic peak of the azide group at 2106 cm–
1 was monitored by infrared spectroscopy upon increasing the azide group ratio. As fresh 
stock solution was continuously provided, a more prominent azide stretching band at 2106 
cm–1 was observed in the exchanged sample which indicates the incorporation of more 
azide-BTB ligands in PCN-333(Fe) (Figure 2.9a). Knowing this, a click reaction between 
the azide-functionalized PCN-333(Fe) and methyl propiolate was performed in the 
presence of CuI in DMF (65 °C, 20 h). The disappearance of this azide IR peak at 2106 
cm–1 shown in Figure 2.9b suggests a successful anchorage of methyl propiolate as well 
as completion of the click reaction. The PXRD pattern of the clicked sample also 
confirmed well-maintained crystallinity owing to the robustness of PCN-333(Fe) (Figure 
2.10). 
 
 
Figure 2.10 Comparison of PXRD patterns of before/after click reaction of methyl 
propiolate and azide-BTB exchanged PCN-333(Fe). 
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 To investigate the potential utility of functionalized PCN-333, we further sought 
to expand our experimental design by introducing 4,4-difluoro-4-bora-3a,4a-diaza-s-
indaene (BODIPY), a well-known fluorophore due to its excellent photochemical stability, 
tunable photophysical properties, and high quantum yield. Fluorescence measurements 
involve high sensitivity and rapid implementation, and thus fluorophores such as BODIPY 
derivatives can be widely employed in the MOF field. However, the incorporation of 
fluorophores in MOF as ligands would take substantial synthetic efforts while the 
anchorage of such compounds to a functionalized MOF through a postsynthetic approach 
is more practical.44,68,69 To illustrate our concept, terminal alkyne functionalized BODIPY 
(14) was synthesized to perform a click reaction with azide-functionalized PCN-333(Fe). 
Although the IR spectrum suggests a successful click reaction on PCN-333(Fe), attempts 
to observe fluorescence from BODIPY-clicked PCN-333(Fe) were not successful due to 
the presence of Fe(III) which can quench the emission of BODIPY (Figure 2.11). To avoid 
the interference from the Fe(III) node, we chose colorless PCN-333(Sc) to show the click 
reaction more clearly. 
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Figure 2.11 IR spectra of before/after click reaction of 14 and azide-BTB exchanged 
PCN-333(Fe)  
 
 
 
Figure 2.12 (left) Azide-BTB exchange ratio (%) in PCN-333(Sc) for different incubation 
times. (right) IR spectra of azide-BTB exchanged PCN-333(Sc) that having different ratios 
of azide-BTB.  
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 The exchanged samples with different ratios of the azide group were prepared by 
changing the stock solution as previously found. The extent of azide-BTB exchange was 
determined by 1H NMR spectroscopy upon digestion of samples (Figure 2.12). 
Considering carboxylates bind less strongly to Sc(III) than Fe(III), ligand exchange in 
PCN-333(Sc) should occur more easily. As observed in the exchanging process, ligand 
exchange in PCN-333(Sc) reached an equilibrium quickly because of the easier M–L bond 
dissociation (Figure 2.3f). However, the thermodynamic equilibrium of the exchange 
process was almost independent from M–L bond nature as we analyzed and a slightly 
lower extent of the exchange saturation point was observed in BTB exchange. 
Nonetheless, azide-functionalized BTB showed a comparable exchanged ratio in PCN-
333(Sc) as in PCN-333(Fe).  
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Figure 2.13 (a) Click reaction scheme performed on PCN-333(Sc) with BODIPY 
fluorophore. Photographs are before and after BODIPY introduction on PCN-333(Sc). (b) 
Solid-state fluorescence emission spectra of azide-BTB exchanged PCN-333(Sc) (blue) 
and BODIPY-clicked PCN-333(Sc) (red). λex = 450 nm. (c) Comparison of solid-state 14 
and BODIPY-clicked PCN-333(Sc) (left). Photographs of (i) pristine PCN-333(Sc), (ii) 
azide-BTB exchanged PCN-333(Sc), and (iii) BODIPY-clicked sample in both solid-state 
and suspension (right). 
 
 The click reaction of azide-functionalized PCN-333(Sc) and alkyne-BODIPY (14) 
was successfully performed with a catalytic amount of CuI in THF (65 °C, 21 h) 
(Figure 2.13a). To our delight, BODIPY-clicked PCN-333(Sc) showed strong 
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fluorescence in both suspension and solid-state. Notably, the emission of BODIPY-
clicked PCN-333(Sc) in the solid state is green (λ = 550 nm; Figure 2.13b) suggesting that 
the clicked dye behaves as a monomeric dye, while dye aggregates (14) showed a red 
emission (Figure 2.13c). After close examination of the structure of PCN-333, it is very 
likely that the large pores provide enough space for clicked dyes to be spatially separated 
thereby emitting as single dye molecules. A click reaction on the samples containing 
different loading of azide groups showed that higher loading of azide groups resulted in a 
slight red shift in emission maxima (Figure 2.14). 
 
   
Figure 2.14 (left) Fluorescence emission spectra of azide-BTB exchanged PCN-333(Sc) 
and 14 clicked MOFs in acetone. λex = 450 nm. (right) Solid-state fluorescence emission 
spectra of azide-BTB exchanged PCN-333(Sc) and 14 clicked MOFs. λex = 450 nm. 
 
2.4 Conclusions 
 In summary, a facile functionalization assisted by structural attributes of PCN-333 
has been studied while maintaining the integrity of the parent MOF including ultralarge 
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pores, chemical robustness, and crystallinity. The foregoing results showed a promise that 
the extent of exchange can be tailored by varying temperature, concentration, or 
incubation time as potential applications may require. Furthermore, a variety of functional 
groups can be incorporated into PCN-333 via this strategy to covalently anchor guest 
species. Along this line, introduction of a secondary functionality was successfully 
performed via a click reaction with a BODIPY fluorophore. We anticipate the 
functionalized PCN-333 can serve as a stable platform for further chemistry to be explored 
in future applications. 
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3. DUAL EXCHANGE IN PCN-333: A FACILE STRATEGY TO CHEMICALLY 
ROBUST MESOPOROUS CHROMIUM METAL–ORGANIC FRAMEWORK 
WITH FUNCTIONAL GROUPS* 
3.1 Introduction 
 As an emerging class of inorganic–organic hybrid materials, metal–organic 
frameworks (MOFs) have gained growing attention as advanced porous materials.1 The 
unique combinations of organic/inorganic building blocks that compose these materials 
allow diverse functions leading to various applications.23-25,70-76 Among many features of 
MOFs, mesoporosity is of great interest due to the prospect of hosting large guest 
molecules such as organometallic complexes, nanoparticles, and enzymes, creating 
diverse applications with MOFs.10,28,77-79 Aside from such encapsulation within the large 
pores, molecular level design of organic ligands provides tailor-made structures and 
functionalities for targeted applications.80-85 
 It would be ideal if a mesoporous MOF could be directly synthesized from the 
ligand with a predesigned functionality. It has been shown, however, that in many cases 
this does not lead to a desired product due to the changes in molecular geometry of the 
ligand upon addition of functional group.55,86 As a classic tactic for the aforementioned 
difficulty, postsynthetic exchange has greatly promoted the functionalization of MOFs.42-
46,48-53,55-58,61-63,66,87-92  However, most parent MOFs require that postsynthetic processes 
occur under mild conditions to maintain their integrity. Despite the advances of 
                                                
*Reproduced with permission from Park, J.; Feng, D.; Zhou, H.–C., J. Am. Chem. Soc., 2015, 137, 11801–
11809. Copyright 2015 American Chemical Society. 
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postsynthetic exchange and solvent assisted linker exchange, introduction of various kinds 
of reactive functional groups is still challenging. Also, such methods usually involve labile 
metal–ligand (M–L) bonds in the MOF, suggesting a latent instability of the parent 
material. Therefore, the resulting product with postsynthetically inserted functional ligand 
still needs to overcome the stability issue. 
 With growing attention, MOFs have been utilized in various applications, 
including catalysis, sensing, biomedical imaging, as well as the areas of gas storage and 
separation.23-25,70-73,75,76 As MOF applications have gained broader impacts in materials 
science, it gradually requires even more sophisticated design of materials encompassing 
their compatible stability in targeted applications (i.e., aqueous stability for biomedical 
applications), as well as pore size and shape. As a result, demands for framework 
robustness have increased in pursuit of applicability of MOF in more complex systems.32-
34,41,93-103 However, most reported mesoporous MOFs suffer from weak chemical stability, 
mainly arising from the labile M–L bond in those frameworks.26,29-31,38 Also, reticular 
chemistry which usually involves the extension of linkers to obtain larger pores tends to 
weaken the stability of frameworks.27,104,105 Therefore, extremely inert M–L bond is highly 
encouraged to increase the stability of MOFs with mesopores. 
 On the basis of literature reporting, Cr(III) based clusters might be strong 
candidates to serve as an inorganic node to support mesoporous MOFs as compared to 
other trivalent metal species due to the kinetic inertness of Cr(III).93,106-109 However, such 
inert Cr–carboxylate bonding also impedes the direct synthesis of chromium MOFs (Cr-
MOFs), resulting in few Cr-MOF examples.93,106,108,109 Although postsynthetic metal 
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metathesis has led to obtaining MOFs that cannot be synthesized directly,39,66,110-126 there 
is only one successful example where almost complete exchange, via a microporous 
Cr(II)-MOF intermediate, has yielded a Cr(III) MOF.127 Moreover, the successful 
synthesis of Cr-MOFs typically involves water as a solvent, where solubility of larger 
organic ligands required to achieve larger pores can be rather poor.93,106-109 In particular, 
mesoporous structures are commonly limited to specific topologies, requiring a subtle 
control of synthesis to have the expected configuration of both inorganic and organic 
building blocks,35,108 which often limits the variation of synthetic conditions in Cr-MOF 
system. 
 In addition to the synthetic difficulties, the functionalization of Cr-MOFs has been 
a great challenge. For instance, functionalization through the ligand design in one of the 
most famous mesoporous MOFs, MIL-101(Cr) (MIL stands for Matérial Institut 
Lavoisier), has been limited to a small subset of functional groups, such as −Br, −NO2, 
and −SO3H, while relatively practical functional groups in organic reactions (e.g., −OH, 
−NH2) on the ligands often undergo decomposition under the hydrothermal condition 
(∼200 °C) required for synthesis.128 Although postsynthetic modification could somewhat 
alleviate such difficulties, the conflict between the harsh reaction conditions and inherent 
stability of the parent MOF still hampers the diversification of functionalization. In 
comparison, postsynthetic ligand exchange may be more suitable to diversify the library 
of functionalized Cr-MOFs. However, the inertness of Cr-MOF also impedes efficient 
postsynthetic ligand exchange processes.63,88 
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 Herein we present a stepwise exchange strategy of both ligands and metals, namely 
dual exchange in PCN-333(Fe) for the preparation of functionalized PCN-333(Cr) (PCN 
stands for Porous Coordination Network). After the dual exchange process, functionalized 
PCN-333(Cr) shows well preserved crystallinity, porosity, as well as enhanced chemical 
stability. Understanding of chemical dynamics along with the dual exchange in PCN-
333(Fe) may allow for a generalized route to functionalized Cr-MOFs, which will exhibit 
a maintained structural integrity of parent MOF with desired functional groups and 
enhanced stability. Furthermore, having studied the incorporation of various functional 
groups in PCN-333(Fe), dual exchange shows a great potential to employ many different 
functional groups in the highly stable Cr-MOF platform. 
3.2 Experimental section 
Instrumentation 
 Nuclear magnetic resonance (NMR) spectra were recorded on Varian Inova 500 
spectrometer unless otherwise noted. Powder X-ray diffraction (PXRD) was carried out 
on a Bruker D8-Focus Bragg–Brentano X-ray powder diffractometer equipped with a Cu 
sealed tube (λ = 1.54178) at 40 kV and 40 mA. Fourier transform infrared (FT-IR) 
measurements were performed on a Shimadzu IR Affinity-1 spectrometer. Scanning 
electron microscope (SEM) was performed on QUANTA 450 FEG and energy dispersive 
X-ray spectroscopy (EDS) was carried out by X-Max20 with Oxford EDS system 
equipped with X-ray mapping. N2 adsorption–desorption isotherms at 77 K were 
measured by using a Micrometritics ASAP 2420 system. A high-purity grade (99.999%) 
of gas was used throughout the sorption experiments. Sample was activated by solvent 
  51 
exchange (in several cycles using fresh acetone and hexanes), followed by degassing at 
elevated temperature (150 °C) for 2 h.  
Synthesis 
 Synthesis of PCN-333(Fe). H3TATB (60 mg), anhydrous FeCl3 (60 mg), and 
trifluoroacetic acid (0.6 mL) were dissolved in 10 mL DEF. The mixture was heated in 
150 °C oven for 12 h until a brown precipitate formed. The resulting brown precipitate 
was centrifuged and washed with fresh DMF five times. 
 Synthesis of PCN-333(Sc). H3TATB (80 mg) and ScCl3·6H2O (200 mg) were 
dissolved in 10 mL DMF. The mixture was heated in 150 °C oven for 2 h until a white 
precipitate formed. The resulting white precipitate was centrifuged and washed with fresh 
DMF five times. 
 General procedure for ligand exchange of PCN-333(Fe). First, as-synthesized 
PCN-333(Fe) (ca. 50 mg) was thoroughly washed with hot DMF and the isolated sample 
was then incubated with a stock solution of N3–BTB (50 mg in 10 mL of DMF) at 85 °C 
for 12 h. 
 General procedure for the preparation of PCN-333(Cr). Approximately 50 mg 
of as synthesized PCN-333(M) sample is initially immersed in the CrCl3·6H2O stock 
solution (200 mg in 10 mL of DMF) in 20 mL vial in a 150 °C oil bath. After 30 min of 
first incubation, the solution was decanted after centrifugation and additional 30 min of 
reaction was performed with new CrCl3·6H2O stock solution. Resulting product was then 
thoroughly washed with DMF five times. (Note: To preserve the morphology of the 
exchanged product, the reaction was not stirred, but refluxed. However, we observed the 
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exchange underwent slightly faster with stirring to yield similar exchanged metal ratio. In 
addition, according to our control experiment (pure CrCl3·6H2O in DMF), when heating 
at 150 °C is longer than 3 h, green precipitates gradually formed. Therefore, it is suggested 
not to leave the exchange reaction in mother solution too long at high temperature, to 
prevent possible formation of insoluble Cr formates or other unknown species, which are 
likely to affect porosity and crystallinity of the product.) 
 General procedure for metal metathesis of N3–PCN-333(Fe). Approximately 
10 mg of N3–PCN-333(Fe) samples are initially immersed in the CrCl3·6H2O stock 
solution (40 mg in 2 mL of DMF) at 150 °C oven. After 30 min of first incubation, the 
solution was decanted after centrifugation and additional 30 min of reaction was 
performed with new CrCl3·6H2O stock solution. Resulting product was then thoroughly 
washed with DMF five times. 
Sample activation procedure  
 Thoroughly washed samples underwent solvent exchange with acetone followed 
by hexanes at least five times, respectively and dried in a pre-heated 85 °C oven for 30 
min. Resulting powder was then activated for BET measurement at 150 °C for 2 h. 
MOF digestion  
 Approximately 10 mg of sample was digested with 37% HCl, refluxed overnight, 
and washed with water until a neutral pH was reached. DMSO-d6 (0.5 mL) was added to 
dissolve the ligands. The 1H NMR spectrum (500 MHz) was collected at room temperature 
(∼21 °C). 
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Supernatant analysis 
 Upon completion of treatment, the supernatant was removed to examine TATB or 
N3–BTB released from the parent MOF. The aliquot of supernatant was filtered through a 
syringe filter to exclude the possible presence of MOF crystals remaining and the ligands 
in supernatant were recovered by acidification with few drops of 1 M HCl, followed by 
washing with water. The resulting precipitates were dried and analyzed by 1H NMR 
spectroscopy. 
Click reaction  
 TEPP (50 mg) was added to a mixture of N3–PCN-333(Cr) (30 mg) and CuI (5 
mg) in DMF (7 mL) in a round-bottom flask. The reaction mixture was stirred at 60 °C 
for 28 h. The resulting precipitate was collected by centrifugation, washed thoroughly with 
DMF followed by acetone and hexanes, and dried to afford a dark purple solid in 
quantitative yield. 
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3.3 Results and discussion 
 
Figure 3.1 (a) Ligands in MIL-100 (BTC) and PCN-333 (TATB). (b) The largest cage in 
PCN-333. (c) Supertetrahedron in PCN-333. 
 
PCN-333: An ideal scaffold for functionalizable Cr-MOF with mesoporosity 
 Our group recently reported a mesoporous MOF, PCN-333,40 constructed from 
trivalent metal ions and isoreticular structure to MIL-100.93 Due to the larger size of 
composing ligand 4,4′,4″-s-triazine-2,4,6-triyl-tribenzoate (TATB), extended version of 
benzene-1,3,5-tricarboxylate (BTC), PCN-333 exhibits larger pores (∼5.5 nm) than that of 
MIL-100 (∼2.9 nm), which allow the incorporation larger guest species as well as faster 
diffusion and provide sufficient room for chemical reactions in the mesopores (Figure 3.1). 
Having utilized the structural support of PCN-333, we recently studied a facile route to 
functionalize PCN-333(M) [M = Fe(III), Sc(III)] via postsynthetic ligand exchange.129 As 
a result of the ligand exchange, a variety of reactive functional groups were introduced 
into PCN-333 to covalently anchor the guest molecules. Despite the successful 
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introduction of various functional groups into PCN-333, however, its innate stability at 
the expense of the extended ligand to achieve larger pore still remains a challenge for its 
utilization in harsh chemical conditions for MOFs (e.g., water) due to the relative lability 
of the Fe(III)– or Sc(III)–carboxylate bonds in aqueous environment. Having reviewed the 
reported stability of Cr-MOFs, we conceived that PCN-333(Cr) with covalent anchors 
might serve as a better platform for the utilizations in harsh environment. However, a 
direct synthesis of PCN-333(Cr) is not trivial due to the conflict between the hydrothermal 
synthetic condition required for the synthesis of Cr-MOFs and the poor solubility of TATB 
in water. Moreover, even if PCN-333(Cr) was obtained, it would be challenging to 
introduce functional group into the framework through the postsynthetic ligand exchange, 
because the kinetic inertness of Cr(III) prevents an effective ligand exchange process. 
Therefore, a stepwise exchange was considered to obtain functionalized PCN-333(Cr). 
Optimization for metal metathesis in PCN-333 
 Having determined that a functionalizable PCN-333(Cr) might serve as a useful 
platform by providing exceptional stability and diverse functionality with large room for 
chemical reactions within the pores, we designed a procedure to achieve the targeted 
product, namely dual exchange. Possible routes to functionalized PCN-333(Cr) via dual 
exchange were conceived as two main schemes as shown in Scheme 3.1: (1) Metal 
exchange followed by ligand exchange and (2) Ligand exchange followed by metal 
exchange. 
 Prior to examining a better strategy to obtain functionalized PCN-333(Cr), PCN-
333(Sc) and PCN-333(Fe) were tested for a Cr(III) metathesis to choose the most suitable 
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base MOF for successful dual exchange. PCN-333 was synthesized as previously reported. 
Because Cr(III) salts often yield insoluble formates due to DMF decomposition with long 
reaction time at high temperature, the reaction time was limited to preserve crystallinity 
and porosity while maintaining a high metal exchange ratio. After optimization for the 
reaction time, the following Cr(III) metathesis in PCN-333(M) was performed for 1 h by 
replacement of CrCl3·6H2O stock solution in DMF after the first 30 min of reaction. 
 To investigate an optimal exchange reaction temperature, first, PCN-333(Sc) and 
PCN-333(Fe) were incubated for 1 h (by changing stock solution after first 30 min) in 
Cr(III) stock solution at 85 and 150 °C in preheated ovens. Interestingly, both PCN-
333(Sc) and PCN-333(Fe) showed no apparent color changes upon metathesis at 85 °C 
(Figure 3.2b,c). Energy-dispersive X-ray (EDX) spectra revealed low exchange ratios of 
both samples (37.0% for PCN-333(Sc/Cr) and 23.0% for PCN-333(Fe/Cr)), and especially 
poor powder X-ray diffraction (PXRD) patterns of PCN-333(Sc) (Figure 3.2). Notably, 
PCN-333(Sc) showed slightly higher Cr(III) exchange ratio than that of PCN-333(Fe) at 
85 °C, while showing no PXRD pattern, which suggests its lability, whereas at 150 °C, 
both samples generally showed much higher Cr(III) exchange ratios than those at lower 
temperature [64.8% for PCN-333(Sc/Cr) and 99.8% for PCN-333(Fe/Cr)]. 
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Figure 3.2 (a) Exchanged Cr(III) ratios in PCN-333(Sc) (left) and PCN-333(Fe) (right) 
after metal metathesis at different temperatures for 1 h. (b-c) Photographs and PXRD 
patterns of PCN-333(Sc) (b) and PCN-333(Fe) (c) after metal metathesis at different 
temperatures for 1 h. 
 
 In particular, Cr(III) metathesis from PCN-333(Fe) showed near complete 
exchange along with well-maintained crystallinity and porosity, which were confirmed by 
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PXRD (Figure 3.2c) and N2 sorption at 77 K, respectively (Figure 3.3). On the other hand, 
the diffraction of PCN-333(Sc) almost completely disappeared after the Cr(III) metathesis. 
It is reasoned that these results are due to the discrepancy between dissociation rates of 
leaving metal species in the framework and incoming metal species from the solution. For 
instance, in our previous study of ligand exchange in PCN-333, the successful ligand 
exchange was carried out at low temperature (85 °C), which suggests it gives enough 
energy to overcome the energy barrier of Sc(III)–carboxylate or Fe(III)–carboxylate bond 
dissociations within the framework. Closely looking at the metal metathesis process, the 
M–L bond dissociation is required for both incoming metal complex and metals in the 
parent MOF to accomplish the overall exchange process. Even though the temperature is 
sufficient enough for the ligand dissociation in the framework, much slower ligand 
dissociation in the incoming Cr(III) complex can still be a rate limiting step. Therefore, 
the Cr(III) metathesis at low temperature was not successful. On the other hand, when the 
given energy is enough for breaking Cr(III)–X (i.e., Cl–) bond from Cr(III) salts and 
following association with the open carboxylates in the framework after Fe(III) 
dissociation for successful exchange, Cr(III) exchange reached to higher exchange ratio 
in both cases (Figure 3.2a). When it comes to the retention of framework structure, 
however, the metathesis in PCN-333(Fe) was superior to PCN-333(Sc), presumably due 
to the relative robustness of PCN-333(Fe) resulting from the slower Fe(III)–carboxylate 
dissociation rate than that of PCN-333(Sc) allowing compatible exchange environment 
with Cr(III) association. Particularly, in the metal metathesis of labile PCN-333(Sc) 
platform, the framework would undergo significant destruction by free Cr(III) and 
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decomposed reactive species from DMF before obvious metal metathesis happened.127 
After discovering the previous result, PCN-333(Fe) was chosen as a platform for studying 
the dual exchange. 
 
Figure 3.3 (a) Photographs of PCN-333(Fe) and PCN-333(Cr) exchanged at 150 °C. (b) 
N2 sorption isotherm of PCN-333(Fe) and PCN-333(Cr) at 77 K. 
 
 
Figure 3.4 (a) Entropy change and (b) enthalpy change of the system during the ligand 
exchange. 
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Analysis of dual exchange 
 Following up on our previous study, exploring the chemical dynamics of ligand 
exchange in PCN-333,129 we further sought to expand our observations and 
rationalizations focused on changes of entropy and enthalpy during the dual exchange. As 
was discussed in the previous study, the entropy change of the system (ΔSsys), comprising 
a solid-state MOF and exchanging solution during the ligand exchange, was assumed to 
be largely dependent on ΔS in solution, as ΔS in the solid state MOF may be negligible. 
Thus, the ligand exchange process in PCN-333 was driven by a drastic entropy increase 
(ΔSsysLE > 0) upon the provision of excess amount of the exchanging ligands (Figure 3.4). 
Similarly, the entropy change of the system during the metal metathesis (ΔSsysMM) follows 
the same concept (Figure 3.5); thus, it yields a positive ΔSsysMM due to the excess input of 
Cr(III) in solution to replace Fe(III) in the framework. In Ssys standpoint, therefore, both 
ligand exchange and metal metathesis should have entropy contributions for the desired 
exchanges from the excess of exchanging entries. 
 
 
Figure 3.5 (a) Entropy and (b) enthalpy change of system during the metal metathesis. (c) 
Gibbs free energy of system during the metal metathesis in PCN-333. 
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 When it comes to the enthalpy analysis of the ligand exchange process in PCN-
333, as the degree of exchange increases the enthalpy of the system (Hsys) also increases 
(ΔHsys > 0) due to the insertion of BTB (1,3,5-benzenetribenzoate) derivatives with 
unfavored conformation in the framework (Figure 3.6). For this reason, although the large 
ΔSsys at the early stage of ligand exchange could drive the exchange reaction forward, the 
system establishes an equilibrium with a certain ratio of ligand exchange. 
 
 
Figure 3.6 Structures of TATB and BTB derivative (OH-BTB). Top view (left) and side 
view (right) showing preferred non-planarity of BTB derivative.  
 
 However, metal metathesis between Fe(III) and Cr(III) accompanies the changes 
in M–L bond nature, comprising the framework, whereas the bond nature in the ligand 
exchange remains the same as Fe(III)–L bond (L represents carboxylate) in the 
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framework. Meanwhile, metal metathesis also involves changes of enthalpy in solution. 
For example, Fe(III) ions, coming out from the framework replace Cr(III) in the provided 
CrX6 complex (X = Cl–, DMF), resulting in FeX6 species in solution. Consequently, there 
are two processes involving enthalpy changes of the system: (1) ΔHFe, corresponding to 
the enthalpy change of Fe(III) from the MOF to the solution; (2) ΔHCr corresponding to 
the enthalpy change of Cr(III) species from solution to the MOF. Thus, the enthalpy 
change of the system can be represented as ΔHsys = ΔHFe + ΔHCr. 
 Understanding of ΔHsys during metal metathesis can be interpreted by focusing on 
electrostatic interaction and orbital interaction upon the exchange event. First, the Cr(III) 
has a smaller ionic radius than that of high spin Fe(III), leading to a larger Z/r value.130 
Considering carboxylate (L) is also a harder Lewis base compared to ligands, X, when 
Cr(III) coordinates to the carboxylates in the framework, the electrostatic interaction 
becomes stronger, providing larger enthalpy change upon metathesis compared to 
Fe(III).131 
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Figure 3.7 Analysis of the orbital interaction contribution to ΔHsys using ligand field 
theory with a simplified coordination environment (Oh) for the metal metathesis process 
in PCN-333. 
 
 Aside from the electrostatic interaction, the orbital interaction also changes for 
each metal species along with the metathesis. To compare the changes in orbital 
interaction, which contributes to ΔHsys, ligand field theory (LFT) was applied to simplify 
the given scenario. Although the actual coordination environment for the M(III) (M = Cr 
or Fe) in the framework gives rise to a C4v symmetry due to the two different axial ligands 
and that for MX6 species in the solution may even vary, herein we assumed Oh symmetry 
for both cases to simplify the analysis of the contributions from the coordinating ligands 
to ΔHsys. 
 Considering ligands X in solution are relatively weaker field ligands than 
carboxylate (L),132 and the metal-carboxylate (M–L) bonds are dominant in the 
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framework, the changes in the coordinating ligands upon metathesis will have impacts on 
ΔHsys. For example, when Cr(III) is exchanged from solution into the framework, 
the d orbital splitting energy changes from ΔOX to ΔOL (Figure 3.7). As Cr(III) 
has d3 configuration, such coordination environment change gives out a net ligand field 
stabilization energy (LFSE) of −1.2(ΔOL – ΔOX). Therefore, from the Cr(III) standpoint, as 
ΔOL is larger, the system gets more stabilized. On the other hand, because Fe(III) adopts 
high spin d5 configuration with weak field ligands, the LFSE is canceled out from its two 
electrons in eg orbitals, resulting in no stabilization impacts from the exchange event. 
Overall, the system gets more stabilized after metal metathesis from the orbital interaction 
aspect. In short, while both electrostatic interaction and orbital interaction go through the 
changes during the metal metathesis, the absolute value of ΔHCr is more likely to be larger 
than that of ΔHFe, making the ΔHsys negative and the overall metal metathesis from PCN-
333(Fe) to PCN-333(Cr) an exothermic process. Thus, the metal metathesis from PCN-
333(Fe) to PCN-333(Cr) can be considered as a both entropically and enthalpically 
favored process. 
 According to the findings in the previous section, the metal metathesis is optimized 
at high temperatures (150 °C). Interestingly, we found the metatheses of from Sc(III) to 
Cr(III) and Fe(III) to Cr(III) at 85 °C showed very low exchange ratios, suggesting indeed 
Cr(III)–X bond has to be sufficiently activated by high temperature. Such high 
temperature not only provided sufficient energy for Cr(III)–X bond dissociation, but also 
allowed a short reaction time, avoiding a long exposure of MOF in the reactive 
environment which further guarantees the framework intactness. Moreover, owing to the 
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high reaction temperature, the entropy contribution to ΔGsys is magnified from 
the TΔS term, which pushes the exchange more forward. In particular, our optimized 
metathesis involves the exchange of fresh the CrCl3·6H2O solution after first 30 min of 
exchange; and thus this can remove the Fe(III) in the solution to facilitate an entropy 
driven process, further driving the reaction forward to the almost fully exchanged PCN-
333(Cr). 
 
 
Scheme 3.1 Energy Diagrams of Two Possible Dual Exchange Routes to Functionalized 
PCN-333(Cr). 
 
Functionalization of PCN-333(Cr) through dual exchange 
 Considering the previous results, schematic energy diagrams representing possible 
dual exchange pathways are summarized in Scheme 3.1. Pathway 1 (path 1) shows a case 
where the dual exchange to get the functionalized PCN-333(Cr) in an order of ligand 
exchange followed by metal metathesis. As shown in path 1, each step involves 
kinetically and thermodynamically favored process as analyzed the given temperature was 
sufficient to drive the reactions forward. From the framework standpoint, path 1 involves 
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a dissociation of Fe-carboxylate bonds at each step, which takes less energy than breaking 
Cr–carboxylate bond. 
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Figure 3.8 PXRD patterns of as-synthesized materials. 
 
 On the other hand, path 2, in which the functionalization (ligand exchange) is 
done after Cr-MOF formation (metal metathesis), requires a large amount of energy to 
overcome the barrier of Cr–carboxylate bond dissociation for the ligand exchange step. 
Therefore, to obtain functionalized PCN-333(Cr), thermodynamically favored path 1 was 
chosen for the double exchange in the following experiments. However, to confirm our 
hypothesis, path 2 was also examined for its feasibility for dual exchange. Having 
prepared PCN-333(Cr) by the optimized condition as previously described, first a ligand 
exchange in PCN-333(Cr) was tested via path 2 as shown in Scheme 3.1. For an incoming 
ligand, one of BTB derivatives having an azide group (N3–BTB; shown in Figure 3.9a) 
was chosen as a model inserting ligand because of its versatile utilities in many 
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applications and allowance of click reaction after successful implantation of functional 
group, so as to confirm the feasibility of a secondary chemical reaction onto dual 
exchanged PCN-333(Cr). The ligand exchange followed the optimized condition (85 °C, 
12 h) from our previous study wherein the exchange condition guarantees the crystallinity 
and porosity.129 As a result of dual exchange following the path 2, though crystallinity of 
PCN-333(Cr) was retained after going through the ligand exchange, 1H NMR analysis of 
supernatant of reaction revealed that no TATB released from PCN-333(Cr) under the 
given condition, as expected. 
 
 
Figure 3.9 (a) N3–BTB used for ligand exchange and photographs of N3–PCN-333(Fe), 
N3–PCN-333(Cr), and N3–PCN-333(Cr) after click reaction. (b) N2 sorption isotherm of 
N3–PCN-333(Fe), N3–PCN-333(Cr), and N3–PCN-333(Cr) after click reaction. (c) PXRD 
patterns of N3–PCN-333(Fe) and (d) N3–PCN-333(Cr) after different treatments. 
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Having demonstrated path 2 is not suitable to realize dual exchange on the PCN- 
333(Fe) platform, we then sought to optimize path 1 to obtain the dual exchanged product. 
Again the ligand exchange from TATB to N3–BTB in PCN-333(Fe) was performed as 
previously stated. 1H NMR study confirmed that the ligand exchange ratio in PCN- 
333(Fe) showed a similar N3–BTB ratio to the previous report (∼30%). Also, the N3–BTB 
inserted PCN-333(Fe) (N3–PCN-333(Fe)) showed well retained crystallinity and porosity 
(Figures 3.8 and 3.9). In addition, a characteristic stretching band of the azide group at 
2106 cm–1 was observed from infrared (IR) spectrum of N3–PCN-333(Fe). As a second 
step of dual exchange in path 1, the previously optimized condition for metal metathesis 
was then applied to obtain the azide functionalized PCN-333(Cr) (N3–PCN-333(Cr)). 
After 1 h of Cr(III) metathesis, the dual exchanged sample was prepared accompanying 
with an obvious color change from bright yellow to green (Figure 3.9a). EDX results 
revealed that ∼97% of Fe(III) in N3–PCN-333(Fe) was exchanged to Cr(III) without 
compromising its crystallinity (Figure 3.9 and Table 3.1).  
Table 3.1 Summary of dual exchange 
Entry 
N2 uptake 
(cm3/g)a 
Pore volume 
(cm3/g) 
Exchanged Cr 
(%)b 
PCN-333(Fe) 1985 3.07 n/a 
PCN-333(Cr) 1838 2.84 ~99 
N3-PCN-333(Fe) 1663 2.57 n/a 
N3-PCN-333(Cr) 1707 2.64 ~97 
Clicked-PCN-
333(Cr) 1033 1.60 n/a 
aN2 sorption was measured at 77 K. bBased on EDX results.
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Figure 3.10 DFT pore size distribution of samples obtained from N2 sorption isotherm at 
77 K. 
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Figure 3.11 IR spectra of double exchanged N3-PCN-333(Cr).  
 
 Additionally, 1H NMR analysis of supernatant of Cr(III) exchange reaction 
showed no detectable TATB or N3–BTB ligands leaching out from the parent MOF, which 
further suggests there is minimal destruction of framework as supported by PXRD. As 
shown in Figure 3.9b, the porosity of N3–PCN-333(Cr) was almost perfectly retained 
compared to its starting material, N3–PCN-333(Fe). According to DFT pore size 
distribution, a reduced pore size of the smallest pore in both N3–PCN-333(Fe) and N3–
PCN-333(Cr) was observed (Figure 3.10). This suggests the presence of functional group 
on the N3–BTB affected the smallest cage most. However, as we analyzed in the previous 
study, the middle-sized cages (∼4.5 nm) and the largest cages (∼5.5 nm) remained less 
affected due to their extralarge size. Thus, dual exchanged PCN-333(Cr) also showed well 
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preserved characteristics of mesoporosity after going through a sequential exchange of 
ligands and metals. IR spectrum of N3–PCN-333(Cr) clearly showed the azide stretching 
band, which further confirms the undamaged functional group after the dual exchange 
process (Figure 3.11). In addition, after the metal metathesis from Fe(III) to inert Cr(III) 
of azide functionalized PCN-333, significantly enhanced stability than that of the parent 
material was observed. For instance, PXRD patterns showed that crystallinity of N3–PCN-
333(Cr) remains intact after submersion in deionized water for 7 days whereas that of N3–
PCN-333(Fe) showed gradually decreasing crystallinity upon the identical treatment. 
Moreover, N3–PCN-333(Cr) showed well maintained crystallinity in harsh conditions, 
such as in 1 M HCl and 10 mM NaOH after treatment for 24 h, while N3–PCN-333(Fe) 
was dissolved under the same conditions (Figures 3.9c,d). These findings suggest that dual 
exchange can be used as a means to prepare functionalized Cr-MOF. Expectedly, our 
results show successful dual exchange process via path 1, but not via path 2. This may 
seem different from a work by Cohen and co-workers that has studied a similar concept, 
called tandem exchange,49 which is the only example involving both ligand exchange and 
metal metathesis within one framework yet to our best knowledge. Tandem exchange 
allowed for the preparation of microporous heterometallic zeolitic imidazolate 
frameworks (ZIFs), where two routes (e.g., different sequences of exchanges similar to 
Scheme 3.1) showed very similar results out of any pathway because of the similar lability 
of Zn–imidazolate and Mn–imidazolate bonds. Nonetheless, considering the different M–
L bond natures and structures of each MOF, our rationalizations still validate the 
unfeasibility of dual exchange via path 2, while supporting path 1 in the current work and 
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the results of Cohen’s work. As we have demonstrated the successful ligand exchange in 
PCN-333(Fe) with a variety of BTB derivatives, other functional groups could also be 
introduced into PCN-333(Cr). Therefore, dual exchange strategy not only provides a facile 
route to obtain extremely robust Cr-MOFs, but also allows a generalized functionalization 
method of highly stable Cr-MOFs, which can vastly expand the scope of MOF 
applications. 
 
Figure 3.12 (a) TEPP used for the click reaction in N3-PCN-333(Cr). (b) IR spectra of N3-
PCN-333(Cr) before and after the click reaction. (c) SEM-EDX mapping of N3-PCN-
333(Cr) after the click reaction. 
 
 
Click reaction in N3–PCN-333(Cr) 
 Having dual exchanged MOF prepared, a click reaction was performed on N3–
PCN-333(Cr) to demonstrate the introduction of large entity (Table 3.1). To illustrate our 
concept, meso-tetra(4-ethylphenyl)porphyrin (TEPP) was synthesized due to its two-
dimensional large size (18 Å × 18 Å), which will demonstrate the feasibility of covalent 
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anchorage of a large guest molecule in the dual exchanged platform. The center of TEPP 
was metalated with Zn(II) aiming to achieve information about its spatial distribution by 
scanning electron microscopy/energy-dispersive X-ray spectroscopy (SEM/EDX). With 
this in mind, the click reaction between the N3–PCN-333(Cr) and Zn-TEPP was performed 
in the presence of CuI in DMF (60 °C, 28 h) with stirring. The completion of reaction was 
determined by the disappearance of the azide band at 2106 cm–1 in the IR spectrum as 
shown in Figure 3.12b. The color of sample changed from green to dark purple upon the 
anchorage of Zn-TEPP in PCN-333(Cr), indicating successful incorporation of the 
strongly colored porphyrin (Figure 3.9a). In addition, the PXRD pattern of the clicked 
MOF also showed unaltered diffraction peaks, suggesting the robustness of PCN-333(Cr) 
scaffold (Figure 3.8). In parallel, porosity of N3–PCN-333(Cr) was also examined. Figure 
3.9b showed reduced N2 uptake, which distinctly indicates the inserted TEPP does take up 
the corresponding pore volume in the MOF. Nevertheless, even after the incorporation of 
such large entity, the material still retains sufficient porosity (pore volume 1.60 cm3/g) 
which may allow a volumetric capacity for further generations of guest molecules 
inclusion in PCN-333(Cr). As the size of TEPP is larger than the smallest cages (11 Å) in 
PCN-333, but much smaller than the middle sized cages (45 Å) and the largest cages (55 
Å), theoretically Zn-TEPP can only occupy the middle sized cages and the largest cages. 
Expectedly, the pore size distribution showed the decreased size of middle cages and 
largest cages, as well as significantly decreased pore volume of those two cages while the 
smallest cage is not much affected after N3–BTB insertion, which matches well with our 
size analysis (Figure 3.13). Next, we further sought to visualize positions of Zn-TEPP in 
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the PCN-333(Cr). As shown in Figure 3.12c, SEM/EDX mapping of this sample shows 
the inserted Zn-TEPP molecules via click reaction are well distributed throughout the 
crystals, indicating the exchanged ligands are well dispersed and the click reaction 
occurred evenly in the MOF through the efficient diffusion utilizing its large pores. 
Considering an ideal atomic ratio between M(III) and ligands in PCN-333(M) is 3:2 by 
structure, the ratio of ∼5:1 between Cr(III) and N3–BTB is expected in the framework, 
based on the ∼30% of ligand exchange. In accordance with this analysis, the EDX results 
of clicked-PCN-333(Cr) matched well (Cr:Zn = 4.86:1), which further supports most azide 
group in the MOF reacted with the large guest molecule, TEPP, as well as successful 
incorporation of N3–BTB (Table 3.2). 
 
Figure 3.13 Comparison of DFT pore size distributions before and after the click reaction 
with TEPP (obtained from N2 sorption isotherm at 77 K). 
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Table 3.2 Summary of EDX results. Numbers presented in the table were the average of 
at least three independent measurements. *Standard Deviation. 
Sc 
(atomic %) 
Fe 
(atomic %) 
Cr 
(atomic %) 
Cr Exchange 
Ratio (%) *SD (%)
PCN-333(Sc/Cr) 
at 85 °C 2.99 n/a 1.77 37.03 ±3.79 
PCN-333(Sc/Cr) 
at 150 °C 2.08 n/a 3.68 64.83 ±2.12 
PCN-333(Fe/Cr) 
at 85 °C n/a 4.83 1.56 23.02 ±8.34 
PCN-333(Fe/Cr) 
at 150 °C n/a 0.02 5.02 99.79 ±0.30 
N3-PCN-
333(Fe/Cr) 
at 150 °C 
n/a 0.09 4.4 97.48 ±3.56 
Fe 
(atomic %) 
Cr 
(atomic %) 
Zn 
(atomic %) Cr:Zn ratio 
Clicked-N3-PCN-
333(Cr) 0 3.69 0.76 4.86:1 
3.4 Conclusions 
In summary, a dual mode of postsynthetic exchange (dual exchange), involving a 
sequential exchange of ligands and metals in PCN-333(Fe) has been studied for the 
preparation of functionalized PCN-333(Cr). These results illustrate a possible step forward 
for the functionalization of mesoporous Cr-MOFs that allow covalent anchors for guest 
molecules, sufficient room (extralarge pore) for the introduction of secondary 
functionality, and exceptional stability from inert Cr(III). In addition, our rational design 
and analyses of dual exchange process give a comprehensive understanding of chemical 
dynamics in PCN-333 during dual exchange, following up our previous study of ligand 
exchange in this platform. The dual exchanged Cr-MOF, N3–PCN-333(Cr) showed 
maintained integrity of the parent MOF, functionality, and enhanced chemical stability. 
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Meanwhile, dual exchange strategy may allow incorporation other wanted functional 
groups into PCN-333(Cr) platform, as noted. These findings have enabled the preparation 
of functionalized PCN-333(Cr) with a design flexibility to be utilized as a stable platform 
for a variety of desired applications by exploiting facile functionalization, enhanced 
chemical stability, and extremely large pores which will allow for more possible chemistry 
with MOFs. 
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4. PHOTOCHROMIC METAL–ORGANIC FRAMEWORKS: REVERSIBLE 
CONTROL OF SINGLET OXYGEN GENERATION* 
4.1 Introduction 
 Singlet oxygen (1O2) is a reactive oxygen species (ROS) which can be generated 
by cellular metabolism, redox chemistry, or photosensitization between a photosensitizer 
and molecular oxygen (3O2) upon irradiation.133-138 The development of a photosensitizer 
for the generation of singlet oxygen is of great interest owing to potential applications 
including industrial wastewater, photochemical synthesis, and photodynamic therapy 
(PDT).139-146 While progress has been made to advance photosensitizers, more recently 
the design of a system in which the production of singlet oxygen is can be controlled or 
activated, upon environmental changes or interaction with biomolecules or nanomaterials, 
has attracted growing attention.139,147-153 However, such methods often involve irreversible 
or passive interaction, which may lead to imprecise control over 1O2 generation. In this 
sense, a system which inherently bears a photosensitizer and control functionality could 
be ideal to achieve controlled generation of singlet oxygen. 
 Photochromic molecules, which upon photoirradiation exhibit a reversible 
transformation between isomers having different properties, hold considerable promise 
for optical switches as a control unit in smart materials.154-156 Of the many photochromic 
compounds, dithienylethene (DTE) derivatives are one of the most promising class of 
compounds because of their thermal stability, rapid response, and fatigue resistance.154,157-
                                                
*Reproduced with permission from Park, J.; Feng, D.; Yuan, S.; Zhou, H.-C. Angew. Chem. Int. Ed. 2015, 
54, 430–435. Copyright 2015 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim. 
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160 By employing the DTE photochromic switch and a porphyrinic photosensitizer in a 
homogeneous bicomponent system, Feringa et al. have recently demonstrated reversible 
control of singlet oxygen generation.161  
 Attachment of the catalyst onto solid support materials, such as silica or metal 
oxides, has shown the potential to integrate distinctive attributes of both homogeneous 
and heterogeneous catalysis.162-164 For instance, a heterogeneous system of two or more 
incompatible components could be of great value because of the ability to accommodate 
various functionalities as well as efficient recovery and recyclability. Along these lines, 
researchers have strived to design a photosensitizer in a hybrid material form to 
incorporate these features into one system for photocatalysis.165-173 However, most of the 
approaches suffer from synthetic difficulty, leaching, and improper spatial 
arrangement.162,167,174 
 Metal–organic frameworks (MOFs) are an emerging class of porous materials and 
have captured widespread research interest because of their design flexibility and viability 
in potential applications such as gas storage/separation, sensing, and catalysis.1,70,71 More 
recently, MOFs have been explored as light-harvesting platforms.6,175-179 Because MOFs 
provide highly ordered structures in proximity to each other but not in direct contact, 
incorporation of chromophores as linkers to construct MOFs gives rise to an efficient 
platform for energy transfer. As a result of the structural diversity and tunability of MOFs, 
it is very convenient to introduce multiple functional moieties into the framework, thus 
making MOFs as ideal candidates for realizing cooperative functionalities based on 
periodic arrangement on a molecular scale.180 Meanwhile, leaching of each component 
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can be alleviated on account of the strong coordination bond. Moreover, the porous feature 
of MOFs allows all the functionalities within the framework to be accessible by incoming 
reactants regardless of their solubility. 
 Herein, we present two MOFs, namely PC-PCN (photochromic porous 
coordination network) and SO-PCN (singlet oxygen-generating porous coordination 
network) which contain 1,2-bis(2-methyl-5-(pyridin-4-yl)thiophen-3-yl)cyclopent-1-ene 
(BPDTE) as a photochromic switch. Notably, a molecular dyad system which contains a 
photochromic switch and photosensitizer was well established with SO-PCN. The 
reversible control over 1O2 generation through a competition of energy transfer pathways 
upon irradiation at specific wavelengths in SO-PCN was studied. Also, SO-PCN was 
demonstrated as a heterogeneous catalyst for photooxidation of 1,5-dihydroxynaphthalene 
(DHN). 
4.2 Experimental section 
Materials 
 All starting materials and solvents were used as received without further 
purification from commercial suppliers. 2-Chloro-5-methylthiophene was purchased from 
Alfa Aesar. Silica gel (40 − 42 µm) was purchased from Silicycle Inc. The abbreviation 
for some solvents and reagents were listed here: N,N-dimethylformamide (DMF), 
dimethylsulfoxide (DMSO), acetonitrile (MeCN), tetrahydrofuran (THF), and ethyl 
acetate (EtOAc). 
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Instrumentation 
 Synthetic manipulations that required an inert atmosphere (where noted) were 
carried out under nitrogen using standard Schlenk techniques. Nuclear magnetic resonance 
(NMR) spectra were recorded on Mercury 300 spectrometer and Varian Inova 500 
spectrometer. The chemical shifts are given in units of δ (ppm) relative to 
tetramethylsilane (TMS) where δ (TMS) = 0, or referenced to the residual solvent 
resonances. Splitting patterns are denoted as s (singlet), d (doublet), t (triplet), q (quartet), 
quin (quintet), m (multiplet), and br (broad). Single crystal diffraction data set was 
collected at 110 K on a Bruker APEX CCD diffractometer with MoKα radiation (λ = 
0.71609 Å). Powder X-ray diffraction (PXRD) was carried out on a Bruker D8-Focus 
Bragg-Brentano X-ray powder Diffractometer equipped with a Cu sealed tube (λ = 
1.54178) at 40 kV and 40 mA. UV-Vis spectra were recorded on Shimadzu UV-2450 
spectrophotometer. Fluorescence spectra were recorded on Horiba Fluorolog 
spectrofluorometer. Fourier transform infrared (IR) measurements were performed on a 
Shimadzu IR Affinity-1 spectrometer.  High resolution electrospray ionization mass (ESI-
MS) spectra was obtained at Texas A&M university mass spectrometry facility. 
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Synthesis 
 
Scheme 4.1 Synthetic scheme of 3 
 
 1,5-Bis-3-(2-chloro-5-dimethylthienyl)-1,5-pentadione (1). To a mixture of 2-
Chloro-5-methylthiophene (5 g, 37.7 mmol) and glutaryl chloride (3 g, 17.95 mmol) in 
nitromethane (150 mL) was added AlCl3 (5.3 g, 39.5 mmol) under N2 atmosphere at 0 °C. 
The solution was then stirred for 4 h at room temperature. Afterward, the reaction mixture 
was poured onto ice-water and the resulting mixture was extracted with CH2Cl2. The 
combined organic layers were dried over anhydrous MgSO4, the solvent was removed in 
vacuo and the resulting crude product was purified by column chromatography (silica, 
hexanes: EtOAc = 30:1) to yield 1 as a light yellow solid (84%).1H NMR (500 MHz, 
CDCl3): δ = 7.18 (s, 2H), 2.86 (t, 4H), 2.66 (s, 6H), 2.06 (quin, 2H). 13C NMR (125 MHz, 
CDCl3): 194.9, 147.7, 134.9, 126.8, 125.3, 40.5, 18.1, 16.1. 
 1,2-bis(5-chloro-2-methylthiophen-3-yl)cyclopent-1-ene (2). TiCl4 (3.9 g, 20.7 
mmol) was dissolved cautiously in ice-cooled dry THF (200 mL) under N2 atmosphere 
whereupon the solution turned yellow. To the mixture was added Zn powder (1.63 g, 25 
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mmol) and the resulting mixture was stirred for 45 min at 65 °C. Afterwards, the reaction 
was cooled to 0 °C with an ice bath and compound 1 (3 g, 8.3 mmol) was added and was 
reheated to 65 °C for 4 h. A few drops of saturated aq. K2CO3 solution was added to the 
mixture followed by filtration over Celite and washing with EtOAc, and the filtrate was 
dried over anhydrous MgSO4. The crude product was purified by column chromatography 
(silica, pure hexanes) to afford 2 as a pale yellow solid (91%). 1H NMR (500 MHz, 
CDCl3): δ = 6.58 (s, 2H), 2.71(t, 4H), 2.02 (qiun, 2H), 1.88 (s, 6H). 13C NMR (125 MHz, 
CDCl3): δ = 134.8, 134.4, 133.3, 126.7, 125.2, 38.3, 22.8, 14.2. 
 1,2-bis(2-methyl-5-(pyridin-4-yl)thiophen-3-yl)cyclopent-1-ene (3). To a two-
neck round bottom flask, 1,2-bis(5-chloro-2-methylthiophen-3-yl)cyclopent-1-ene (2.44 
g, 7.41 mmol) and dry THF (30 mL) were added under nitrogen atmosphere. The resulting 
mixture was cooled with an ice bath and 2.5 M n-BuLi (6.52 mL, 16.3 mmol) was slowly 
added. During the addition the mixture turned dark pink. Upon completion of addition, it 
was stirred for another 30 min at the same temperature. Subsequently, tris-n-butylborate 
(5.12 g, 6.0 mL, 22.23 mmol) was added and the resulted orange solution was allowed to 
warm up to room temperature and stirred for 1h. Concurrently to another two-neck flask 
equipped with a condenser, Pd(PPh3)4 (500 mg, 5 mol%) was suspended in THF (25 mL) 
and the resulting mixture was heated at 70 °C. After 30 min, aqueous 2.5 M K2CO3 (30 
mL), ethylene glycol (10 drops), 4-bromopyridine hydrochloride (3.16 g, 16.3 mmol) were 
added.  Afterwards, previously prepared reaction mixture was slowly added to this orange 
solution. The mixture was heated at 70 °C overnight until complete consumption of 
starting materials and cooled to room temperature followed by addition of water (20 mL). 
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Crude was extraction with diethyl ether and the combined organic phases were dried over 
anhydrous MgSO4, the solvent was removed under vacuum and the resulting crude 
product was purified by column chromatography (silica, pure acetone) to yield 3. The 
product was obtained as a light violet solid in 91% yield. 1H NMR (500 MHz, CDCl3): δ 
= 8.55 (d, 4H), 7.43(d, 4H), 7.28 (s, 2H), 2.87 (t, 4H), 2.14 (quin, 2H), 2.05 (s, 6H). 
 
Scheme 4.2 Synthesis of M-TCPP 
 
 5,10,15,20-Tetrakis(4-methoxycarbonylphenyl)porphyrin (TPPCOOMe). To 
refluxed propionic acid (100 mL) in a 500 mL three-neck flask were added pyrrole (3.0 g, 
0.043 mol) and methyl p-formylbenzoate (6.9 g, 0.042 mol), and the mixture was refluxed 
for 12 h in dark. After the reaction mixture was cooled to room temperature, crystals were 
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collected by filtration to afford purple crystals (1.9 g, 21% yield). 1 H NMR (300 MHz, 
CDCl3 ) δ = 8.81 (s, 8H), 8.43 (d, 8H), 8.28 (d, 8H), 4.11 (s, 12H), 2.83 (s, 2H). 
 [5,10,15,20-Tetrakis(4-carboxyphenyl)porphyrinato]-Zn(II). The obtained 
ester compound (0.75 g) was stirred in THF (25 mL) and MeOH (25 mL) mixed solvent, 
to which a solution of KOH (2.63 g, 46.95 mmol) in H2O (25 mL) was introduced. This 
mixture was refluxed for 12 h. After cooling down to room temperature, THF and MeOH 
were evaporated. Additional water was added to the resulting water phase and the mixture 
was heated until the solid was fully dissolved, then the homogeneous solution was 
acidified with 1 M HCl until no further precipitate was detected. The violet solid was 
collected by filtration, washed with water and dried in vacuum. FTIR (KBr): ν= 3438 (m), 
3040 (m), 2665 (w), 1680 (s), 1605 (s), 1565 (m), 1504 (m), 1423 (s), 1316 (m), 1291 (s), 
1182 (m), 1105 (m), 1002 (s), 867 (m), 798 (s), 768 (m), 720 (m) cm-1. 
 [5,10,15,20-Tetrakis(4-methoxycarbonylphenyl)porphyrinato]-Fe(III) 
Chloride. A solution of TPP-COOMe 0.854 g (1.0 mmol) and FeCl2·4H2O (2.5 g, 12.8 
mmol) in 100 mL of DMF was refluxed for 6 h. After the mixture was cooled to room 
temperature, 150 mL of H2O was added. The resultant precipitate was filtered and washed 
with 50 mL of H2O for two times. The obtained solid was dissolved in CHCl3, followed 
by washing three times with 1 M HCl and twice with water. The organic layer was dried 
over anhydrous magnesium sulfate and evaporated to afford quantitative dark brown 
crystals. FTIR (KBr): ν= 3444 (m), 3034 (w), 2634 (w), 1702 (s), 1614 (s), 1570 (m), 
1404 (s), 1311 (m), 1277 (s), 1204 (m), 1180 (m), 1106 (m), 1004 (s), 862 (m), 799 (s), 
770 (s), 721 (m) cm-1. 
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 Synthesis of PC-PCN. BPDTE (9 mg), DBTCB (10 mg), Zn(NO3)2.6H2O (35 
mg), and tetrafluoroboric acid (one drop) in 2 mL of DMF were ultrasonically dissolved 
in a 4 mL Pyrex vial. The mixture was heated at 85 ºC in a pre-heated oven for 18 h. After 
cooling to room temperature, a light yellow crystal was harvested. 
 Synthesis of SO-PCN. H2-TCPP (10 mg), Zn(NO3)2.6H2O (35 mg) in 2 mL of 
DMF/DEF were ultrasonically dissolved in a 4 mL Pyrex vial. The mixture was heated at 
85 ºC in a pre-heated oven for 2 h. After that, BPDTE (9 mg) and tetrafluoroboric acid (1 
µL) were added and the mixture was heated for 12 h. After cooling to room temperature, 
purple crystals were harvested.  
Instrumental set-up and general procedure 
 Spectrophotometric grade CH3CN was used for spectroscopic measurements 
(Acros). Zn-TCPP was excited by 405 nm CW laser and laser power was measured by a 
laser powermeter (Thorlabs). Visible irradiation was provided using a fiber optic coupled 
halogen lamp (150 W, AmScope) combined with a 450 nm long pass filter (Thorlabs). UV 
irradiation was made using a 365 nm spectroline lamp (0.2 amp). To close the BPDTE 30 
min of UV irradiation was employed, while 2 h of visible light was irradiated to re-open 
the BDPTE pillar. 
 Prior to addition of the DPBF, SO-PCN was washed thoroughly with hot DMF 
followed by acetonitrile until no residual ligands in the supernatant were detected by UV-
Vis spectroscopy. Acetonitrile was bubbled with oxygen for 20 min before the 
measurements, where experiments are conducted in the presence of oxygen. For the 
control experiment in which the absence of oxygen was required, stock solution and 
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reaction medium were bubbled with nitrogen flow for 30 min. All stock solutions and SO-
PCN samples prepared were kept in the dark before the measurements. 
4.3 Results and discussion 
 Porphyrin derivatives have been widely used for 1O2 generation because of their 
well-known photochemistry and high efficiency in light harvesting.140 The dithienylethene 
derivative, BPDTE, serving as a photochromic switch can undergo a reversible 6π 
electrocyclic reaction upon photoirradiation at distinct wavelengths (e.g., ultraviolet or 
visible). The open and closed forms of BDPTE resulting from photoisomerization exhibit 
distinctive absorption properties, and can provide different energy transfer pathways for 
photosensitizers to control the 1O2 generation (Figure 4.1a,c). As one of the most 
frequently used linkers in porphyrinic MOFs, tetrakis(4-carboxyphenyl)-porphyrin 
(TCPP) has been extensively explored to construct different MOFs.6,177,181 Particularly, 
pillar-layer three-dimensional (3D) frameworks, which are constructed from TCPP mixed 
with linear dipyridyl linkers, have been widely studied because of the ease of design and 
synthesis. Simultaneously, BPDTE, having dipyridyl heads, is ideal for forming the pillar-
layer structure with TCPP to provide a solid-state platform for the controlled generation 
of singlet oxygen.  
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Figure 4.1 (a) Photoisomerization of BPDTE under UV and visible light. (b) Structures 
of ligands consist of 2D layers in PC-PCN and SO-PCN, respectively. (c) UV-Vis spectra 
of H4Zn-TCPP and two different forms of BPDTE. 
 
 Such structures lead to a paddlewheel-type of inorganic building block and gives 
rise to a 1:1 ratio between the photosensitizer (TCPP) and the photochromic switch 
(BPDTE), and precisely matches the stoichiometry in an ideal energy transfer process. We 
selected Zn2+ as the inorganic species, because its d10 configuration is unlikely to disturb 
the energy transfer between TCPP and BPDTE. In general, photoisomerizations rarely 
occur in crystals because a large structural change is extremely unfavorable in the solid 
state. As an exceptional example, DTE derivatives undergo only a small structural change 
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upon photoisomerization and therefore photochromism in the single crystalline phase can 
be achieved.182 Thus BPDTE in the framework may still retain its photochromic property 
without significant alteration or breaking of the 3D structure. 
 The solvothermal reaction of BPDTE, TCPP (no metal), Zn(NO3)2⋅6H2O in DMF 
and tetrafluoroboric acid at 85 °C for 15 hours resulted in platelike, dark-purple single 
crystals (SO-PCN). Although some of the single crystals are large enough in two of the 
three dimensions, because of the limited thickness of the crystals, diffractions from certain 
directions are too weak to determine the overall structure. Since the crystal growth 
behavior differs with the variation of the metal species within the TCPP center, as 
observed for a series of Zr-MOFs,33,183  we tried other metallo-TCPP (M-TCPP, where M 
is Cu, Co, Ni, Mn, and Fe) species and obtained much thicker crystals using Fe-TCPP. 
With better diffraction patterns, the space group of SO-PCN was determined to be 
P4/mmm, which has a unit cell parameter of a≈16.63 Å and b≈22.28 Å. From the solved 
structure, porphyrin layers are clearly observed while the pillars are missing because of 
the random orientation of the pillars resulting from the free rotation of the single bonds. 
However, the distance between Zn2 paddlewheels in the adjacent layers precisely matches 
the length of BPDTE, which indicates the formation of our expected structure. The 
simulated structure showed good agreement with the experimental PXRD pattern of SO-
PCN. 1H NMR spectrum, upon digestion of SO-PCN, shows a 1:1 ratio between Zn-TCPP 
and BPDTE, and further confirms the structure. 
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Figure 4.2 Illustration of reversible photochromic reaction in PC-PCN. Colorless single 
crystal (left, bulk in yellow) turns blue (right, bulk in purple) upon UV irradiation (λ=365 
nm) and it goes back to colorless form under visible light (with λ=450 nm cut-on filter). 
Single crystals are highlighted in the insets. 
 
 Intuitively, direct evidence showing the presence of BPDTE in SO-PCN could be 
a color change of BPDTE upon photoirradiation. However, the dark-purple Zn-TCPP 
impedes the observation of the color change from the photochromic pillar. Hence, we 
chose a colorless tetratopic carboxylate linker DBTCB, which has been reported to form 
a similar structure with TCPP, to show the photochromism of the BPDTE pillar (Figure 
4.1b). Under similar solvothermal conditions, a colorless flake-shaped single crystal of 
PC-PCN, which has a light-yellow color in the bulk sample, was obtained (Figure 4.2). 
Single-crystal X-ray diffraction of PC-PCN shows dipyridine coordination but the BPDTE 
pillar was not clearly solved because of the significant disorder as discussed above. PC-
PCN exhibits the same layer to layer distance (21.69 Å) as in SO-PCN and also exhibits a 
1:1 ratio between BPDTE and DBTCB, thus further validating SO-PCN as our expected 
structure. When the open form of PC-PCN in the bulk was irradiated under ultraviolet 
(UV) light, deep-purple crystals of PC-PCN were clearly observed by the naked eye within 
10 minutes, and suggests the pillar ligands were closed. Irradiation with visible light 
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(λ>450 nm) was performed on these purple crystals to re-open the closed pillars and the 
recovery of the light-yellow color was observed in 1 hour. We further examined the 
photochromic reaction in a single crystal to single crystal fashion in PC-PCN. As shown 
in Figure 4.2, single crystallinity of PC-PCN was almost completely maintained upon 
alternating irradiation, thus demonstrating excellent structural reversibility of the BPDTE 
pillar within the framework. 
 
 
Figure 4.3 (a) Proposed mechanism of energy transfer (EnT) in SO-PCN. (b) Illustration 
of switching operation in SO-PCN. 
 
 Having demonstrated the photoisomerization of BPDTE in PC-PCN, we then 
examined SO-PCN for regulating 1O2 generation. To evaluate the ability of SO-PCN in 
generating singlet oxygen, 1,3-diphenylisobenzofuran (DPBF), a well-known 1O2 
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scavenger, was used to detect the 1O2 produced in our system. Upon oxidative degradation 
of DPBF by 1O2, the absorption of DPBF at λ=410 nm decreased, thus serving as an 
indication of the singlet oxygen generated. First, the experiment was carried out using a 
visible light source (λ>450 nm) at room temperature to examine the photosensitizing 
ability of SO-PCN. Prior to addition of the probe, SO-PCN was washed thoroughly with 
hot DMF followed by acetonitrile until no residual ligands in the supernatant were 
detected by UV-Vis spectroscopy. Acetonitrile was bubbled with oxygen for 20 minutes 
before the measurements. 
 
Figure 4.4 (a) Absorbance decay of DPBF (left) and the corresponding spectra in the 
presence of SO-PCN (right). (b) Emission spectra of SO-PCN showing reversibility. (c) 
Comparison of decay rate of DPBF upon on/off switching. 
 
 As a control experiment, DPBF (50 µM) in acetonitrile without SO-PCN was 
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irradiated by visible light (λ>450 nm). Only a negligible decrease in the absorbance of 
DPBF was observed during 150 seconds of irradiation, and indicates DPBF was stable 
under these conditions. Knowing this, we examined the photosensitization of the open 
form of SO-PCN (1.42 µmol) using DPBF (50 µM) in 2.8 mL of acetonitrile. Upon 
irradiation, the absorbance at λ=410 nm showed a complete degradation within 150 
seconds, thus suggesting excellent photosensitizing ability of SO-PCN (Figure 4.4a). 
 
 
Figure 4.5 Scheme of switching operation in SO-PCN. 
 
 Next, we investigated the control of the switch (BPDTE) embedded in SO-PCN 
for 1O2 generation upon photoisomerization. Figure 4.3a illustrates a proposed mechanism 
of control of 1O2 generation in SO-PCN by an energy transfer (EnT) process. Energy 
transfer of excited Zn-TCPP is known to be dependent on triplet energy of BPDTE161,184-
186 because of different photophysical properties of its isomers. When Zn-TCPP in SO-
PCN is excited, the triplet energy of 3[Zn-TCPP]* can follow different pathways for 
energy transfer depending on the state of BPDTE. For example, 1O2 can be generated when 
the EnT process occurs from 3[Zn-TCPP]* in the open form of SO-PCN to 3O2 (Path 1 in 
Figure 4.3a). Another pathway is based on the energy state of closed form of BPDTE, 
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which lies at a lower energy than that of 3[Zn-TCPP]*, thus the energy transfer takes place 
to the closed BPDTE and results in quenching of 1O2 generation. The feasibility of 
reversible energy transfer of the TCPP-BPDTE dyad in SO-PCN was evaluated by 
recording emission spectra. We chose a Soret band (λ=420 nm) to excite the SO-PCN to 
circumvent potential interference of the switching operation (Figure 4.5). The emission 
spectrum of open SO-PCN shows emission maxima at λ=605 nm and λ=655 nm in CH3CN 
(λex=420 nm). To close the BPDTE pillars in SO-PCN, UV light (λ=365 nm) was used. 
The emission was gradually quenched by EnT to the closed BPDTE and no further 
quenching was observed after 30 minutes. Recovery of emission upon photoisomerization 
was subsequently carried out with visible light (λ>450 nm), and a complete recovery was 
made in 120 minutes (Figure 4.4b). 
 
Figure 4.6 Control experiments showing absorbance decay of (green) pure DPBF in the 
absence of SO-PCN and (blue) DPBF with the closed form of SO-PCN in the absence of 
oxygen. 
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 After validating reversibility in SO-PCN, the system was excited by a λ=405 nm 
CW laser to examine the controlled 1O2 generation by on/off switching (Figure 4.3b). 
Evolution of 1O2 with the open form of SO-PCN was monitored by UV/Vis spectra every 
10 seconds. Over the course of 60 seconds with 6 mW cm−2 of laser power, 30 % of DPBF 
absorption decreased compared to its initial absorption, whereas the closed form of SO-
PCN showed an approximately 15 % decrease in absorbance at λ=410 nm. A steeper slope 
of the open form of SO-PCN suggests the energy of 3[Zn-TCPP]* was transferred to 3O2 
to generate 1O2, while that of the closed form was quenched by closed BPDTE, thus 
resulting in less efficient 1O2 generation (Figure 4.4c). When we attempted to perform a 
control experiment, we found that the laser irradiation led to a complete degradation of 
DPBF in the absence of SO-PCN within 60 seconds (Figure 4.6). Presumably because of 
the light sensitive nature of DPBF, the laser significantly affected DPBF solution in the 
absence of other chromophores. To obtain a practical blank of our system, we further 
examined the system with DPBF and the closed form of SO-PCN. An N2 saturated solvent 
was employed to suppress the supply of oxygen so that we could examine the system 
solely with photodegradation of DPBF in the presence of closed SO-PCN (other 
chromophores). Interestingly in this control experiment, the rate and extent of decrease in 
absorption at λ=410 nm of DPBF were very similar to previous experimental data of the 
closed SO-PCN with oxygen (Figure 4.6), and further confirms that a successful switching 
operation, using photoisomerization of BPDTE towards 1O2 generation in SO-PCN, was 
demonstrated. 
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Figure 4.7 (a) Photooxidation of DHN catalyzed by SO-PCN in the presence of oxygen 
and light irradiation. (b) UV-Vis spectra of photooxidation of DHN in CH3CN catalyzed 
by SO-PCN. Inset: Absorbance of juglone (λ=419 nm) as a function of reaction time.  
 
 In addition to the ability to generate singlet oxygen, we further sought to study 
potential use of SO-PCN as a heterogeneous catalyst. Catalytic performance was 
demonstrated by photooxidation of DHN, which is mediated by 1O2 and resulted in the 
corresponding oxidized product juglone (Figure 4.7a). The photooxidation was carried out 
with 0.036 mmol of DHN in acetonitrile with 10 % SO-PCN (open form) under visible 
light irradiation (λ>450 nm). As the reaction occurred, the absorption peaks of the starting 
material at λ=298 nm and 330 nm decreased, whereas a characteristic peak of juglone 
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around λ=419 nm increased. After 30 hours, a significant decrease in absorption of DHN 
was observed, while leaching was not seen (Figure 4.7b). 
4.4 Conclusions 
 In summary, through a classical pillar-layer structure, we have developed two 
photochromic MOFs, PC-PCN and SO-PCN. Photochromism has been successfully 
realized in PC-PCN while maintaining its single crystallinity. In particular, as a solid-state 
material which inherently integrates a photochromic switch and photosensitizer, SO-PCN 
has demonstrated reversible control of 1O2 generation. Meanwhile, SO-PCN shows 
catalytic activity towards photooxidation of DHN. Based on the photophysical properties 
of the chromophore dyads realized within the MOF regime, our findings can be extended 
to the design of materials for potential applications in photocatalysis, photoswitching, and 
sensing. 
  
97 
5. CONTROLLED GENERATION OF SINGLET OXYGEN IN LIVING CELLS
WITH TUNABLE RATIOS OF THE PHOTOCHROMIC SWITCH IN METAL–
ORGANIC FRAMEWORKS* 
5.1 Introduction 
The development of photosensitizers that can control the generation of singlet 
oxygen (1O2) has gained increasing attention in photodynamic therapy (PDT) research to 
reduce nonspecific damage from undesirably generated 1O2.147,148 PDT is a minimally 
invasive cancer treatment using cytotoxic 1O2 that is generated by energy transfer (EnT) 
from an excited photosensitizer to molecular oxygen (3O2) upon appropriate light 
irradiation.187,188 In this regard, the addition of an activation step provides another layer of 
selectivity on top of the localized nature of PDT, which is based on the directed light 
placement at the tumor site. As such, PDT with an activatable photosensitizer becomes an 
appealing therapeutic option whose sensitizing ability is activated in response to target 
stimuli.147,189-191 However, common activation mechanisms often involve irreversible or 
passive means. Therefore, the capability of controlling 1O2 generation in a non-invasive 
and reversible manner is highly desired in photosensitizers. 
To address this issue, a molecular dyad consisting of a porphyrinic photosensitizer 
and a dithienylethene (DTE) derivative as a molecular switch to reversibly turn on/off the 
1O2 generation was reported.154,161,192-194 However, the delivery of such a complex system 
*Reproduced with permission from Park, J.; Jiang, Q.; Feng, D.; Zhou, H.-C., Angew. Chem. Int. Ed. 2016,
55, 7188–7193. Copyright 2016 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim. 
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with multiple components is a formidable challenge in biological environments owing to 
the different molecular properties of each component, resulting in distinctive cell response 
or permeability.195,196  
As a promising class of nanocarriers, metal–organic frameworks (MOFs) have 
captured extensive research interest because of their high porosity, synthetic tunability, 
and structural diversity.1,13,197 Recently, MOFs have been studied as an efficient platform 
for energy transfer between linkers because of the highly accessible and spatially discrete 
linkers in the framework.100,177,186,198-201 Herein we show energy transfer-based 1O2-
controlled PDT using a Zr-MOF as a nanocarrier, in which the photosensitizing system 
installed in the MOF pores can control the 1O2 generation using a photochromic switch. A 
widely employed photosensitizer, porphyrin140 and a DTE derivative were successfully 
incorporated into the Zr-MOF with adjustable ratios. Our strategy, therefore, allows 
optimization of the energy transfer for 1O2 control via fine-tuning of the ratios between 
two dyes incorporated into the MOF, as well as a successful delivery of the dyad into cells. 
5.2 Experimental section 
Materials 
Terephthalic acid (BDC) and 4-(2-Hydroxyethyl) piperazine-1-ethanesulfonic 
acid (HEPES) were purchased from Sigma-Aldrich. Tetrakis(4-carboxyphenyl)porphyrin 
(H2TCPP) was purchased from Frontier Scientific. Dulbecco’s modified Eagle medium 
(DMEM/HIGH GLUCOSE 1X) were purchased from HyClone, GE Life Sciences. Fetal 
bovine serum (FBS) was purchased from Gibco, Thermo Fisher Scientific. Cell culture 
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reagents were purchased from Invitrogen. Singlet Oxygen Sensor Green were purchased 
from Life Technologies (USA). Cell Counting Kit-8 (CCK-8) was obtained from 
Beyotime Institute of Biotechnology. Other chemicals were of at least analytical grade and 
were used as received. All aqueous solutions were prepared with Milli-Q water generated 
from a Milli-pore system (Bedford, MA). All other not mentioned starting materials and 
solvents were used as received without further purification from the following suppliers 
(Alfa Aesar, Sigma-Aldrich, TCI America, Cambridge Isotope, Oakwood Products, Fisher 
Scientific). The abbreviation for some solvents and reagents were listed here: N,N-
dimethylformamide (DMF), ethyl acetate (EtOAc), and dimethylsulfoxide (DMSO).  
Instrumentation 
Synthetic manipulations that required an inert atmosphere (where noted) were 
carried out under nitrogen using standard Schlenk techniques. Nuclear magnetic resonance 
(NMR) spectra were recorded on Varian Inova 500 spectrometer. The chemical shifts are 
given in units of δ (ppm) relative to tetramethylsilane (TMS) where δ (TMS) = 0, or 
referenced to the residual solvent resonances. Splitting patterns are denoted as s (singlet), 
d (doublet), t (triplet), q (quartet), quin (quintet), m (multiplet), and br (broad). Powder X-
ray diffraction (PXRD) was carried out on a Bruker D8-Focus Bragg-Brentano X-ray 
Powder Diffractometer equipped with a Cu sealed tube (λ = 1.54178) at 40 kV and 40 mA. 
N2 sorption isotherms at 77 K were measured by using a Micrometritics ASAP 2420 
system with high-purity grade (99.999%) of gases. UV-Vis spectra were recorded on 
Shimadzu UV-2450 spectrophotometer. Fluorescence spectra were recorded on a Hitachi 
F-4600 spectrometer (Hitachi Co. Ltd., Japan) with Xe lamp as the excitation source at 
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room temperature. Visible irradiation was provided using a fiber optic coupled halogen 
lamp (150 W, AmScope) combined with a 450 nm long pass filter (Thorlabs). UV 
irradiation was made using a 365 nm spectroline lamp (0.2 amp) unless otherwise noted. 
Dynamic light scattering and Zeta potential were measured at 25 °C on a Zetasizer Nano 
ZS ZEN3600 analyser (Malvern Instrument Ltd, UK). Singlet oxygen was generated from 
a CEL-S500 xenon lamp with separate passing filter (power density was 100 mW/cm2). 
Confocal laser scanning microscopy (CLSM) images were performed on an Olympus 
FV1000-IX81 CLSM and a Leica TCS SP confocal system (Leica, Germany). TEM 
images were taken on a transmission electron microscopy (JEOL JEM-2100F, Japan) 
operated at an acceleration voltage of 200 keV by dropping solution onto a carbon-coated 
copper grid. SEM image were recorded on a scanning electron microscopy (Hitachi 
S4800, Tokyo, Japan) operates at 10 keV. Energy-dispersive X-ray spectroscopy (EDS) 
characterization were taken on a scanning electron microscopy (Hitachi S4800, Tokyo, 
Japan) operates at 15 keV. X-ray photoelectron spectroscopy (XPS) was performed on an 
ESCALab 220i-XL electron spectrometer from VG Scientific using 300 W Al Kα 
radiation.  
Cell culture 
 Murine melanoma cell line B16F0 (called as B16) was supplied by KeyGEN 
Biotech. Co., Ltd. Cells were cultured in high-glucose DMEM supplemented with 10% 
(v/v) FBS and 1% antibiotics (penicillin/streptomycin, 100 U/mL) at 37 °C under a 5% 
CO2 atmosphere.  
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Cytotoxicity assay 
 The cytotoxicity of materials was tested on B16 cells using a standard CCK-8 
assay, as previously described. Cells were plated at a density of 1×104 /well in a 96-well 
cell culture plate at 37 °C under 5% CO2 atmosphere for 24 h. The cells were treated with 
increasing concentrations (20, 40, 60, 80, 100 µM) of samples (100 µL/well) as treatment 
group, treated with free DMEM (100 µL/well) as control group for 24 h at 37 °C under a 
5% CO2 atmosphere respectively. Afterward, the cells were grown in a fresh DMEM for 
another 24 h. Then combined CCK-8/DMEM solution (10 µL/100 µL) was added to each 
well for additional 1 h incubation under the same condition. An enzyme-linked 
immunosorbent assay (ELISA) reader (infinite M20, Tecan, Austria) was used to measure 
the OD450 (Absorbance value) of each well. The following formula was used to calculate 
the viability of cell growth: Cell Viability (%) = [(As-Ab) / (Ac-Ab)] ⋅ 100% 
Each independent experiment was performed in triplicate (As = OD value of treatment 
group, Ac = OD value of control group and the Ab = OD value of blank well). 
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Synthesis 
 
Scheme 5.1 Synthetic scheme of BCDTE. 
 
 1,5-Bis-3-(2-chloro-5-dimethylthienyl)-1,5-pentadione (1). To a mixture of 2-
Chloro-5-methylthiophene (5 g, 37.7 mmol) and glutaryl chloride (3 g, 17.95 mmol) in 
nitromethane (150 mL) was added AlCl3 (5.3 g, 39.5 mmol) under N2 atmosphere at 0 °C. 
The solution was then stirred for 4 h at room temperature. Afterward, the reaction mixture 
was poured onto ice-water and the resulting mixture was extracted with CH2Cl2. The 
combined organic layers were dried over anhydrous MgSO4, the solvent was removed in 
vacuo and the resulting crude product was purified by column chromatography (silica, 
hexanes: EtOAc = 30:1) to yield 1 as a light yellow solid (84%).1H NMR (500 MHz, 
CDCl3): δ = 7.18 (s, 2H), 2.86 (t, 4H), 2.66 (s, 6H), 2.06 (quin, 2H). 13C NMR (125 MHz, 
CDCl3): 194.9, 147.7, 134.9, 126.8, 125.3, 40.5, 18.1, 16.1. 
 1,2-bis(5-chloro-2-methylthiophen-3-yl)cyclopent-1-ene (2). TiCl4 (3.9 g, 20.7 
mmol) was dissolved cautiously in ice-cooled dry THF (200 mL) under N2 atmosphere 
whereupon the solution turned yellow. To the mixture was added Zn powder (1.63 g, 25 
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mmol) and the resulting mixture was stirred for 45 min at 65 °C. Afterwards, the reaction 
was cooled to 0 °C with an ice bath and compound 1 (3 g, 8.3 mmol) was added and was 
reheated to 65 °C for 4 h. A few drops of saturated aq. K2CO3 solution was added to the 
mixture followed by filtration over Celite and washing with EtOAc, and the filtrate was 
dried over anhydrous MgSO4. The crude product was purified by column chromatography 
(silica, pure hexanes) to afford 2 as a pale yellow solid (91%). 1H NMR (500 MHz, 
CDCl3): δ = 6.58 (s, 2H), 2.71(t, 4H), 2.02 (quin, 2H), 1.88 (s, 6H). 13C NMR (125 MHz, 
CDCl3): δ = 134.8, 134.4, 133.3, 126.7, 125.2, 38.3, 22.8, 14.2. 
 1,2-Bis(5-(4-ethyloxycarbonylphenyl)-2-methylthien-3-yl)cyclopent-1-ene (3). 
1,2-bis(5-chloro-2-methylthiophen-3-yl)cyclopent-1-ene (2) (2.00 g, 6.07 mmol) was 
dissolved in 60 mL of anhydrous THF and n-BuLi (2.5 M in hexane, 6.56 mL, 16.40 
mmol) was added dropwise at 0 °C. The solution was then stirred and warmed to room 
temperature for 30 min. Then, tri(n-butyl) borate (4.91 mL, 18.22 mmol) was added in 
one portion and the resulting mixture was stirred at room temperature for 1 h. In the 
meantime, ethyl 4-bromobenzoate (2.92 mL, 18.22 mmol) was dissolved in 20 mL of THF 
with Pd(PPh3)4 (0.70 g), and the mixture was stirred at room temperature for 15 min then 
heated to 80 °C. An aqueous solution of Na2CO3 (2 M, 50.0 mL) and the previously 
prepared solution of the borylated bisthienylcyclopentene were slowly added and the 
mixture was stirred at 80 °C for 16 h. After cooling to room temperature, 100 mL of water 
were added and the mixture was extracted with 50 mL of diethyl ether three times. The 
combined organic phases were washed with brine, dried over MgSO4. Purification by 
column chromatography (silica, petroleum ether: EtOAc = 10:1) afforded compound 3 
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(2.4 g, 71%) as a pale yellow solid. 1H NMR (500 MHz, CDCl3): δ (ppm) = 7.99 (d, 4 H), 
7.53 (d, 4 H), 7.12 (s, 2 H), 4.37 (q, 4 H), 2.85 (t, 4 H), 2.10 (quin, 2H), 2.02 (s, 6 H), 1.40 
(t, 6H). 13C NMR (126 MHz, CDCl3): δ (ppm) = 166.34, 138.57, 138.54, 137.01, 136.24, 
134.77, 130.20, 128.63, 125.48, 124.82, 60.93, 38.48, 23.03, 14.59, 14.39. 
 1,2-Bis(5-(4-carboxyphenyl)-2-methylthien-3-yl)cyclopent-1-ene (4) 
(BCDTE). 1,2-Bis(5-(4-ethyloxycarbonylphenyl)-2-methylthien-3-yl)cyclopent-1-ene 
(3) (1.0 g, 1.8 mmol) was suspended in 160 mL 1,4-dioxane/H2O (v:v = 1:1), and 2 g of 
KOH solution was added. The mixture was stirred overnight under reflux. The pH value 
was adjusted to ~pH 2 using 2 M HCl. The resulting white precipitate was collected by 
centrifugation, washed with water, and dried under vacuum to afford BCDTE (0.94 g, 
99%). 1H NMR (500 MHz, DMSO-d6): δ (ppm) = 12.93 (s, 2H), 7.92 (d, 4H), 7.66 (d, 
4H), 7.47 (s, 2H), 2.85 (t, 4 H), 2.07 (quin, 2H), 1.93 (s, 6H). 13C NMR (126 MHz, DMSO-
d6): δ (ppm) = 166.93, 137.83, 137.66, 137.07, 135.36, 134.29, 130.21, 129.05, 126.05, 
124.67, 38.12, 22.32, 14.16. 
 
Figure 5.1 Products by addition of the starting materials together when dissolving (left) 
and addition of BA stock solution to the mixture of BDC and ZrOCl2·8H2O in DMF 
(right). 
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 UiO-66 nanoparticles. Terephthalic acid (BDC) (15 mg, 0.09 mmol), zirconyl 
chloride octahydrate (ZrOCl2·8H2O) (20 mg, 0.062 mmol), and benzoic acid (BA) (200 
mg, 1.6 mmol) in 3 mL of N,N-dimethylformamide (DMF) were ultrasonically dissolved 
in a Pyrex vial. The reaction mixture was stirred (300 rpm) at 90 °C for 2.5 h. After the 
reaction is done, UiO-66 nanoparticles were collected by centrifugation (15000 rpm, 20 
min) followed by washing with fresh DMF for 3 times. The resulting UiO-66 nanoparticles 
were suspended in DMF for further characterization and analysis. 
 Note: The sequence of adding starting materials was important to obtain 
nanoparticles. All starting materials had to be added together with other starting materials 
to yield UiO-66 nanoparticles (Fig. S1, left). When BDC and ZrOCl2·8H2O were 
dissolved and stayed longer than ca. 5 min before the addition of BA, the reaction did not 
form nanoparticles, but clear solution under given reaction condition (Fig. S1, right). 
Therefore, this finding was applied in the following syntheses as well. 
 Sample 1. H2TCPP (0.5 mg, 0.0006 mmol), BDC (15 mg, 0.09 mmol), 
ZrOCl2·8H2O (20 mg, 0.062 mmol), and BA (200 mg, 1.6 mmol) in 3 mL of DMF were 
ultrasonically dissolved in a Pyrex vial. The reaction mixture was stirred (300 rpm) at 90 
°C for 2.5 h. The oil bath was covered with aluminum foil to avoid lights. After the 
reaction is done, nanoparticles were collected by centrifugation (15000 rpm, 20 min) 
followed by washing with fresh DMF for 3 times. The resulting nanoparticles were 
suspended in DMF for further characterization and analysis. 
 Sample 2. H2TCPP (0.5 mg, 0.0006 mmol), BCDTE (1 mg, 0.002 mmol), BDC 
(15 mg, 0.09 mmol), ZrOCl2·8H2O (20 mg, 0.062 mmol), and BA (200 mg, 1.6 mmol) in 
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3 mL of DMF were ultrasonically dissolved in a Pyrex vial. The reaction mixture was 
stirred (300 rpm) at 90 °C for 2.5 h. The oil bath was covered with aluminum foil to avoid 
lights. After the reaction is done, nanoparticles were collected by centrifugation (15000 
rpm, 20 min) followed by washing with fresh DMF for 3 times. The resulting nanoparticles 
were suspended in DMF for further characterization and analysis. 
 Sample 3. H2TCPP (0.5 mg, 0.0006 mmol), BCDTE (5 mg, 0.01 mmol), BDC (15 
mg, 0.09 mmol), ZrOCl2·8H2O (20 mg, 0.062 mmol), and BA (200 mg, 1.6 mmol) in 3 
mL of DMF were ultrasonically dissolved in a Pyrex vial. The reaction mixture was stirred 
(300 rpm) at 90 °C for 2.5 h. The oil bath was covered with aluminum foil to avoid lights. 
After the reaction is done, nanoparticles were collected by centrifugation (15000 rpm, 20 
min) followed by washing with fresh DMF for 3 times. The resulting nanoparticles were 
suspended in DMF for further characterization and analysis. 
 Sample 4. H2TCPP (0.5 mg, 0.0006 mmol), BCDTE (10 mg, 0.02 mmol), BDC 
(15 mg, 0.09 mmol), ZrOCl2·8H2O (20 mg, 0.062 mmol), and BA (200 mg, 1.6 mmol) in 
3 mL of DMF were ultrasonically dissolved in a Pyrex vial. The reaction mixture was 
stirred (300 rpm) at 90 °C for 2.5 h. The oil bath was covered with aluminum foil to avoid 
lights. After the reaction is done, nanoparticles were collected by centrifugation (15000 
rpm, 20 min) followed by washing with fresh DMF for 3 times. The resulting nanoparticles 
were suspended in DMF for further characterization and analysis. 
 Sample 5. H2TCPP (0.5 mg, 0.0006 mmol), BCDTE (15 mg, 0.03 mmol), BDC 
(15 mg, 0.09 mmol), ZrOCl2·8H2O (20 mg, 0.062 mmol), and BA (200 mg, 1.6 mmol) in 
3 mL of DMF were ultrasonically dissolved in a Pyrex vial. The reaction mixture was 
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stirred (300 rpm) at 90 °C for 2.5 h. The oil bath was covered with aluminum foil to avoid 
lights. After the reaction is done, nanoparticles were collected by centrifugation (15000 
rpm, 20 min) followed by washing with fresh DMF for 3 times. The resulting nanoparticles 
were suspended in DMF for further characterization and analysis. 
 Sample 6. H2TCPP (0.5 mg, 0.0006 mmol), BCDTE (20 mg, 0.04 mmol), BDC 
(15 mg, 0.09 mmol), ZrOCl2·8H2O (20 mg, 0.062 mmol), and BA (200 mg, 1.6 mmol) in 
3 mL of DMF were ultrasonically dissolved in a Pyrex vial. The reaction mixture was 
stirred (300 rpm) at 90 °C for 2.5 h. The oil bath was covered with aluminum foil to avoid 
lights. After the reaction is done, nanoparticles were collected by centrifugation (15000 
rpm, 20 min) followed by washing with fresh DMF for 3 times. The resulting nanoparticles 
were suspended in DMF for further characterization and analysis. 
 Sample 7. BCDTE (20 mg, 0.04 mmol), BDC (15 mg, 0.09 mmol), ZrOCl2·8H2O 
(20 mg, 0.062 mmol), and BA (200 mg, 1.6 mmol) in 3 mL of DMF were ultrasonically 
dissolved in a Pyrex vial. The reaction mixture was stirred (300 rpm) at 90 °C for 2.5 h. 
The oil bath was covered with aluminum foil to avoid lights. After the reaction is done, 
nanoparticles were collected by centrifugation (15000 rpm, 20 min) followed by washing 
with fresh DMF for 3 times. The resulting nanoparticles were suspended in DMF for 
further characterization and analysis.  
 Synthesis of large batch of samples. The syntheses can be scaled up to five times 
of that of the small batch scale while maintaining stoichiometry. 
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Table 5.1 Summary of synthetic conditions. 
Samples BDC (mg) TCPP (mg) BCDTE (mg) 
UiO-66 NP 15 n/a n/a 
1 15 0.5 n/a 
2 15 0.5 1 
3 15 0.5 5 
4 15 0.5 10 
5 15 0.5 15 
6 15 0.5 20 
7 15 n/a 20 
 
Transmission electron microscopy (TEM) 
 MOF nanoparticles were washed with fresh DMF three times to remove residual 
starting materials, then washed with pure water three time to remove excess DMF. The 
resulting samples were re-dispersed in water for the preparation. TEM images were taken 
on a JEOL JEM-2100F, operated at an acceleration voltage of 200 keV by dropping 
solution onto a carbon-coated copper grid. Image-Pro Plus software (version 5.1) was used 
to calculate the average size.  
 
 
Figure 5.2 TEM image of UiO-66 nanoparticles. Scale bar = 200 nm. 
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Figure 5.3 TEM images of samples 1 – 6. Scale bars = 200 nm. 
Scanning electron microscopy (SEM) 
MOF nanoparticles were washed with fresh DMF three times to remove excess 
starting materials, then washed with pure water three times to remove excess DMF. The 
resulting samples were re-dispersed in water for preparation. SEM images were recorded 
on a Hitachi S4800 (Tokyo, Japan), operated at 10 keV by dropping solution onto a silicon 
wafer, then dried in air.  
Figure 5.4 SEM images of UiO-66 nanoparticles and samples 1-6. Scale bars = 200 nm. 
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Table 5.2 Summary of nanoparticle sizes from the TEM and SEM images. 
Samples TEM diameter (nm) SEM diameter (nm) 
UiO-66 62 ± 8 76 ± 6 
1 52 ± 6 69 ± 5 
2 49 ± 6 68 ± 4 
3 53 ± 6 63 ± 4 
4 48 ± 6 68 ± 4 
5 48 ± 3 64 ± 4 
6 48 ± 3 66 ± 4 
 
 DLS and ζ-potential measurement in water were conducted on a Zetasizer Nano 
ZS ZEN3600 analyzer (Malvern Instrument Ltd, UK) equipped with a 50 mW single laser 
diode (633 nm). Scattered light was detected at 165° and analyzed using a log correlator 
over 120 accumulations. The peak averages of histograms from number distributions out 
of 120 accumulations were reported as the Z-average diameters of the particles. The ζ-
potential of the particles in suspension was obtained by measuring the electrophoretic 
movement of charged particles under an applied electric field. The ζ-potential was 
measured at twelve regions in the flow cell, and a weighted mean was calculated. These 
twelve measurements were used to correct for electro-osmotic flow that was induced in 
the cell due to the surface charge of the cell wall. Each sample was measured three times. 
 
Table 5.3 Physiochemical properties of samples. 
Samples DLS (nm) PDI ζ potential (mV) 
1 70 ± 19 0.080 31.6±6.90 
2 68 ± 20 0.133 32.4±5.52 
3 68 ± 19 0.122 35.6±6.70 
4 68 ± 20 0.127 35.2±6.11 
5 73 ± 20 0.076 35.0±6.24 
6 65 ± 24 0.276 31.3±7.86 
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5.3 Results and discussion 
While incorporation of the desired functional molecules as linkers of the MOF 
could be straightforward, there are several major obstacles to be applied in living cells for 
the desired 1O2 control. First, porphyrin and DTE derivatives are not suitable for 
constructing stable MOFs, compatible in physiological environments owing to their large 
sizes.202 Moreover, classical mixed-linker strategies to incorporate multiple functionalities 
often employ labile coordination bonds, resulting in an instability of the framework in 
aqueous media.203 In particular, the mixed-linker strategy usually yields a locked ratio 
between pre-designed functional molecules in the framework when the linkers are not 
topologically identical,31,204,205 which could inherently limit the tuning of the system for 
targeted application. Therefore, a system, where the ratio between photosensitizer and 
photochromic switch can be tuned in the MOF, is highly desired to optimize the 
controllability of 1O2 generation. 
We chose UiO-66 as a base platform to build a photosensitizing MOF system that 
can realize a reversible control of 1O2 generation for PDT. As an archetype of Zr-MOF, 
UiO-66 exhibits excellent chemical stability through coordination bonds between high 
valent ZrIV and carboxylate. 96,206 Meanwhile, 2,12-connected fcu-a net of UiO-66 allows 
for many sub-networks, including bcu-a, reo-a, hxg-a, or high-defect frameworks.207-210 
Accompanied with the reduced connectivity, available coordination sites on Zr6 clusters 
[Zr6O4OH4(COO)12] can be generated for the introduction of the functionalities via 
postsynthetic modification.211 However, the narrow pore window and small pore size of 
UiO-66 hinder the entrance of large DTE and porphyrin derivatives into the framework 
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when postsynthetically approached. Therefore, we turned to an in situ insertion of these 
molecules into UiO-66 nanoparticles with a thermodynamic controlled synthesis. 
 
Figure 5.5 (a) Structures and photoisomerization of BCDTE and (b) structure of TCPP. 
(c) UV-Vis absorption spectra of BCDTE (30 µM) and TCPP (2 µM). Inset: photographs 
of BCDTE open (left) and closed (right) isomers. (d) Proposed scheme of 1O2 control via 
competitive EnT pathways upon photoisomerization. 
  
In order to incorporate the photosensitizing system (dyad), derivatization of DTE 
and porphyrin cores to 1,2-bis(5-(4-carbonxyphenyl)-2-methylthien-3-yl)cyclopent-1-
ene (BCDTE) and a free-base tetrakis(4-carboxyphenyl)-porphyrin (TCPP) was 
implemented for their potential coordination to Zr6 cluster (Figure 5.5a,b). Because the 
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energy transfer efficiency for switching on/off the 1O2 generation is highly dependent on 
the molar ratios between the photosensitizer and photochromic switch,161 we designed 
photosensitizing systems in UiO-66 nanocarriers (1–6) by increasing the feed ratio of the 
BCDTE switch at a constant amount of TCPP for fine-tuning of the photosensitization 
and switching ability. 
 
 
Figure 5.6 (a) Defective structure of UiO-66 with inserted TCPP and BCDTE, and a 
proposed binding scheme of TCPP and BCDTE on Zr6 cluster. (b) SEM image of sample 
6. Scale bar = 100 nm. (c) UV-Vis absorption spectra of samples 1–6, normalized at the 
same concentration of TCPP. (d) PXRD patterns of UiO-66 nanoparticles and samples 
1–6.  
 
Interestingly, the optimized synthetic condition modified from the reported 
synthesis of UiO-66 nanoparticles, 212,213 where TCPP and BCDTE were simply added 
with other starting materials, could produce a pure phase of UiO-66 nanoparticles rather 
than a mixture of different MOFs (Figure 5.6). It is reasoned that the superior 
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thermodynamic stability of UiO-66 inhibits possible formation of BCDTE-Zr-MOF, while 
the growth of TCPP-Zr-MOF, despite its high thermodynamic stability, was controlled by 
the low dose of TCPP.214 Therefore, the single phase of UiO-66 can be targeted regardless 
of the complexity of the system. Meanwhile, both TCPP and BCDTE, containing multiple 
carboxylates, can readily participate in the coordination of Zr6 clusters by partially 
substituting terephthalate linkers during the growth of UiO-66 (Figure 5.6a). Once TCPP 
and BCDTE were installed inside the framework, the "ship-in-a-bottle" effect resulting 
from the small pore windows of UiO-66 and the robustness Zr-COO bonds can prevent 
the leaching of the inserted functionalities, thus maintaining the desired ratio after the 
synthesis.215 More importantly, since TCPP and BCDTE are not serving as the linkers, our 
design allows for tuning the molar ratios between two dyes upon varying synthetic 
conditions, as well as the proximity of the dyes within the MOF nanoparticle for efficient 
energy transfer. 
 
Table 5.4 UV-Vis spectroscopically determined ratios between BCDTE/TCPP in samples 
(1–6). 
Samples BCDTE/TCPP Ratio 
1 n/a 
2 1.0 
3 4.2 
4 8.1 
5 10.5 
6 11.4 
 
TEM and SEM images of 1–6 show approximately 70 nm of spherical 
nanoparticles with a high uniformity and a narrow size distribution (Figure 5.6b and 
Figures 5.2-5.4). After confirming the phase purity of 1–6 (Figure 2d), the ratio between 
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BCDTE and TCPP in each sample was then determined by UV/Vis spectra (Table 5.4). 
Adjustable ratios of the incorporated molecules were further confirmed by XPS and EDS 
data (Tables 5.5,5.6). The homogeneity of the dyad in the samples was also confirmed by 
UV/Vis spectroscopy showing linear responses of each compound in the MOF (Figure 
5.7) and TEM/EDS mapping results (Figure 5.8). 
 
Figure 5.7 Absorbance of BCDTE (λabs = 330 nm) and TCPP (λabs = 421 nm) in 3, 
respectively, as a function of stock volume of 3.  
 
 
Table 5.5 Contents of S and Zr in the samples from EDX characterization. 
 
Samples S (Atomic%) Zr (Atomic%) S/Zr Ratio 
1 0.03±0.03 4.40±0.46 0.007±0.006 
2 0.06±0.01 4.24±0.35 0.014±0.001 
3 0.22±0.06 4.10±0.23 0.054±0.012 
4 0.36±0.12 3.48±0.94 0.100±0.009 
5 0.60±0.11 4.39±0.36 0.136±0.013 
6 0.61±0.10 3.67±0.49 0.166±0.007 
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Figure 5.8 TEM/EDS mapping of sample 6. Scale bars = 500 nm. 
 
Table 5.6 Summary of XPS results. Contents of S2p, N1s and Zr3d in samples (1-6). 
Samples S2p (Atomic %) 
N1s 
(Atomic %) 
Zr3d 
(Atomic %) S/Zr Ratio 
1 0.1 1.51 5.35 ∼0.02 
2 0.3 1.44 5.39 ∼0.06 
3 0.52 1.58 4.94 ∼0.11 
4 0.77 1.3 4.96 ∼0.16 
5 0.85 1.44 4.53 ∼0.19 
6 1 1.46 4.7 ∼0.21 
 
The 1O2 generation controllability of the photosensitizing systems 1–6 was tested 
upon photoisomerization. A proposed mechanism for the control of 1O2 generation is 
centered on competitive energy transfer pathways of TCPP emission between closed 
BCDTE and 3O2 (Figure 5.5d). Representative photoisomerization of BCDTE isomers 
was shown in Figure 5.5c, exhibiting distinctive changes in absorption profile. Depending 
on the form of BCDTE isomers, therefore, the excited energy of TCPP can take different 
S Zr 
S+Zr TEM 
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energy transfer routes as shown in Figure 5.5d. For instance, when the BCDTE switch is 
in the open form, the energy transfer occurs from 3TCPP* to 3O2, resulting in 1O2 
generation.161 On the other hand, the closed BCDTE upon UV irradiation quenches the 
1O2 generation due to possible EnT pathway to the closed BCDTE over 3O2. To validate 
the feasibility of photoisomerization of BCDTE in UiO-66 nanoparticles, we prepared a 
sample only with BCDTE in UiO-66 (7) using the same synthetic strategy. Upon UV 
irradiation (λ=302 nm) on the open form of BCDTE at UiO-66, the maximum absorbance 
of BCDTE was observed in 10-15 s, while prolonged UV irradiation led to a decrease in 
absorbance (Figure 5.10a). The reverse reaction was also tested with a visible irradiation 
(λ>450 nm) and a near complete recovery was achieved in 15 min (Figure 10b). It is worth 
noting that sample 7 shows much faster photoisomerization than that of other reported 
MOFs in which the photochromic molecules were incorporated as the linker.186,216,217 
Knowing this, sample 6 was also tested for the photoisomerization. The reversible 
photoisomerization was clearly observed on a similar time frame while showing 
characteristic bands of both TCPP and BCDTE (Figure 5.9). 
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Figure 5.9 UV-Vis absorption spectra of open and closed isomers of 6. 
 
 Because the emission of TCPP could strongly indicate the results of proposed 
energy transfer, the viability of regulating energy transfer pathways in our system was 
then evaluated by fluorescence spectroscopy. The photosensitizing system 6 was chosen 
because the highest ratio of BCDTE over TCPP would result in the greatest quenching 
ability. The system was excited at the Soret band (λ=420 nm) of TCPP to avoid possible 
intervention of the switching operation. The emission spectrum of 6 with the open switch 
(denoted as 6-o) shows an emission maximum at 650 nm. To this sample, UV irradiation 
was applied to close the BCDTE switch in 6. As expected, the emission at 650 nm was 
quenched upon UV irradiation, suggesting energy transfer occurred to the closed BCDTE 
as proposed (Figure 5.10c). Reverse photoisomerization of BCDTE was subsequently 
carried out with visible irradiation (λ>450 nm), and a recovery of emission was achieved 
in 15 min, consistent with UV/Vis spectroscopic studies. Next, reversibility of the system 
was monitored by recording changes in emission intensity at 650 nm by alternating cycles 
of switching on/off. Slight loss of fatigue resistance was observed as cycles proceeded, 
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which may be attributed to the substituent effect on DTE switch as studied in literature.218 
Nevertheless, in system 6, the BCDTE to TCPP ratio can be as high as around 11:1, in 
which the emission of TCPP can be sufficiently quenched by a high concentration of the 
closed form of BCDTE. 
 
 
Figure 5.10 (a) Changes in the UV-Vis absorption of sample 7 upon UV irradiation at 
302 nm and (b) recovery of UV-Vis absorption of 7 upon visible irradiation (λ > 450 nm 
with long pass filter) in DMF. (c) Emission spectra of open and closed isomers of 6. λex 
= 420 nm. (d) Changes in emission intensity of 6 at 650 nm over few cycles of 
photoisomerization. λex = 420 nm.  
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Figure 5.11 (a) Irradiation time-dependent SOSG fluorescence response incubated with 
the closed form of samples 1–6 upon 420 nm irradiation for photosensitization. λex = 504 
nm, λem = 550 nm. (b) In vitro PDT efficacy of sample 1 and 6-c at various concentrations 
in B16 melanoma cells. Incubation time = 24 h. Irradiation time = 30 min. c-f) CLSM 
images of B16 cells treated with 20 µM of samples 1 and 6, respectively (middle row). 
Cells treated with (c) FBS free DMEM as a control; (d) sample 1; (e) sample 6-o; (f) 
sample 6-c for 60 min, respectively. The corresponding DIC images are shown at top 
row. Fluorescence intensity profiles within the line across B16 cells are shown at bottom 
row. Scale bars = 20 µm. 
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After validating the reversible nature, [BCDTE]-dependent 1O2 controllability was 
then examined with the closed form of BCDTE in each sample to compare the quenching 
efficiency of 1O2 generation. The generated 1O2 was monitored by turn-on fluorescence of 
singlet oxygen sensor green (SOSG). Samples 1–6 (closed forms) were irradiated by 420 
nm (100 mW/cm2) to generate 1O2. As expected, the 1O2 quenching efficiency was 
proportional to the concentration of BCDTE switch in each system (Figure 5.11a). In 
particular, 6 showed almost a near complete quenching of 1O2 upon turn-off operation, 
suggesting energy transfer to 3O2 was indeed more efficiently inhibited by the higher 
concentration of the closed BCDTE in 6. 
 
 
Figure 5.12 PXRD patterns of UiO-66 nanoparticle soaked in HEPES buffer (0.01 M, pH 
7.4, 37 °C). 
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Figure 5.13 Colloidal stability of UiO-66 nanoparticles in water for seven days. Cumulant 
results were recorded for hydrodynamic meter. Data are means ± s.d. (N = 3). 
 
Having confirmed their 1O2 controllability as well as effective photosensitization, 
we then evaluated the applicability of the systems in live cells. First, stability of the 
nanocarrier was examined in aqueous media where PXRD and dynamic light scattering 
(DLS) data showed no obvious destruction of the framework over a week (Figures 5.12 
and 5.13). In vitro PDT studies were then carried out using B16 melanoma cells, a skin 
cancer model. Imaging capability of the material was examined by 1, composed of only 
TCPP in UiO-66 nanoparticles, showing a strong red fluorescence, indicative of the 
emission from the photosensitizer (Figure 5.11d). Next, B16 cells were treated with 6-o 
(the same TCPP equiv), exhibiting red emission as intense as 1, which suggests the excited 
energy of TCPP was not disturbed by the open switch in 6 (Figure 5.11e). Switching ability 
of 6 was then validated by the cells incubated with the closed 6 (denoted as 6-c), which 
shows a negligible fluorescence as a result of the proposed energy transfer to the closed 
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form of BCDTE (Figure 5.11f). In addition, cell viability tests show low cytotoxicity of 
materials 1–6 to B16 cells at various concentrations for as long as 48 h (Figure 5.14). 
 
Figure 5.14 Cell viability of B16 cells incubated with samples (1-6) at various 
concentrations for 48 h. Data are means ± s.d. N = 3. 
 
 
 
Figure 5.15 (a) Proposed delivery of the photosensitizing system (BCDTE and TCPP) 
via MOF nanoparticle formulation (left) and a mixture of small molecules in solution 
(right). (b) Comparison of in vitro PDT efficacy between 6-c and 6-o at various 
concentrations in B16 cells upon irradiation at 420 nm. Incubation time = 24 h. Irradiation 
time = 30 min. (c) Comparison of in vitro PDT efficacy between open and closed forms 
of free BCDTE/TCPP mixture at various concentrations in B16 cells upon irradiation at 
420 nm. Incubation time = 24 h. Irradiation time = 30 min.  
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Next, in vitro PDT efficacy was examined in B16 melanoma cells. While various 
control groups showed no apparent phototoxicity, sample 1 showed a significant PDT 
efficacy (Figure 5.11b). In particular, the cells treated with 6-c showed almost no PDT 
efficacy, clearly supporting our hypothesis that energy transfer-based control of 1O2 
generation was indeed realized in cell model (Figure 5.11b). To further confirm this 
concept, we directly compared PDT efficacy between 6-c and 6-o. As shown in Figure 
5b, the PDT results indicate that switching operation can turn on 1O2 generation in 6-o, 
enabling desired control of 1O2 for PDT through the photochromic switch. As a control 
experiment, the switching ability and ensuing PDT efficacy of a homogeneous mixture of 
BCDTE and TCPP molecules (without MOF nanoparticle formulation) were tested at the 
same concentrations as those in 6. Interestingly, PDT efficacy of the small molecule 
system (open BCDTE/TCPP mixture) was less effective than that of 6-o, further 
supporting the improved PDT efficacy by enhanced permeability and retention (EPR) 
effect, of which the improved delivery was achieved by the UiO-66 nanocarrier (Figure 
5.15b,c). In particular, the results indicate that delivery of the mixture to target cells with 
their optimized molar ratio might be challenged presumably due to biological barriers 
(e.g., different cell permeability), suggested by noticeable loss of 1O2 control (green in 
Figure 5.15c). Furthermore, the failure of maintaining effective local concentration of the 
homogeneous mixture of the dyad in the cells may also result in a significantly diminished 
control for 1O2 quenching (Figure 5.15a). Therefore, in situ incorporation of multiple 
functionalities in MOF nanoparticle not only enhanced the delivery and PDT efficacy of 
the photosensitizing system over the molecular analogues, but also can be an attractive 
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strategy to maintain the pre-designed system with multiple components (i.e., the 
optimized ratio) for desired applications. 
5.4 Conclusions 
In summary, our strategy of the in situ incorporation of the multiple functionalities 
in the MOF nanoparticle has been successfully demonstrated with a tunable ratio of the 
photochromic switch for the control of 1O2 generation. This method also shows great 
potential for protected delivery of an integrated photosensitizing system as desired, 
allowing enhanced in vitro PDT efficacy with superior controllability of 1O2 generation, 
using a MOF formulation compared to that of homogeneous mixture of the dyad.  
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6. SIZE-CONTROLLED SYNTHESIS OF PORPHRYINIC METAL–ORGANIC 
FRAMEWORK AND FUNCTIONALIZATION FOR TARGETED 
PHOTODYNAMIC THERAPY* 
6.1 Introduction 
 Nanotechnology has shown great potential for cancer treatment due to the unique 
properties of nanomaterials, including optical, electrical, and magnetic behaviors. 
Meanwhile understanding the interactions between the nanomaterials and biological 
systems with respect to their size, shape, and surface chemistry is of significant importance 
when designing nanomaterials to improve the precision of cancer therapy.219-222 Current 
nanomaterials in cancer therapy have evolved to improve specific accumulation at the 
tumor site with two major mechanisms: passive and active targeting. Passive targeting is 
often referred to as the enhanced permeability and retention (EPR) effect, while active 
targeting is achieved by coating targeting ligands onto the nanomaterials that can promote 
cellular uptake at the tumor sites.223,224 
 With conventional nanomaterials, however, achievement of such targeting 
modalities is often complex, because nanomaterials are usually employed as carriers of 
therapeutics or imaging agents, of which their inherent traits are hardly modifiable at a 
molecular level.196 Recent studies reveal that physical parameters of nanomaterials have 
shown a strong correlation to cellular processes.225-230 However, engineering of 
                                                
*Reproduced with permission from Park, J.; Jiang, Q.; Feng, D.; Mao, L.; Zhou, H.-C., J. Am. Chem. Soc., 
2016, 38, 3518–3525. Copyright 2016 American Chemical Society. 
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nanoparticles to carry a single variable for studying a targeted parameter remains a 
daunting challenge with formulations of conventional nanoparticles, because these often 
depend on more than one single factor.231 Thus, such systems could disturb interpretation 
of the pure effects of the targeted parameter under controlled conditions, against other 
dependent variables. Therefore, it is of critical importance to integrate functionality into 
materials while having controllability of size and shape with no significant alteration of 
their designed physicochemical properties, as well as with a high degree of uniformity.231-
233 
 As an emerging modality of cancer treatments, photodynamic therapy (PDT) has 
gained attention due to its minimally invasive nature and innate selectivity upon a 
localized irradiation at the tumor sites.187,234 PDT requires a combination of light, a 
photosensitizer (PS), and tissue oxygen to generate cytotoxic singlet oxygen (1O2) that can 
damage tumors. Although porphyrin derivatives are widely employed photosensitizers in 
PDT, the effective delivery of porphyrinic molecules to the tumor sites still leaves much 
to be desired due to their hydrophobic nature.195 Alternatively, nanomaterials have been 
involved as carriers for PDT therapeutics, but these examples often show limitations of 
imprecise control of loading, increased toxicity, leaching, and instability.232,235,236 As an 
emerging class of porous materials, metal–organic frameworks (MOFs) have earned a 
significant amount of attention due to their superior design flexibility from their 
components of organic linkers and inorganic building blocks.1,237 Despite broad interest 
in the synthesis of new MOFs, formulations of MOFs as nanomaterials have been 
relatively underdeveloped but a few synthetic methods (e.g., microwave, modulating 
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chemical, spray-drying) have been applied.213,238-240 Thus, expanding the study of 
nanomaterials with the design flexibility of MOFs at a molecular level can greatly 
diversify the core function of nanoparticles, broadening the scope of applications beyond 
the traditional use of their pores as carriers.13,197,241-246 For instance, MOFs can integrate 
photosensitizers in periodic arrays, significantly reducing quenching of excited energy in 
a minimal volume, while allowing the accessibility of substrates due to their porous 
features. 25,177,198 In that regard, having MOFs as a base platform of nanomaterials can be 
advantageous due to their structural and chemical tunability via a bottom-up design. Here 
we show size-dependent targeted photodynamic therapy with porphrynic Zr-MOF 
nanoparticles, PCN-224. The size-dependent cellular uptake and ensuing PDT were 
studied with various sizes of PCN-224 nanoparticles with an imaging and a therapeutic 
modality from the porphyrinic linker. In addition, further functionalization with folic acid 
(FA) onto the Zr6 cluster in the MOF was also demonstrated, showing enhanced PDT 
efficacy owing to the active targeting of the modified MOF nanomaterial. 
6.2 Experimental section 
Materials 
 Folic acid and 4-(2-Hydroxyethyl) piperazine-1-ethanesulfonic acid (HEPES) 
were purchased from Sigma-Aldrich. Tetrakis(4-carboxyphenyl)porphyrin (H2TCPP) was 
purchased from Frontier Scientific. Dulbecco’s modified Eagle medium (DMEM/HIGH 
GLUCOSE 1X) were purchased from HyClone, GE Life Sciences. Fetal bovine serum 
(FBS) was purchased from Gibco, Thermo Fisher Scientific. Cell culture reagents were 
purchased from Invitrogen. Cell Counting Kit-8 (CCK-8) and Mito Tracker Green FM dye 
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were obtained from Beyotime Institute of Biotechnology (Beijing, China). Hoechst 33342 
was obtained from Solarbio (Beijing, China). Lyso Tracker Green DND-26 and Singlet 
Oxygen Sensor Green were purchased from life technologies (USA). Other chemicals 
were of at least analytical grade and were used as received. All aqueous solutions were 
prepared with Milli-Q water generated from a Milli-pore system (Bedford, MA). All other 
not mentioned starting materials and solvents were used as received without further 
purification from the following suppliers (Alfa Aesar, Sigma-Aldrich, TCI America, 
Cambridge Isotope, Oakwood Products, Fisher Scientific). The abbreviation for some 
solvents and reagents were listed here: N,N-dimethylformamide (DMF), and 
dimethylsulfoxide (DMSO).  
Instrumentation 
 Synthetic manipulations that required an inert atmosphere (where noted) were 
carried out under nitrogen using standard Schlenk techniques. Powder X-ray diffraction 
(PXRD) was carried out on a Bruker D8-Focus Bragg-Brentano X-ray powder 
Diffractometer equipped with a Cu sealed tube (λ = 1.54178) at 40 kV and 40 mA. N2 
sorption isotherms at 77 K were measured by using a Micrometritics ASAP 2420 system 
with high-purity grade (99.999%) of gases. UV-Vis spectra were recorded on Shimadzu 
UV-2450 spectrophotometer and TU-1900 spectrophotometer (Beijing Purkinje General 
Instrument Co. Ltd., China). Fluorescence spectra were recorded on a Hitachi F-4600 
spectrometer (Hitachi Co. Ltd., Japan) with Xe lamp as the excitation source at room 
temperature. Dynamic light scattering and Zeta potential were measured at 25 °C on a 
Zetasizer Nano ZS ZEN3600 analyser (Malvern Instrument Ltd, UK). Singlet oxygen was 
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generated from a CEL-S500 xenon lamp (Ceaulight, Beijing) with separate passing filter 
(power density was 100 mW/cm2). Confocal laser scanning microscopy (CLSM) images 
were performed on an Olympus FV1000-IX81 CLSM and a Leica TCS SP confocal 
system (Leica, Germany). Inductively coupled plasma mass spectrometry (ICP-MS) was 
carried out on an Agilent 7700x series ICP-MS instrument. TEM images were taken on a 
transmission electron microscopy (JEOL JEM-2100F, Japan) operated at an acceleration 
voltage of 200 keV by dropping solution onto a carbon-coated copper grid. 
Cell culture  
 Human cervical carcinoma cell line (HeLa cells) and human lung adenocarcinoma 
cell line (A549 cells) were supplied by Peking Union Medical College Hospital (Beijing, 
China). Cells were cultured in high-glucose DMEM supplemented with 10% (v/v) FBS 
and 1% antibiotics (penicillin/streptomycin, 100 U/mL) at 37 °C under a 5% CO2 
atmosphere. 
ICP-MS analysis 
 Inductively coupled plasma mass spectrometry (ICP-MS) was carried out on an 
Agilent 7700x series ICP-MS instrument. Cells were cultured in 35 mm glass-bottomed 
dishes at a density of 1.0x106/well. After incubation with different concentrations of 
PCN224 nanoparticles for certain time, the cells were digested with 0.25% pancreatin at 
37 °C for 60 seconds and centrifuged at 2000 rpm for 5 min. Precipitations were lysed in 
nitric acid at 200 °C for 1 h, then re-suspended in 5% nitric acid overnight for the 
preparation. For ICP-MS analysis, 20 µL of the cell lysates was diluted to 2 mL with Milli-
Q water. ICP-MS calibration standards was used for preparing the calibration curves, of 
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which Zr4+ concentrations were 0, 0.01, 0.1, 1, and 10 ppb (µg/mL). The isotope detected 
was 90Zr, and the readings were made in He gas mode. 
Synthesis of single crystalline PCN-224 
 Single crystalline PCN-224. 5,10, 15, 20 -Tetrakis (4-carboxyphenyl)porphyrin 
(H2TCPP) (10 mg, 0.013 mmol), zirconyl chloride octahydrate (ZrOCl2·8H2O) (30 mg, 
0.093 mmol), and benzoic acid (BA) (300 mg, 2.4 mmol) in 2 mL of N,N-
Dimethylformamide (DMF) were ultrasonically dissolved in a Pyrex vial. The reaction 
mixture was heated in the 120 °C oven for 24 h. After cooling down to room temperature, 
dark purple crystals were harvested by filtration. 
Variation of DMF 
 80 mL DMF sample. H2TCPP (100 mg, 0.13 mmol), ZrOCl2·8H2O (300 mg, 0.93 
mmol), and benzoic acid (2.8 g, 23 mmol) were dissolved in 80 mL of DMF in a 250 mL 
round bottom flask and the mixture was stirred (300 rpm) at 90 °C for 5 h. After the 
reaction is done, PCN-224 nanoparticles were collected by centrifugation (15000 rpm, 30 
min) followed by washing with fresh DMF for 3 times. The resulting PCN-224 
nanoparticles were suspended in DMF for further characterization and analysis. 
 100 mL DMF sample (reference condition). H2TCPP (100 mg, 0.13 mmol), 
ZrOCl2·8H2O (300 mg, 0.93 mmol), and benzoic acid (2.8 g, 23 mmol) were dissolved in 
100 mL of DMF in a 250 mL round bottom flask and the mixture was stirred (300 rpm) at 
90 °C for 5 h. After the reaction is done, PCN-224 nanoparticles were collected by 
centrifugation (15000 rpm, 30 min) followed by washing with fresh DMF for 3 times. The 
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resulting PCN-224 nanoparticles were suspended in DMF for further characterization and 
analysis. 
 120 mL DMF sample. H2TCPP (100 mg, 0.13 mmol), ZrOCl2·8H2O (300 mg, 
0.93 mmol) and benzoic acid (2.8 g, 23 mmol) were dissolved in 120 mL of DMF in a 250 
mL round bottom flask and the mixture was heated at 90 °C for 5 h under stirring. After 
the reaction is done, PCN-224 nanoparticles were purified by centrifugation (15000 rpm, 
30 min) followed by washing with fresh DMF for 3 times. The resulting PCN-224 
nanoparticles were suspended in DMF for further characterization and analysis. 
 140 mL DMF sample. H2TCPP (100 mg, 0.13 mmol), ZrOCl2·8H2O (300 mg, 
0.93 mmol), and benzoic acid (2.8 g, 23 mmol) were dissolved in 140 mL of DMF in a 
250 mL round bottom flask and the mixture was stirred (300 rpm) at 90 °C for 5 h. After 
the reaction is done, PCN-224 nanoparticles were collected by centrifugation (15000 rpm, 
30 min) followed by washing with fresh DMF for 3 times. The resulting PCN-224 
nanoparticles were suspended in DMF for further characterization and analysis. 
Variation of benzoic acid 
 2.2 g benzoic acid sample. H2TCPP (100 mg, 0.13 mmol), ZrOCl2·8H2O (300 mg, 
0.93 mmol), and benzoic acid (2.2 g, 18 mmol) were dissolved in 100 mL of DMF in a 
250 mL round bottom flask and the mixture was stirred (300 rpm) at 90 °C for 5 h. After 
the reaction is done, PCN-224 nanoparticles were collected by centrifugation (15000 rpm, 
30 min) followed by washing with fresh DMF for 3 times. The resulting PCN-224 
nanoparticles were suspended in DMF for further characterization and analysis. 
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 2.6 g benzoic acid sample. H2TCPP (100 mg, 0.13 mmol), ZrOCl2·8H2O (300 mg, 
0.93 mmol), and benzoic acid (2.6 g, 21 mmol) were dissolved in 100 mL of DMF in a 
250 mL round bottom flask and the mixture was stirred (300 rpm) at 90 °C for 5 h. After 
the reaction is done, PCN-224 nanoparticles were collected by centrifugation (15000 rpm, 
30 min) followed by washing with fresh DMF for 3 times. The resulting PCN-224 
nanoparticles were suspended in DMF for further characterization and analysis. 
 2.8 g benzoic acid sample. H2TCPP (100 mg, 0.13 mmol), ZrOCl2·8H2O (300 mg, 
0.93 mmol), and benzoic acid (2.8 g, 23 mmol) were dissolved in 100 mL of DMF in a 
250 mL round bottom flask and the mixture was stirred (300 rpm) at 90 °C for 5 h. After 
the reaction is done, PCN-224 nanoparticles were collected by centrifugation (15000 rpm, 
30 min) followed by washing with fresh DMF for 3 times. The resulting PCN-224 
nanoparticles were suspended in DMF for further characterization and analysis. 
 3.0 g benzoic acid sample. H2TCPP (100 mg, 0.13 mmol), ZrOCl2·8H2O (300 mg, 
0.93 mmol), and benzoic acid (3.0 g, 24 mmol) were dissolved in 100 mL of DMF in a 
250 mL round bottom flask and the mixture was stirred (300 rpm) at 90 °C for 5 h. After 
the reaction is done, PCN-224 nanoparticles were collected by centrifugation (15000 rpm, 
30 min) followed by washing with fresh DMF for 3 times. The resulting PCN-224 
nanoparticles were suspended in DMF for further characterization and analysis. 
 3.3 g benzoic acid sample. H2TCPP (100 mg, 0.13 mmol), ZrOCl2·8H2O (300 mg, 
0.93 mmol), and benzoic acid (3.3 g, 27 mmol) were dissolved in 100 mL of DMF in a 
250 mL round bottom flask and the mixture was stirred (300 rpm) at 90 °C for 5 h. After 
the reaction is done, PCN-224 nanoparticles were collected by centrifugation (15000 rpm, 
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30 min) followed by washing with fresh DMF for 3 times. The resulting PCN-224 
nanoparticles were suspended in DMF for further characterization and analysis. 
Variation of H2TCPP 
 50 mg H2TCPP sample. H2TCPP (50 mg, 0.07 mmol), ZrOCl2·8H2O (300 mg, 
0.93 mmol), and benzoic acid (2.9 g, 24 mmol) were dissolved in 100 mL of DMF in a 
250 mL round bottom flask and the mixture was stirred (300 rpm) at 90 °C for 5 h. After 
the reaction is done, PCN-224 nanoparticles were collected by centrifugation (15000 rpm, 
30 min) followed by washing with fresh DMF for 3 times. The resulting PCN-224 
nanoparticles were suspended in DMF for further characterization and analysis. 
 75 mg H2TCPP sample. H2TCPP (75 mg, 0.09 mmol), ZrOCl2·8H2O (300 mg, 
0.93 mmol), and benzoic acid (2.9 g, 24 mmol) were dissolved in 100 mL of DMF in a 
250 mL round bottom flask and the mixture was stirred (300 rpm) at 90 °C for 5 h. After 
the reaction is done, PCN-224 nanoparticles were collected by centrifugation (15000 rpm, 
30 min) followed by washing with fresh DMF for 3 times. The resulting PCN-224 
nanoparticles were suspended in DMF for further characterization and analysis. 
 100 mg H2TCPP sample. H2TCPP (100 mg, 0.13 mmol), ZrOCl2·8H2O (300 mg, 
0.93 mmol), and benzoic acid (2.9 g, 24 mmol) were dissolved in 100 mL of DMF in a 
250 mL round bottom flask and the mixture was stirred (300 rpm) at 90 °C for 5 h. After 
the reaction is done, PCN-224 nanoparticles were collected by centrifugation (15000 rpm, 
30 min) followed by washing with fresh DMF for 3 times. The resulting PCN-224 
nanoparticles were suspended in DMF for further characterization and analysis. 
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 125 mg H2TCPP sample. H2TCPP (125 mg, 0.16 mmol), ZrOCl2·8H2O (300 mg, 
0.93 mmol), and benzoic acid (2.9 g, 24 mmol) were dissolved in 100 mL of DMF in a 
250 mL round bottom flask and the mixture was stirred (300 rpm) at 90 °C for 5 h. After 
the reaction is done, PCN-224 nanoparticles were collected by centrifugation (15000 rpm, 
30 min) followed by washing with fresh DMF for 3 times. The resulting PCN-224 
nanoparticles were suspended in DMF for further characterization and analysis. 
 150 mg H2TCPP sample. H2TCPP (150 mg, 0.19 mmol), ZrOCl2·8H2O (300 mg, 
0.93 mmol), and benzoic acid (2.9 g, 24 mmol) were dissolved in 100 mL of DMF in a 
250 mL round bottom flask and the mixture was stirred (300 rpm) at 90 °C for 5 h. After 
the reaction is done, PCN-224 nanoparticles were collected by centrifugation (15000 rpm, 
30 min) followed by washing with fresh DMF for 3 times. The resulting PCN-224 
nanoparticles were suspended in DMF for further characterization and analysis. 
Thermodynamic analysis 
 When the concentration of the system is diluted to 1/n, the concentration of PCN-
224 monomer can be represented as the following.  
PCN-224monomer = [𝑍𝑟$ 𝑇𝐶𝑃𝑃 (.*] = -×[/01 23 45×46]× 7899×46 4.:23×46 45  
= -×[/01 23 45]×[7899]4.:[23]45 ×𝑛<.*   (eq 1) 
 Similar to the variable of TCPP, [𝑍𝑟$(𝐵𝐴)(A]  is also proportional to 𝑍𝑟$(𝑇𝐶𝑃𝑃)(.* . Therefore, a similar trend of size change in PCN-224 particles was 
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expected when varying the amount of Zr source. However, as ZrOCl2·8H2O undergoes 
severe hydrolysis and generates large amount of HCl, increasing the amount of Zr source 
led to significant protonation of porphyrin center in TCPP leading to a formation of 
different phase.  
ln𝐾 = E∆G∅I7 = − ∆K∅I7 + ∆M∅I  (eq 2) 
 For the equilibrium constant (K), theoretically, temperature change can affect K 
value, thus influencing the concentration of PCN-224 monomer. Since the formation of 
MOF is an exothermic process (negative ∆𝐻∅), increasing the reaction temperature will 
result in a decreased K value, thus resulting in decreased monomer concentration (eq 2). 
However, because the impact of temperature on K is not linear in a range that can 
guarantee phase purity of MOF, the effect of temperature was not fully studied to tune the 
size of PCN-224 nanoparticles.  
6.3 Results and discussion 
Size-controlled synthesis of PCN-224 nanoparticles 
 In MOFs, each linker is spatially isolated by the framework, thus greatly 
preserving its molecular property regardless of dimensions. As a result, MOFs can be fully 
utilized as are small molecules, while their built-in properties are not affected by particle 
size.24 We conceived that this feature would allow for maximization of passive targeting 
by screening optimal size of MOF nanoparticles for PDT. To investigate size-dependent 
targeted PDT, a Zr(IV)-based porphyrinic MOF was chosen as a model system to test our 
hypothesis. Zr(IV) is known for relatively good biocompatibility while its high valence 
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allows strong electrostatic interaction with the carboxylate linkers in the MOF for the 
framework robustness.96,247 Meanwhile, the photosensitizing ability as well as the 
emissive nature of the porphyrinic linker endows the theranostic modality of MOF, 
making this platform multifunctional. The concept of PDT was demonstrated by Lin and 
co-workers during the course of our study. Nonetheless, we believe that the investigation 
of size and other factors on a suitable platform (e.g., controlled morphology) would allow 
us to study a correlation between MOF nanoparticles and cellular uptake for maximization 
of therapeutic efficacy, addressing a gap in the literature.  
 
 
Figure 6.1 Illustration of PCN-224 structure. (a) 6-connected Zr6 cluster 
(Zr6O4(OH)4(H2O)6(OH)6(COO)6), tetratopic linker (tetrakis (4-carboxyphenyl)porphyrin 
(H2TCPP)), and 3D nanoporous framework of PCN-224. (b) A cubic unit of PCN-224 and 
schematic illustration of spherical PCN-224 nanoparticles on the basis of building of cubic 
units, yielding different sizes. 
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 Of the many reported porphyrinic Zr-MOFs, PCN-224 was considered as a strong 
candidate due to its extraordinary chemical stability and nanoporous channels, allowing 
efficient diffusion of molecular oxygen.33,34,183 Most importantly, the cubic space group 
of PCN-224 would allow for isotropic growth of crystals, enabling clearer size evaluation 
without having to carry dependent variables along with the size variation (e.g., aspect 
ratio, thickness in a rod, or a plate morphology) (Figure 6.1). Therefore, we chose PCN-
224 as a model system for studying the particle size effect for targeted PDT.183 
 However, downsizing of PCN-224 from a millimeter scale to nanoscale upon 
varying the synthetic condition was not trivial due to the easy formation of unwanted 
phases. To overcome such difficulty, thermodynamic analysis was attempted along with 
the manipulation of synthetic conditions to tune the size of PCN-224 to nanoscale. In 
principle, MOF formation can be simplified as ligand substitution reactions on the metal 
clusters.41,240 This simple coordination chemistry enables us to derive an equilibrium of 
MOF formation. In the specific example of PCN-224 synthesis, the equilibrium of the 
PCN-224 monomer [Zr6 (TCPP)1.5] formation can be simplified as eq 3 where excessive 
benzoic acid (BA) was employed as a competing reagent that is assumed to competitively 
coordinate to Zr6 cluster, forming Zr6(BA)12. In this work, the PCN-224 monomer was 
defined as a soluble species with a negligible scattering contribution, where the formula 
of Zr6(TCPP)1.5 is derived from a repeating unit of PCN-224 (H2O and extra OH– in the 
Zr6 cluster are ignored). Therefore, the formation of the PCN-224 monomer can be 
summarized as eq 4. 
 (eq 3) 
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 (eq 4) 
 Ideally, manipulation of any factor in eq 4 would cause a change in the 
concentration of the PCN-224 monomer, which would eventually affect the particle size 
through the nucleation step.213,248-250 However, our attempts to directly tune these factors 
(e.g., benzoic acid) from its synthetic condition of millimeter-sized single crystals failed 
to reduce the size to nanoscale, while giving phase impurity, presumably due to the 
dramatic change in the ratios between each reactant. 
Table 6.1 Effect of the reaction volume on the particle size. 
DMF (mL) D (nm)a PDI 
80 225.7 ± 30.2 0.005 
100 95.9 ± 24.0 0.103 
120 71.6 ± 18.2 0.080 
140 42.1 ± 11.0 0.191 
 
Table 6.2 Effect of benzoic acid (competing reagent) on the particle size. 
Benzoic Acid (g) D (nm)a PDI 
2.2 23.8 ± 6.8 0.239 
2.6 60.2 ± 15.7 0.086 
2.8 94.1 ± 24.2 0.132 
3.0 182.8 ± 46.6 0.072 
3.3 232.5 ± 51.8 0.055 
 
Table 6.3 Effect of H2TCPP on the particle size. 
H2TCPP (mg) D (nm)a PDI 
50 280.4 ± 36.3 0.032 
75 110.4 ± 30.0 0.197 
100 84.1 ± 23.2 0.215 
125 64.8 ± 18.0 0.196 
150 57.9 ± 15.5 0.177 
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 Thus, we embarked on downsizing PCN-224 by diluting the system to preserve 
the phase purity from unchanged stoichiometry between reactants, while aiming to create 
more MOF monomers, which would result in smaller particles (Tables 6.1-6.3). Upon five 
times of dilution from its single crystal synthetic condition, PCN-224 nanoparticles with 
a size of ∼90 nm, based on dynamic light scattering (DLS) in DMF, were achieved and 
this condition was established and denoted as a reference condition for the following 
investigation. Then, we sought to realize a precise size control of the particles in the nano 
regime by utilizing different impact of size-tuning ability of each factor as analyzed. 
According to eq 4, for instance, the concentration of PCN-224 monomer is strongly 
dependent on the concentration of BA due to the high order of [BA]12 in the equation, 
suggesting a significant impact of [BA] on the size of PCN-224 nanoparticles. Starting 
from the reference condition, when the amount of BA was varied with a ∼200 mg interval 
from 2.2 to 3.3 g, the size of PCN-224 nanoparticles increased from 24 to 232 nm (Table 
6.2). The tuning of the particle size in a narrower range was observed from variation of 
[TCPP] due to a lower order ([TCPP]1.5) in the equation, making it a suitable variable for 
fine-tuning (Table 6.3). These results are also consistent with our thermodynamic analysis. 
For instance, according to eq 4, the increased amount of BA would result in decreased 
number of the PCN-224 monomer in the system, thus yielding larger nanoparticles. 
Similarly, varying the concentration of TCPP can also change the concentration of the 
monomer in an opposite trend to BA, which can also be predicted by eq 4. Therefore, 
adjustment of each factor in eq 4 allows fine-tuning of the size of PCN-224 nanoparticles. 
These results also suggest that understanding the size tunability of each factor holds great 
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potential in providing design insights for nanomaterials that require such control in diverse 
future applications.  
Figure 6.2 Characterization of PCN-224 nanoparticles. (a) Size-dependence of emission 
spectra (λex = 420 nm). Inset: 90 nm-PCN-224 dispersed in water under (left) ambient light 
and (right) UV irradiation (λ = 365 nm), respectively. (b) N2 adsorption isotherms of PCN-
224 (bulk sample, 90 nm-PCN-224 before and after the water treatment (37 °C, 24 h). (c) 
Powder X-ray diffractions of PCN-224 nanoparticles after stability test (0.1 M HEPES, 
pH 7.4, 37 °C). 
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Figure 6.3 PXRD of PCN-224 samples with BA variation. 
 
 Among the variables, the set varied with the concentration of benzoic acid was 
chosen for detailed studies, due to an ease of variable control and a broad range of sizes. 
Powder X-ray diffraction (PXRD) data clearly show the pure phase of PCN-224 (Figure 
6.3). To further confirm our hypothesis that the identity of MOF nanoparticles will not be 
altered by size variation, photophysical properties of the BA-varied set were tested by 
UV–vis and fluorescence spectroscopy. In absorption spectra, a slight red shift was 
observed as the particle size increased along with more scattering, as expected from typical 
observation in nanomaterials (Figure 6.4). Interestingly, their emission profiles, which are 
closely related to the photosensitization to generate 1O2, show the same emission maxima 
(λem = 650 nm) for any size of samples, indicating the molecular level of design is well 
maintained regardless of their size (Figure 6.2a). 
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Figure 6.4 Absorption spectra of PCN-224 samples with different sizes varied by BA.  
 
 Having confirmed this unaltered molecular property of different sizes of PCN-224 
nanoparticles, the stability of the framework in aqueous media was then examined. 
In Figure 6.2b, N2 sorption of nanoparticles showed well maintained porosity compared 
to that of bulk crystalline PCN-224. Notably, after 24 h of water treatment at 37 °C, the 
porosity of PCN-224 nanoparticles was still preserved only with a slight decrease in 
N2 uptake probably due to the inevitable destruction of the framework under aqueous 
condition (Figure 6.2b). PXRD data also confirmed that PCN-224 nanoparticles can retain 
their crystallinity in buffer (0.1 M HEPES, pH 7.4, 37 °C) for 2 days while gradually 
decreasing in crystallinity over 7 days (Figure 6.2c). In particular, PXRD data revealed 
that PCN-224 nanoparticles treated with cell culture medium, DMEM for 24 h maintained 
the crystallinity. These results indicate that PCN-224 nanoparticles would remain intact 
as the MOF until PDT treatment, considering typical cellular internalization and 
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irradiation time for the treatment. To our surprise, PCN-224 nanoparticles can also be well 
dispersed in both DMF and H2O in the absence of additional surfactant (Figure 6.2a inset). 
With most other conventional nanoparticles, surfactants are often required to prevent 
strong interparticle interaction for better dispersibility. Perhaps due to the 3D cubic grid-
like porous structure of PCN-224 as well as its spherical morphology, it may provide 
tangential contact between particles, allowing minimal interaction on their surface. The ζ 
potential of PCN-224 nanoparticles of ∼20 mV also supports their moderate dispersibility 
(Table 6.4).  
 
Table 6.4 Summary of physicochemical properties of PCN-224 nanoparticles.  
PCN-224 label BA (g) TEM (nm) Dh (nm) PDI ζ potential (mV) 
30 nm 2.2 33 ± 4 65 ± 3 0.246 19.6±6.41 
60 nm 2.6 59 ± 5 114 ± 3 0.067 25.3±6.27 
90 nm 2.8 91 ± 8 137 ± 2 0.053 19.8±7.15 
140 nm 3.0 144 ± 7 197 ± 1 0.035 22.7±5.92 
190 nm 3.3 189 ± 11 255 ± 2 0.025 20.7±5.59 
 
Table 6.5 Physiochemical properties of PCN-224 samples with different sizes varied by 
BA. 
Sample 
label 
TEM diameter 
(nm) Dh (nm) PDI ζ potential (mV) 
30 nm 33 ± 4 65 ± 3 0.246 19.6±6.41 
60 nm 59 ± 5 114 ± 3 0.067 25.3±6.27 
90 nm 91 ± 8 137 ± 2 0.053 19.8±7.15 
140 nm 144 ±7 197 ± 1 0.035 22.7±5.92 
190 nm 189 ± 11 255 ± 2 0.025 20.7±5.59 
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Figure 6.5 TEM images and cellular studies of PCN-224 nanoparticles. (a) TEM images 
of PCN-224 nanoparticles of 30, 60, 90, 140, and 190 nm. (b) Cellular uptake of PCN-224 
samples with different sizes at various incubation time. Concentration = 20 µM. (c) 
Cellular uptake of different sized PCN-224 nanoparticles at various concentrations. 
Incubation time = 24 h. Data are based on ICP analysis of the Zr concentration internalized 
into HeLa cells. Data are means ± s.d. (N = 3). 
 
 
Passive targeting: particle size-dependent cellular uptake and PDT 
 Although the effect of physical dimension of some other nanoparticles (i.e., gold 
nanoparticles, carbon nanotubes) for cellular uptake has been studied, it has been known 
that their correlations are also significantly affected by the composition of the 
nanomaterials.14 Considering only a rare example can be referred as a study of the size-
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related cellular response with MOF nanomaterials,206 PCN-224 model platform, covering 
a broad range in interest of biological studies, can provide important design insight for 
future study in MOF size-cell interaction. To determine the size-dependent cellular 
response, five size fractions, ranging from 30 to 190 nm, based on transmission electron 
microscopy (TEM) results, were applied to HeLa (human cervical cancer) cells (Table 
6.4 and Figure 6.5a). Quantitative analysis of uptake of the nanoparticles was achieved 
using inductively coupled plasma mass spectrometry (ICP-MS) upon cell digestion. To 
begin, time-dependent cellular uptake of PCN-224 nanoparticles was studied to obtain 
insight for kinetics of endocytosis. The cellular uptake showed a plateau around 12 h for 
each fraction (Figure 6.5b). Dose-dependent uptake of PCN-224, ranging from 0.5 to 40 
µM (TCPP equiv), was also carried out. Interestingly, ICP results indicate that different 
amount of Zr entered into the cells, suggesting the different sizes of particles indeed 
resulted in different cellular responses (Figure 6.5c). Notably, 90 nm-PCN-224 showed 
the highest amount of Zr uptake in cells which also suggests the greatest uptake of TCPP 
by MOF structure, among other sizes (Figure 6.6a). 
Table 6.6 Calculated numbers of PCN-224 nanoparticle uptake in each cell. 
Samples Zr/particle (mol) Zr/cell (mol) TCPP/cell (mol) Nparticle/cell 
30 nm-PCN-224 4.95⋅10-21 2.32⋅10-14 5.80⋅10-15 4.68⋅106 
60 nm-PCN-224 3.96⋅10-20 2.78⋅10-14 6.95⋅10-15 7.01⋅105 
90 nm-PCN-224 1.34⋅10-19 4.00⋅10-14 1.00⋅10-14 2.99⋅105 
140 nm-PCN-224 5.03⋅10-19 1.46⋅10-14 3.65⋅10-15 2.90⋅104 
190 nm-PCN-224 1.26⋅10-18 8.20⋅10-15 2.05⋅10-15 6.51⋅103 
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Figure 6.6 Cellular response and PDT efficacy of PCN-224 nanoparticles. (a) Size-
dependent cellular uptake of PCN-224 nanoparticles. Incubation time = 24 h. (b) 
Cytotoxicity of 90 nm-PCN-224 in HeLa and A549 cells at various concentrations for 48 
h. (c) Control experiments of cytotoxicity in HeLa cells upon light irradiation of 420 and 
630 nm in the absence and presence of 90 nm-PCN-224. Irradiation time = 30 min. (d) 
Comparison of PDT efficacy between different sized PCN-224 nanoparticles and free 
TCPP molecules. Data are means ± s.d. (N = 3). 
 
 
 Having examined size-dependent cellular uptake of PCN-224 nanoparticles, PDT 
efficacy of the five size fractions, each at 20 µM, were tested for HeLa cells under 
irradiation at Soret band (420 nm). Among these five fractions, 90 nm-PCN-224 showed 
the best PDT efficacy of 81%, while 190 nm-PCN-224 gave the lowest efficacy of 49% 
in agreement with the results of cellular uptake (Figure 6.6d). Markedly, free 
photosensitizer (TCPP linker only) showed only 47% in PDT efficacy at the same 
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concentration, which further confirms our hypothesis that MOF nanoparticle formulation 
and the size screening can optimize the performance of the given photosensitizer. 
Interestingly, the PDT efficacy does not show much correlation with the number of 
nanoparticles inside the cells where we converted Zr content to the number of particles 
(Table 6.6). Rather, 90 nm-PCN-224 with a moderate number of particles internalized 
shows the greatest PDT efficacy as a result of the highest Zr/TCPP uptake (Figure 6.6d) 
while showing no evident toxicity of the material itself even at high concentration after 48 
h incubation (viability of ∼90% at 100 µM) (Figure 6.6b). These results clearly show a 
strong correlation between PDT efficacy and the TCPP concentration in the cells, rather 
than the number of particles. Such correlation, therefore, indicates that TCPP linkers in 
PCN-224 nanoparticles are fully utilized regardless of the particle size, as are small 
molecules, resulting from the 3D nanoporous structure of PCN-224 while preference for 
internalization was determined by the size of MOF nanoparticle. It is important to note 
that these results address the need for insights in the design/selection of MOFs, because 
the density of desired function in the framework is proportional to the size, while the size 
parameter is another determinant for optimizing the dynamics between materials and cells. 
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Figure 6.7 (left) Singlet oxygen generation of 90 nm-PCN-224 under 420 nm and 630 nm 
light irradiation. (right) Size-dependent in vitro PDT efficacy of PCN-224 nanoparticles 
in HeLa cells upon 420 nm (blue bars) and 630 nm (red bars) irradiation, respectively. 
Concentration = 20 µM. Incubation time = 24 h. Irradiation time = 30 min. (mean ± s.d., 
N = 3) 
 
 Because TCPP can absorb the light at Q bands other than its Soret band, we further 
investigated the PDT efficacy of the size optimized PCN-224 nanoparticles (90 nm) under 
irradiation at 630 nm, which would provide better tissue penetration in practice. Although 
the irradiation at 420 nm showed slightly better 1O2 generation than at 630 nm due to the 
strong absorption of the Soret band in singlet oxygen generation study, PDT efficacy of 
90 nm PCN-224 under 630 nm irradiation could reach as high as ∼80%, which is almost 
the same as the efficacy under 420 nm irradiation (Figure 6.6c). Presumably due to the 
highly dense assembly of TCPP in PCN-224, while the framework prevents the 
aggregation of photosensitizers, O2 molecules in cells might have sufficient contact with 
surrounding photosensitizers. Consequently, the weaker absorption of TCPP at 630 nm 
irradiation may be compensated by sufficient interaction between O2 and photosensitizers 
inside of PCN-224 nanoparticles, resulting in similar efficacy (Figure 6.7). In addition, the 
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subcellular localization of PCN-224 in HeLa cells was confirmed with fluorescent 
staining. Notably, the red fluorescence of PCN-224 matches well with the green 
fluorescence from Lyso Tracker and Mito Tracker, while showing negligible overlap 
between PCN-224 and nucleus, indicating the PCN-224 nanoparticles are mostly localized 
in the cytoplasm (Figure 6.8). 
 
 
Figure 6.8 Subcellular localization of PCN-224 nanoparticles by staining with organelle 
markers, Hoechst 33342, Lyso Tracker, and Mito Tracker green. 
 
Active targeting: folic acid modification on PCN-224 nanoparticles 
 Folate is a commonly used ligand for targeting folate receptor (FAR) abundant 
tumor cells, including ovarian tumors, to enhance the delivery of 
nanoparticles/drugs.251,252 Therefore, we further sought to build an active targeting 
modality in our platform through postsynthetic folic acid (FA) modification on the surface 
of 90 nm-PCN-224. Because there are available binding sites on the Zr6 cluster in PCN-
224, the carboxylate end of folate could be attached to Zr6 clusters by coordination (Figure 
  151 
6.9a).253 However, as previous results suggest that the size of nanoparticles will also affect 
the uptake, the degree of FA functionalization was designed to bear a minimal size 
expansion to prepare comparable sizes. A series of FA modified 90 nm-PCN-224 was 
prepared by reaction with different stoichiometries of 1/8, 1/4, and 1/2 equiv of FA to the 
available Zr binding sites. The size of samples was confirmed by TEM and DLS, which 
showed the modification extent, not involving drastic changes in size and surface charge 
(Table 6.7). Also, the characteristic absorption band of FA confirmed the different degree 
of FA functionalization as well as quantification of actual FA loading of each sample 
(Table 6.8). 1O2 generating ability of PCN-224 nanoparticles after the FA modification 
remains almost the same as pristine PCN-224 nanoparticles, providing a good control to 
evaluate the influence of FA modification. In order to test the active targeting upon FA 
modification, the PDT efficacy of samples was tested with HeLa cells, known for FAR  
abundant cell line.254 As a result, 1/4FA-PCN-224 showed the most potency: more than 
90% of PDT efficacy, which is an enhancement from unmodified PCN-224 under the same 
condition (Figure 6.9b). Although any degree of FA modification provided an 
enhancement from the unmodified sample, the lesser enhancement from 1/8FA-PCN-224 
may result from insufficient FA density than that of 1/4FA-PCN-224, whereas 1/2FA-
PCN-224 showed the least enhancement perhaps due to the size expansion (Figure 6.9b). 
Overall, this improvement in PDT efficacy shows the great potential of this system of 
which the maximization of the desired function can be achieved through optimizations of 
both physical and chemical properties of the MOF nanoplatform. 
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Table 6.7 Physiochemical properties of FA modified PCN-224 nanoparticles with varying 
loading ratios. 
FA/PCN-224 TEM (nm) Dh (nm) PDI ζ potential (mV) 
0 91 ± 8 137 ± 2 0.053 20.3±4.69 
1/8FA 98 ± 8 143 ± 2 0.091 17.0±4.23 
1/4FA 102 ± 10 156 ± 1 0.213 19.2±4.99 
1/2FA 110 ± 11 175 ± 4 0.178 16.6±3.90 
 
 
 
Table 6.8 Quantification of actual folate loadings on 90 nm-PCN-224 sample (10 µM). 
Based on the chemical formula of PCN-224, each TCPP linker corresponds to four Zr 
atoms. As the concentration of our material (Cpcn) is based on TCPP, the concentration of 
Zr will be 4хCpcn. Since each Zr6 contains 6 available positions for the further coordination 
of carboxylate, ideally each Zr atom corresponds to one folic acid if full occupation of the 
available coordination sites on Zr6 cluster were assumed.  
FA/Zr 
stoichiometry 
FA Concentration (µM) Actual FA/Zr 
ratio (Cl /4Cpcn) Initial (Ci) 
Supernatant 
(Cs) 
Loaded 
(Cl = Ci - Cs) 
0 0 0 0 0 
1/8 5 3.80 1.20 ~3/100 
1/4 10 7.61 2.39 ~3/50 
1/2 20 16.02 3.98 ~1/10 
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Figure 6.9 In vitro PDT study of FA functionalized 90 nm-PCN-224. (a) Scheme of FA 
functionalized PCN-224 nanoparticle and proposed internalization. (b) In vitro PDT 
efficacy of FA functionalized (FA equivalent of 0, 1/8, 1/4, 1/2) 90 nm-PCN-224 at 
various concentrations in HeLa cells. Irradiation at 420 nm for 30 min for PDT. (c) ICP 
analysis of cellular uptake of unfunctionalized and FA functionalized 90 nm-PCN-224 at 
various concentrations in HeLa and A549 cells. Incubation time =24 h. (d,e) Comparison 
of in vitro PDT efficacy of pristine PCN-224 and 1/4FA-PCN-224 in (d) HeLa cells and 
(e) A549 cells. (f) CLSM images of HeLa and A549 cells incubated with pristine PCN-
224 and 1/4FA-PCN-224 samples. Red channel images were obtained from pristine or FA 
functionalized PCN-224. The blue channel images were obtained from Hoechst 33342 
(nucleus). Concentration =20 µM. Incubation time =60 min. Scale bars =20 µm. (g) CLSM 
images of HeLa cells without any treatment (top row); treated with 1/4FA-PCN-224 
(middle row); coincubated with excess amount of free FA (1 mM) and 1/4FA-PCN-224 
(bottom row). Concentration =20 µM. Incubation time =60 min. Scale bars =20 µm. Data 
are means ± s.d. (N = 3). 
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 To further confirm the effect of active targeting, both FA modified and unmodified 
90 nm-PCN-224 were applied to FAR-negative cell line, A549 as a control experiment. 
Interestingly, FA functionalized PCN-224 showed no apparent advantages over 
unmodified nanoparticles both in uptake and ensuing PDT efficacy, rather it showed even 
less merit (Figure 6.9c,e). Likely due to different size preferences for permeability of the 
particles in A549 cells, a slight increase in size of PCN-224 upon FA modification showed 
rather negative impacts on the uptake in FAR negative A549 cells (Figure 6.9c–f). In 
parallel, a competition assay was implemented with 1/4FA-PCN-224 in the presence of 
an excess amount of free FA as a competing ligand for folate receptor.255 Indeed, HeLa 
cells treated with the excess free FA (1 mM) showed much weaker fluorescence in 
confocal microscopy images, indicating functionalized FA on the MOF was involved in 
the uptake event through receptor-mediated endocytosis (Figure 6.9g). 
6.4 Conclusions 
 Through thermodynamic analysis, the size of PCN-224 nanoparticles was 
successfully tuned to a range that is of interest to biological studies (30–190 nm). Our 
hypothesis is successfully proved by preferential cellular uptake of 90 nm-PCN-224 and 
its remarkable PDT efficacy over other sizes, including free TCPP linkers. These results 
clearly demonstrate the fabrication of photosensitizer as MOF nanoparticles followed by 
the optimization of their size parameter indeed play a critical role for improving cellular 
response. Together with our findings in size-controllable synthesis of MOF nanoparticles, 
the PCN-224 nanoplatform demonstrates active targeting modality for further 
enhancement of PDT efficacy, of which the enhancement was obtained by postsynthetic 
  155 
FA modification onto Zr6 cluster. Meanwhile, the potential of theranostic modality was 
demonstrated from the porphyrinic linker in the MOF in cancer cell model. Having 
confirmed the preserved molecular properties of the incorporated linker, invariable to 
MOF sizes, we envision that combination of the synthetic tunability of MOF on the 
molecular scale and its size controllability can create useful tools for specific needs in 
desired applications through chemical, physical, and structural design of MOF 
nanoplatform. 
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7. SUMMARY 
 To tackle some challenges that MOF materials face for broad application, this 
dissertation focused on synthetic methodologies to functionalization of stable MOFs. In 
sections 2 and 3, the strategies of designed functional linker exchange and/or dual 
exchange including metal metathesis successfully demonstrated the introduction of 
functionality and enhanced chemical stability in a mesoporous MOF platform. Possible 
rationales in regards to the observations have also been discussed from a thermodynamics 
and kinetics standpoint, providing a useful insight for these findings to be generalized for 
other MOF systems. 
In section 4, a new 3D MOF consisting of 2D porphyrinic layers pillared by 
photochromic molecular switches was synthesized. This mixed linker MOF was 
demonstrated for the control of 1O2 generation via energy transfer by taking advantage of 
the well-defined structure of the MOF in a periodic array. The features of MOFs 
guaranteed high accessibility for substrates, while preventing quenching of dyes, which is 
detrimental for energy transfer. 
However, the classical Zn-based pillar-layer strategy often yields MOFs with weak 
chemical stability and limits adjusting molar ratios of component linkers due to the 
topological incompatibility. To address this issue, the in situ incorporation of multiple 
functionalities in a highly stable Zr-MOF was proposed for the fine-tuning of the energy 
transfer efficiency to control 1O2 generation. This strategy shows great potential for the 
protected delivery of the integrated photosensitizing system as optimized, allowing 
enhanced in vitro PDT efficacy with superior 1O2 controllability upon MOF formulation 
  157 
compared to that of the homogeneous mixture of the dyad. In terms of PDT, however, 
excitation at longer wavelength of light is highly desired. Therefore, future works will be 
directed toward preparing upconversion MOF nanoplatform, where the photosensitizer in 
the MOF can be excited by near infrared irradiation allowing better practicality in cancer 
treatments. 
In summary, the findings and discussion in this dissertation could provide useful 
tools for the rational design of MOFs for use in specific applications while also placing 
these materials at the forefront of interdisciplinary study.  
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